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Abstract 
Bacteria encounter changes in their environment and must adapt to these 
changes in order to survive. Their ability to adapt is determined by their capacity 
to efficiently regulate their cellular processes. The mechanisms of bacterial 
regulation at the transcriptional level have been investigated by structural and 
functional characterisation of the transcription factor AmtR from Mycobacterium 
smegmatis. M. smegmatis is a soil bacteria capable of utilising alternative nitrogen 
sources during nitrogen limitation. AmtR is an important transcription factor that 
regulates the cellular machinery involved in alternative nitrogen metabolism via a 
novel co-repressor induced mode of regulation. A second pathway that involves 
post-transcriptional regulation was investigated by preliminary characterisation of 
a previously unexplored VapBC family of Type II Toxin Antitoxin (TA) systems 
found in the cyanobacteria Microcystis aeruginosa and Synechocystis sp. 
PCC6803 (Synechocystis). Investigation of the biochemistry of M. aeruginosa 
VapBC systems was limited by poor expression, however a single TA system, 
VapBCMAE43230/20, was successfully purified by incorporating the SUMO fusion 
protein into the expression construct. VapBMAE43230 and VapCMAE43220 are co-
expressed and form a tetrameric complex that appears to be copurified with DNA. 
Similar to M. aeruginosa, only one system, VapBCslr1209/1210, in Synechocystis was 
successfully purified and investigated in vitro. Preliminary EMSA assays indicate 
VapBCslr1209/1210 is autoregulatory and binds to the promoter region of its operon 
by recognising palindromic sequences. The RNA pentaprobe system demonstrates 
that VapCslr1210 has metal
 
dependent endoribonuclease activity that can be 
inhibited by VapBslr1209. Markerless deletion strains of five Synechocystis vapBC 
operons were made and growth experiments of three of the deletion strains were 
conducted. Growth experiments identified a reduced growth rate in two of the 
deletion strains (when compared to the WT strains): ΔvapBCslr1209/1210 and 
ΔvapBCssl2138/sll1092. Transcriptomic analyses of both deletion strains were 
conducted. Preliminary data show that both VapBC systems appear to target genes 
involved in carbon assimilation and metabolism via both photosynthetic and 
heterotrophic processes. Interestingly, VapBCslr1209/1210 targets an operon involved 
in glucose transport, which is also the cellular process targeted by the only other 
well characterised VapBC system from M. smegmatis (VapBC1283/4). These 
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preliminary results point toward a possible similarity in biological function for 
VapBC systems across the prokaryotic tree.   
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1 Introduction 
1.1 Prokaryotic Regulation 
Regulation of prokaryotic metabolism in response to the environment is 
essential for bacterial survivial. Regulation is primarily driven by a signal 
transduction pathway that translates changes in environmental conditions via 
signalling molecules to the regulatory systems of the cell to induce a response. 
The regulatory response occurs at three levels: 1) transcription, 2) post-
transcription and 3) post-translation for efficient energy expenditure in response to 
extra- and intra-cellular nutrient status. Regulation at each level is incredibly 
complex and varies greatly depending on both the status and type of nutrient 
source available.  
 
Archetypal regulation of metabolism at the transcription level is caused by 
transcription factors that bind to promoter regions of genes involved in 
metabolism to change their transcription rate in response to nutrient status signals 
in the cell. The signal is typically in the form of a carbon or nitrogen containing 
substrate, or its metabolite, which binds directly to the transcription factor  (or 
another signalling protein that transfers the signal to the transcription factor) to 
induce a transcriptional response (Babu & Teichmann, 2003; Babu, Luscombe, 
Aravind, Gerstein, & Teichmann, 2004; Commichau, Forchhammer, & Stülke, 
2006; Huffman & Brennan, 2002). Archetypal regulation of metabolism at the 
post-translational level is caused by both enzymatic modification and allosteric 
regulation of a protein to induce activation or inactivation (Arcondéguy, Jack, & 
Merrick, 2001; Goodey & Benkovic, 2008; Kamberov, Atkinson, & Ninfa, 1995). 
Enzymes responsible for post-translational modification by enzymatic 
modifcation are known as signalling proteins such as the PII family, and proteins 
or other molecules that function by allosteric regulation are known as effectors 
and activate or inactivate metabolically relevant proteins in response to changes in 
nutrient status (Arcondéguy et al., 2001; Leigh & Dodsworth, 2007).  
 
Metabolism is also fine tuned at the post-transcription level by a number of 
processes that regulate the translation of messenger RNA (mRNA) into proteins in 
response to changes in the environment. The importance of post-transcriptional 
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regulation has become more evident over recent years and there is now 
overwhelming evidence that it plays a much larger role in cellular adaption than 
previously expected (Hammarlöf, Bergman, Garmendia, & Hughes, 2015). The 
process of post-transcriptional regulation is also much more complex than 
previously thought. Small non-coding RNA (sRNA), RNA binding and RNA 
degrading enzymes, collectively referred to as mRNA interferases, are the major 
players of post-transcriptional regulation in prokaryotes (Gottesman, 2005; 
Hammarlöf et al., 2015). A sRNA typically work by binding to its target mRNA 
transcript and modifying its translation by either stabilizing or destabilizing it. The 
sRNA transcript production can be induced or repressed in response to 
environmental changes (Gottesman, 2005; Vanderpool & Gottesman, 2004). 
sRNA can also affect gene expression and even genomic recombination by 
interacting with the relevant enzymatic machinery for these processes, instead of 
the mRNA itself. An example of this is the CRISPR system found in prokaryotes 
that functions as an adaptable immune mechanism to protect cells from foreign 
nucleic acids, such as viruses (Barrangou et al., 2007; Fineran & Charpentier, 
2012).  
 
mRNA interferases  play a critical role in post-transcriptional regulation by 
inhibiting translation of specific mRNA transcripts involved in certain carbon and 
nitrogen metabolic processes in response to changes in the environment.  
Examples include: RNA binding proteins that bind to and change the rate of 
degradation of specific mRNA targets by recruiting other degrading enzymes 
(Liu, Yang, & Romeo, 1995), and RNA endonucleases that bind to and directly 
degrade specific mRNA targets (Bodogai et al., 2006; Hammarlöf et al., 2015; 
Inouye, 2006; McKenzie, et al., 2012b; Romeo, 1996).  
 
Integrated regulation of carbon and nitrogen metabolism is essential in 
order for organisms to function efficiently and balance their nutrient status and 
energy utilisation in the cell.  For regulation to be effective, bacteria must be able 
to fine tune metabolism by modulating processes at the multiple levels of gene 
expression in response to rapid changes in the environment. Prokaryotic carbon 
and nitrogen metabolism both have unique modes of regulation. Below are 
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examples of the most well understood regulatory mechanisms present in 
prokaryotes. 
 
1.1.1 Regulation of Carbon Metabolism 
For efficient utilisation of carbon to occur the processes of carbon uptake, 
assimilation and metabolism must be tightly controlled. The best example of this 
is carbon catabolite repression (CCR), a phenomenon found in all prokaryotes and 
considered the paradigm of cellular regulation (Deutscher, 2008). CCR is the best 
studied example of a signal transduction pathway that occurs when bacteria are 
exposed to multiple carbon sources and prioritise the uptake and metabolism of 
only one (Deutscher, 2008; Saier, 1998). CCR is conserved in all prokaryotes and 
several different mechanisms have evolved to carry out the process; however, 
each mechanism involves components of the phosphoenolpyruvate:carbohydrate 
phosphotransferase system (PTS) and protein phoshophorylation (Deutscher, 
2008; Postma, Lengeler, & Jacobson, 1993; Saier, 1998).  
 
The PTS is responsible for the regulation of importing and 
phosphorylating sugars. Glucose is the most energy efficient carbon source for 
prokaryotes and glucose levels in the cell determine the phosphorylated state of 
the PTS. Each phosphorylated state of the PTS interacts with a different metabolic 
component of the cell to affect carbon assimilation and catabolism. High intra-
cellular glucose levels induce an un-phosphorylated state of the PTS. This process 
is also called inducer exclusion, and is considered to be a major CCR mechanism, 
where the uptake of the favourable carbon substrate, generally glucose, directly 
alters the state of the PTS system, which results in the inhibition of other carbon 
transporters (Deutscher, 2008) (Figure 1.1). This results in the bacteria investing 
energy only into the transport of the most suitable carbon source for metabolism.  
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Figure 1.1. Mechanism underlying inducer exclusion in enteric bacteria. The 
transport of glucose into the cell results in the phosphorylation of glucose and net 
dephosphorylation of the PTS proteins (EIIBC and EIIA) and inducer exclusion. 
The dephosphorylated EIIAGlc blocks the import of other sugars (e.g. lactose, 
maltose and galactose) by binding to the corresponding transporter or kinase to 
inactivate it. Figure from Bowden et al. (2009). 
 
The PTS also directly interacts with global transcription factors to induce a 
change in expression of multiple cohorts of genes involved in carbon metabolism. 
A well-known example is the CRP/cAMP mediated regulation of gene expression. 
The un-phosphorylated state of the PTS system, which is a result of increased 
intracellular glucose, represses the expression of cAMP synthesising enzymes 
resulting in reduced levels of both cAMP and the cAMP receptor protein (CRP) 
(Figure 1.2). CRP is a global transcription factor that controls the transcription of 
many catabolic genes involved in glucose uptake and alternative carbon 
metabolism, and cAMP is its co-factor. De-phosphorylation of the PTS results in 
the repression of these processes to reduce wastage of cellular energy when 
sufficient glucose is present in the cell (Deutscher, 2008; Ishizuka, Hanamura, 
Inada, & Aiba, 1994). This is a common regulatory mechanism in prokaryotes 
that allows for a fast global physiological response to changes in nutrient status. 
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Figure 1.2. Carbon catabolite 
repression (CCR) in E. coli. 
When phosphorylated, the PTS 
(EIIAGlc-p) binds and activates 
adenylate cyclase (AC), which 
leads to cyclic AMP (cAMP) 
synthesis. High cAMP 
concentrations trigger the 
formation of cAMP–CRP 
complexes, which bind and 
activate the promoters of 
catabolic genes. In its de - 
phosphorylated form the PTS 
(EIIAGlc) cannot activate AC and 
the catabolic genes are repressed. 
Figure from Gorke & Stulke 
(2008). 
 
 
 Another mechanism of CCR involves the global carbon transcription 
factor catabolite repressor-activator (Cra). Cra regulates genes in the PTS system, 
as well as genes involved in carbon uptake, assimilation and metabolism, that 
function independent of the PTS system (Ramseier, 1995). Cra functions by both 
inhibiting and activating the expression of different cohorts of its regulon via 
binding different carbon metabolites as signalling molecules. It can 
simultaneously inhibit a cohort of genes, while inducing another in response to a 
range of different intracellular carbon source levels (Ramseier, 1995; Saier, 1998).  
 
Recent work has revealed that several key enzymes in central carbohydrate 
metabolic pathways are controlled at the post-transcriptional level (Hammarlöf et 
al., 2015; Liu et al., 1995; McKenzie, et al., 2012b; Romeo, 1996). For example, 
the carbon storage regulator protein (CsrA), responsible for the regulation of 
glycogen biosynthesis, negatively regulates the expression of the genes 
responsible for this process during exponential growth. CsrA acts as an mRNA 
interferase and represses the expression of its regulon by binding to mRNA 
transcripts, which accelerates degradation and inhibits translation (Liu et al., 
1995). CsrA has also been shown to simultaneously activate glycolysis during 
exponential phase, and, as a result, is suggested to be an important player in 
appropriately directing the intracellular carbon flux (Liu et al., 1995; Romeo, 
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1996). Additionally, research into an mRNA interferase Virulence associated 
protein (VapC1284) from Mycobacterium smegmatis belonging to the Type II 
toxin-antitoxin (TA) protein family was characterised as a post-transcriptional 
regulator of carbon metabolism. VapC1284 selectively binds and degrades mRNA 
transcripts involved in carbon uptake and metabolism in response to 
environmental changes (McKenzie, et al., 2012b).  
 
For efficient energy expenditure and rapid response to environmental 
conditions prokaryotic regulation of carbon metabolism occurs at both the 
transcription and post transcription stages of gene expression. Transcriptional 
regulation in the form of CCR is present in all bacteria and is an integral 
component of regulating carbon metabolism, allowing bacteria to selectively 
transport and metabolise optimal carbon sources available in their environment 
(Deutscher, 2008). An additional layer of regulation is observed by the mRNA 
interferases that allow rapid re-generation of the mRNA transcript pool in 
response to changing nutrient signals. These examples illustrate only a subset of 
processes present in bacteria that regulate carbon metabolism; however, they do 
provide a good example of the diversity of mechanisms available and the 
sophistication involved at each level of regulation.  
 
1.1.2 Regulation of Nitrogen Metabolism 
Nitrogen regulatory mechanisms vary significantly across the phylogenetic 
spectrum of prokaryotes. However, in most prokaryotes, nitrogen metabolism is 
regulated using a similar signal transduction pathway as with CCR in carbon 
metabolism. This process is mediated by signal transduction proteins that belong 
to one of the most conserved protein families in prokaryotes: the PII superfamily 
(Arcondéguy et al., 2001; Leigh & Dodsworth, 2007). Examples of PII protein 
include GlnB, GlnK, NifI1 and NifI2. A principle characteristic of PII proteins is 
their ability to be switched between two forms by covalent modification when a 
conserved tyrosine residue in the T-loop of the structure is uridylylated or 
adenylylated (Arcondéguy et al., 2001; Williams, Bennett, Barton, Jenkins, & 
Robertson, 2013). The covalent state of the protein is determined by the 
intracellular nitrogen status, and results in inactivation or activation of the PII 
protein (Arcondéguy et al., 2001; Kamberov et al., 1995). Activated PII proteins 
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function to post-translationally modify other proteins involved in nitrogen 
metabolism, including 1) enzymatic proteins, resulting in inactivation or 
activation of specific nitrogen metabolic processes, and 2) transcription factors to 
induce changes in the expression of the genes encoding proteins involved in 
nitrogen metabolism (Arcondéguy et al., 2001; Leigh & Dodsworth, 2007).  
 
One well-studied example is the role of PII proteins in the regulation of 
ammonia assimilation. Ammonia is the least energy expensive nitrogen source for 
prokaryotes, and all other nitrogen sources have to be converted to this to be 
metabolically useable, at a cost to the organism (Arcondéguy et al., 2001; Leigh & 
Dodsworth, 2007). As a consequence, prokaryotic regulation of nitrogen 
metabolism is driven by ammonia availability and assimilation. In most 
prokaryotes, the major mechanism of ammonia assimilation is the glutamine 
synthetase (GS)/glutamate synthase (glutamine:2-oxoglutarate aminotransferase 
or GOGAT) pathway (Arcondéguy et al., 2001; Nolden, Farwick, Kramer, & 
Burkovski, 2001a). The GS/GOGAT pathway is ubiquitous in bacteria and is 
responsible for converting glutamate to glutamine. GOGAT then transfers the 
amido group of glutamine to 2-oxoglutarate (2OG) (the precursor of ammonia 
assimilation).  
 
GS is highly regulated at both the transcriptional and post-transcriptional 
level. It can be reversibly modified by adenylylation at a conserved tyrosine 
residue, which alters its enzymatic activity in response to nitrogen availability 
(Arcondéguy et al., 2001) (Figure 1.3). GS is adenylylated under an increase of 
nitrogen, which results in its inactivation. This modification is controlled by the 
PII proteins GlnB and GlnK (Adler, Purich, & Stadtman, 1975; Arcondéguy et al., 
2001). It is proposed that the physiological significance of this in-activation 
during nitrogen surplus is to prevent ATP and glutamate depletion, allowing rapid 
growth during favourable growth conditions (Kustu, Hirschman, Burton, Jelesko, 
& Meeks, 1984).  
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Figure 1.3. Regulation of glutamine synthetase (GS) by PII mediated post-
translational adenylylation. The activity of GS is regulated by the bifunctional 
enzyme GS-AT, which in turn is controlled by the regulatory protein PII. PII is 
subject to uridylylation (PII-UMP3) and deuridylylation (PII), and binds to GS-AT 
in both the modified and unmodified states with opposing effects on the activities 
of the enzyme. PII-UMP3 activates the AR activity of GS-AT but inhibits its 
adenylyl transferase activity, thus leading to activation of GS via deadenylylation. 
Conversely, in the de-uridylylated state, PII inhibits the deadenylation or removase 
activity of GS-AT and stimulates the adenylylation activity towards GS, thereby 
inhibiting GS. Green and red arrows indicate stimulatory and inhibitory steps in 
the regulation of GS, respectively. Figure from Itzen, Blankenfeldt, & Goody 
(2011). 
 
Similar to carbon metabolism, activation and repression of nitrogen-
regulated genes in bacteria is coordinated by the action of global transcription 
factors. A well studied example is the global nitrogen regulatory (NtrBC) system 
present in enteric bacteria (Keener & Kustu, 1988). The transcription factor NtrC 
is phosphorylated in response to low nitrogen availability, which results in its 
activation and subsequent upregulation of its regulon (Figure 1.4) (Austin & 
Dixon, 1992; Kern et al., 1999). The phosphorylation of NtrC is dependent on the 
PII proteins GlnB and GlnK (Arcondéguy et al., 2001; Atkinson & Ninfa, 1998; 
Kamberov et al., 1995). GlnB and GlnK are post-translationally modified in 
response to nitrogen starvation, which provides an intracellular switch that in turn 
activates a signal transduction cascade that results in the phosphorylation of NtrC 
(Arcondéguy et al., 2001; Kamberov et al., 1995). The result is the induced 
expression of the genes in the NtrC regulon, which encode for ammonium 
transport and assimilation, alternative nitrogen uptake and metabolism, and 
nitrogen fixation (Arcondéguy et al., 2001; Atkinson & Ninfa, 1998; Claverie-
Martin & Magasanik, 1991; Schneider, Kiupakis, & Reitzer, 1998).  In bacteria 
that do not have an NtrC system, such as the firmicutes and some actinobacteria, 
the global transcription factors GlnR, TnR and AmtR function as the major PII 
mediated nitrogen-limiting response players (Arcondéguy et al., 2001; Jakoby, 
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Nolden, Meier-Wagner, Kramer, & Burkovski, 2000; Schreier, Brown, Hirschi, 
Nomellini, & Sonenshein, 1989; Tiffert et al., 2008). 
 
Figure 1.4. The PII mediated two component NtrBC system of enteric 
bacteria. Under nitrogen limiting conditions the PII proteins phosphorylate the 
NtrB (NtrB-P) kinase, which subsequently phosphorylates NtrC (NtrC-P). NtrC-P 
is activated and binds to promoter regions upstream of the genes in its regulon to 
induce expression. The induced expression is referred to as the Ntr response and 
involves genes that encode proteins involved in alternative nitrogen transport and 
metabolism. Figure from Brown et al. (2014).  
 
 PII signalling proteins play a pivotal role in nitrogen metabolism by acting 
as an intra cellular switch that allows a global response within the cell at both the 
transcriptional and post-transcriptional level. The PII proteins post-translationally 
modify global transcription factors, like NtrC, to induce a transcriptional response 
of genes encoding nitrogen related processes. They also post-translationally 
modify critical nitrogen metabolic enzymes, like GS, to activate or inactive them 
in response to changes in nitrogen availability. 
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1.2 Transcriptional Regulation 
Transcription factors are ultimately responsible for inducing the 
transcriptional response to changes in nutrient status provided by signal 
transduction pathways. Transcription factors regulate the transcription of genes 
into mRNA transcripts that are then translated into proteins. They are generally 
homodimeric proteins that contain two domains in each monomer: a DNA binding 
motif and a regulatory domain. There is an extraordinary diversity and abundance 
of transcription factors that span the prokaryotic kingdom, with over 30 different 
superfamilies as defined by their type of DNA binding motif (Huffman & 
Brennan, 2002; Wilson, Charoensawan, Kummerfeld, & Teichmann, 2007).  
 
Transcription factors function by binding to specific DNA sequences in 
the promoter regions of genomic DNA that encode proteins (Huffman & Brennan, 
2002). Binding of the transcription factor to DNA is generally dictated by the 
presence or absence of a signalling molecule or protein. Transcription factors can 
either activate or repress transcription, or both. Previously, it was assumed that the 
DNA binding motif family and its structural location (i.e. C-terminal or N-
terminal) was indicative of a transcription factor’s regulatory function. However, 
it is now suggested that the regulatory function is dictated by the position of its 
binding site on DNA (Babu & Teichmann, 2003).  
 
Generally, activator transcription factors bind upstream of the transcription 
start site and repressors can bind both upstream and downstream of the 
transcription start site. Dual regulators have equal ratios of binding sites upstream 
and downstream of the transcription start site (Babu & Teichmann, 2003). 
Transcription factors binding at upstream sites function to stabilise RNA 
polymerase, the enzyme responsible for transcribing DNA into RNA. Repressor 
transcription factors that bind upstream generally function by recruiting other 
repressor proteins to downstream sites. Transcription factors that bind at 
downstream sites inhibit RNA polymerase activity by steric hindrance.  However, 
there is a diverse range of activation and inhibition mechanisms including DNA 
structure alteration and unwinding, protein-molecule interaction and protein-
protein interactions making transcription factor regulation a very complex process 
to generalise (Babu & Teichmann, 2003; Huffman & Brennan, 2002). This section 
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will focus on transcription factors that are major players of nitrogen regulation in 
actinomycetes, as this is a large focal point of the research presented in this thesis. 
 
1.2.1 GlnR Transcription Factor Protein Family 
GlnR is a global response regulator that belongs to the OmpR transcription 
factor family. Information from X-ray crystallography structures and experimental 
work has shown that GlnR functions as a homodimer, where each monomer is 
made of a regulatory domain and a DNA binding domain (Figure 1.5) (Ling et al., 
2015; Tiffert et al., 2008).  
 
Figure 1.5. X-ray crystal structure ribbon diagram of Amycolatopsis 
mediterranei GlnR. The two molecules constituting the homodimer are coloured 
in yellow and cyan. The dimer interface is shown in magenta. Figure from Lin et 
al. (2014). 
 
GlnR is present in several members of the actinomycetes phylum that do 
not contain a NtrBC system including Streptomyces coelicolor, S. avermitilis, M. 
smegmatis and many pathogenic mycobacteria. GlnR controls over 100 genes, 
with over 25 % of genes encoding ammonium uptake and assimilation, alternative 
nitrogen metabolism, and PII proteins (Amon et al., 2008; Fink, Weissschuh, 
Reuther, Wohlleben, & Engels, 2002; Jenkins, Barton, Robertson, & Williams, 
2013; Jenkins, Robertson, & Williams, 2012; Jessberger et al., 2012). The regulon 
also contains a number of genes encoding enzymes that are predicted to be 
involved in several processes that generate ammonium from urea, suggesting that 
urea is an important alternative nitrogen source for bacteria in this phylum 
(Jenkins et al., 2012). The GlnR DNA binding motif has been identified (AC/T-
Chapter One 
 
12 
 
n9-AC), which is present in every known GlnR binding site (Figure 1.6) (Jenkins 
et al., 2013).  
 
Figure 1.6. GlnR consensus binding motif derived from the GlnR binding 
regions. The height of letters represents the frequency of corresponding 
nucleotides in the GlnR binding site.  Figure from Jenkins et al. (2013). 
 
Activation of GlnR is induced upon nitrogen limitation, however the signal 
that stimulates GlnR to activate the transcription of its regulon is still unknown 
(Amon et al., 2008; Jenkins et al., 2013; Jessberger et al., 2012; Tiffert et al., 
2008). OmpR proteins are characterised as two-component response regulators 
that are activated by post-translational phosphorylation of a conserved amino acid 
residue, similar to the NtrBC system (Amon et al., 2008; Kenney, 2002). 
Conservation of the putative GlnR phosphorylation site is essential in the 
transcriptomic response to nitrogen limitation (Jenkins et al., 2012), however, no 
corresponding kinase has yet been identified (Amon et al., 2008). Metabolic foot-
printing of M. smegmatis has revealed an increased intracellular ratio of 2-
OG:glutamine/glutamate, as well as intracellular levels of a sugar derived 
compound called glucosylglycerate (GGA) during nitrogen limitation. It is 
suggested that 2-OG and GGA could be the nitrogen limitation signal that 
stimulates GlnR to activate transcription of its regulon (Behrends, Williams, 
Jenkins, Robertson, & Bundy, 2012).  
 
GlnR is an example of a transcription factor that functions as a global 
regulator of nitrogen metabolism in several members of the actinomycetes 
phylum, however not all of the genes involved in nitrogen metabolism in these 
organisms are under the control of GlnR. One explanation for this is that there is a 
secondary nitrogen regulator. In fact, there is strong evidence that the TetR-type 
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transcription regulator AmtR plays a secondary role in mycobacteria nitrogen 
regulation (Amon et al., 2008). 
 
1.2.2 The TetR Transcription Factor Protein Family 
The tetracycline repressors (TetR) are one of the most abundant, widely 
distributed and understood transcription factor families. The TetR protein family 
is classified by the original TetR protein, which regulates the tet genes using 
tetracycline and magnesium as the signalling molecule. The tet genes encode 
proteins that impart tetracycline resistance. TetR forms a homodimer with each 
monomer composed of 10 α-helics that form a N-terminal helix turn helix (HTH) 
motif DNA binding domain (DBD) and a large C-terminal ligand binding domain 
(LBD) (Ramos et al., 2005) (Figure 1.7). The LBD is also responsible for 
dimerization of the protein.  
 
Figure 1.7. X-ray crystal structures of TetR. Overlay of DNA-bound (pink) and 
magnesium-tetracycline-bound (grey). Magnesium tetracycline (Mg
2+
-Tet) atoms 
are shown as spheres and DNA is represented as a ball-and-stick model. PDB co-
ordinates for DNA-bound structure from Orth et al. (2000) (PDB ID 1QPI) and 
Mg
2+
-Tet structure from Kisker et al. (1995) (PDB ID 2TRT). Figure was drawn 
using PyMol (Delano, 2002). 
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Members of the TetR family show conservation in the DNA binding motif 
and little to no conservation in the regulatory domain. This is likely to reflect the 
diversity of different signalling molecules recognised in the regulatory domains 
and hence variations in functionality (Ramos et al., 2005). The X-ray crystal 
structures of TetR unbound, bound to tetracycline and bound to DNA have been 
solved (Hinrichs et al., 1994; Kisker, Hinrichs, Tovar, Hillen, & Saenger, 1995; 
Orth et al., 1998; Orth, Schnappinger, Hillen, Saenger, & Hinrichs, 2000). 
Comparative analyses of the structures have revealed insight into the specificity 
and function of TetR. The structures show that the DNA binding motif 
exclusively binds to the major groove of a palindromic DNA sequence, however 
there is no major groove interaction at the central base pair (Figure 1.7). This 
suggests that the spacing, rather than the sequence, within the two half sites of 
recognition is critical for recognition and binding (Huffman & Brennan, 2002). 
Binding of TetR to DNA is disrupted by binding of tetracycline into the LBD. 
This induces a conformational change that results in the DBD rotating via a 
pendulum motion so that the two recognition helices are separated, disrupting the 
contact with DNA (Huffman & Brennan, 2002). 
  
The regulatory functions of members of the TetR transcription factor 
superfamily includes multidrug resistance, global regulation, catabolism, nitrogen 
metabolism, antibiotic biosynthesis, osmotic stress and pathogenicity (Ramos et 
al., 2005). All known members of the family function as repressors and most have 
the same mechanism of protein-DNA interaction disruption by a signalling 
molecule binding to the regulatory region (Ramos et al., 2005). TetR transcription 
factors are particularly abundant in organisms living in fluctuating environments, 
pathogenic bacteria and extremophiles, for example Corynebacterium, 
Mycobacterium, and Deinococcus (Ramos et al., 2005). Considering the diversity 
in function and high representation in organisms subjected to either fluctuating or 
extreme environments, it has been suggested that TetR proteins play a critical role 
in metabolic adaptation.  
 
1.2.2.1 AmtR Transcription Factor Protein Family 
AmtR belongs to the TetR protein family and, like other TetR transcription 
factors, it is found in a range of bacteria that are exposed to fluctuating 
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environments and is recognised as a global nitrogen regulator (Williams et al., 
2013). The role of AmtR in this diverse range of bacteria is not well understood, 
however it has been extensively investigated in the soil actinomycetes 
Corynebacteria glutamicum. C. glutamicum is utilized industrially for its ability to 
synthesise high yields of extra cellular amino acids. Amino acid production is 
entirely dependent on nitrogen metabolism, and, as a result, nitrogen metabolism 
of C. glutamicum is now well understood.   
 
C. glutamicum does not have an NtrBC system and instead the AmtR 
transcription factor functions as the global response regulator to nitrogen 
limitation (Burkovski, 2003; Jakoby et al., 2000; Nolden et al., 2001a). The AmtR 
regulon includes 35 genes that are involved in nitrogen metabolism which are 
repressed under nitrogen sufficient conditions. The repression is lifted by direct 
interaction with the adenylylated form of the PII protein GlnK, a nitrogen 
assimilation regulatory protein, which is only present under nitrogen limiting 
conditions (Figure 1.8) (Beckers et al., 2005; Buchinger et al., 2009; Muhl et al., 
2009; Nolden, Ngouoto-Nkili, Bendt, Kramer, & Burkovski, 2001b; Strosser, 
Ludke, Schaffer, Kramer, & Burkovski, 2004).  
 
Figure 1.8. Analysis of AmtR-GlnK interaction by native gel electrophoresis. 
C. glutamicum GlnK overexpressing cell cultures were grown in either nitrogen 
surplus (+N) or nitrogen limiting (-N) conditions. As a result, Glnk was present in 
either its unmodified (GlnK) or adenylylated form (GlnK-AMP), respectively. 
Fractions of these cells were subjected to native polyacrylamide gel 
electrophoresis, either in the absence (left panel) or presence (right panel) of 
purified AmtR. Cell extracts containing GlnK-AMP resulted in a shift of AmtR 
motility. Figure from Beckers et al. (2005). 
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The AmtR-DNA binding motif is defined as a semi palindromic sequence 
of tttCTATN6AtAGat/aA (with bases represented by capital letters being highly 
conserved) found on both the sense or antisense strand of the promoter region 
(Figure 1.9) (Beckers et al., 2005; Muhl et al., 2009). AmtR-DNA binding has 
been demonstrated both in vitro, and, in some cases, in vivo with a co-factor 
independent binding mechanism (Beckers et al., 2005; Jakoby et al., 2000; Muhl 
et al., 2009). It is assumed that the number of upstream binding sites and 
conservation of the binding motif determines the strength of repression.  
 
Figure 1.9. The AmtR box of C. glutamicum. The AmtR binding motif was 
established based on the binding sites predicted by bioinformatics analyses, which 
were verified by RNA hybridization analyses, real-time RT qPCR and gel 
retardation tests. The height of letters represents the frequency of corresponding 
nucleotides in the AmtR box. Figure from Beckers et al. (2005). 
 
The AmtR regulon is composed of genes that encode proteins that respond 
to nitrogen limitation including ammonia uptake and assimilation, alternative 
nitrogen uptake and metabolism, and the master nitrogen signalling PII protein 
GlnK, showing indirect autoregulation (Beckers, Bendt, Kramer, & Burkovski, 
2004; Beckers, Nolden, & Burkovski, 2001; Bendt, Beckers, Silberbach, 
Wittmann, & Burkovski, 2004; Jakoby et al., 2000; Muhl et al., 2009; Nolden et 
al., 2001a).  This system of nitrogen regulation has only been observed in C. 
glutamicum and introduces a new player, at the level of transcription, to the 
intricate network of prokaryotic nitrogen regulation.  
 
S. avermitilis and M. smegmatis are both members of the actinomycetes that 
do not have a NtrBC system and instead contain both GlnR and AmtR. In S. 
avermitilis the GlnR is suggested to work as a crucial nitrogen regulator, although 
functional studies have not confirmed this (Chen, Zhu, Zheng, Jiang, & Lu, 2013). 
The AmtR has been identified as a regulator involved in alternative urea 
metabolism and amino acid transport, suggesting that it plays an important role in 
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nitrogen metabolism (Chen et al., 2013). In M. smegmatis, GlnR has been 
identified as an important nitrogen regulator with its regulon containing the genes 
responsible for ammonia uptake, assimilation and signal transduction PII proteins, 
as mentioned earlier. Although GlnR has been identified as an important nitrogen 
regulator in mycobacteria, it has also been shown that a number of genes that 
encode for critical proteins required in response to nitrogen limitation are not 
under the control of GlnR. The regulation of these genes is poorly understood and 
it has been suggested that these genes are under control of AmtR (Amon et al., 
2008).  
 
Using the C. glutamicum AmtR DNA binding motif, a bioinformatics 
analysis of the M. smegmatis genome was conducted to identify putative genes 
under the control of AmtR, however, none were found (Amon et al., 2008). 
Further bioinformatic analyses were conducted to characterise the AmtR regulon 
using a different approach (Jessberger et al., 2012). The search criteria for a gene 
under putative AmtR control were based on the degree of (I) co-occurrence and 
co-localization with the amtR gene and (II) involvement in nitrogen metabolism. 
Interestingly, the genes identified were homologous to the genes in the AmtR 
regulon of S. avermitilis (Chen et al., 2013; Jessberger et al., 2012). The genes 
appear to form an operon based on the co-locolization in the genome and 
simultaneous up regulation in response to nitrogen levels. The operon encodes for 
an amino acid permease, a urea carboxylase and associated proteins and an 
amidases  (Figure 1.10).  
 
Figure 1.10. Genomic map of AmtR regulon in M smegmatis. The arrows 
indicate length and transcriptional orientation of annotated genes. Number in 
square brackets show the lengths of intergenic regions in bp.  The AmtR gene 
(msmeg_4300) is found elsewhere in the genome and does not form part of the 
operon. Figure from Jessberger et al. (2012). 
 
To validate this work, M. smegmatis amtR deletion strains were grown 
under nitrogen limitation and demonstrated the de-regulation of this operon in the 
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absence of AmtR (Jessberger et al., 2012). This work confirmed that the M. 
smegmatis AmtR controls a regulon of genes encoding for alternative nitrogen 
uptake and urea metabolism, which is upregulated in nitrogen limitation. As 
mentioned above, the high prevalence of urea uptake and metabolic genes in M. 
smegmatis suggests that urea is an important alternative nitrogen source (Amon et 
al., 2008). This study shows that AmtR plays a role in regulating this alternative 
metabolism. Co-factor independent binding of AmtR to the promoter region of the 
operon was also confirmed and no tested putative signalling molecules were 
observed to influence binding. The signal to lift repression, like GlnR in 
mycobacteria, is currently unknown. Elucidating the signal for these transcription 
factors is critical to improve our understanding of nitrogen metabolic regulation. 
These initial findings suggest M. smegmatis AmtR has a unique role in nitrogen 
regulation and further investigation into the structure and function of AmtR will 
provide greater understanding of the regulatory mechanisms functioning in 
mycobacteria.   
 
1.3 Post-Transcriptional Regulation 
The process of transcription transcribes genetic information from DNA into 
mRNA, which can then be translated into a functional protein. The transcription 
of genes into mRNA is regulated by transcription factors in response to 
environmental signals. Post-transcriptional regulation is the next level of 
regulation, where the translation of mRNA is modulated in response to 
environmental signals by a range of different regulators.  
 
Prokaryotic mRNA is very unstable with half lives on the order of minutes 
(Picard, Dressaire, Girbal, & Cocaign-Bousquet, 2009). The instability of mRNA 
is attributed to the proteins and small non-coding RNA that interact with it and 
determine its fate. Small non-coding RNAs (sRNA) mediate translation by a 
diversity of regulatory mechanisms.  In brief, sRNA binds to RNA recognition 
motifs (RRM) in targeted mRNA transcripts to induce a confirmation change to 
the secondary structure, which can inhibit translation by either increasing the 
degradation rate of the transcript or inhibiting the translational machinery from 
initiating translation (Picard et al., 2009). They can also activate translation by 
stabilising the transcript and recruiting the translational machinery to the ribosome 
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binding site (RBS) (Picard et al., 2009; Vierke, Engelmann, Hebbeln, & Thomm, 
2003). RNA binding and degradation proteins, collectively named mRNA 
interferases, also play a critical role in post-transcriptional regulation.   
 
An interesting protein based regulatory system is the toxin-antitoxin (TA) 
protein system. A number of toxins in the TA systems, such as the Type-II TA 
VapBC protein systems, function as selective mRNA interferases that inhibit 
translation (Inouye, 2006). These systems are well documented as stress-response 
elements and have been shown to specifically target mRNA transcripts involved 
in both carbon and nitrogen metabolism (Bodogai et al., 2006; Inouye, 2006; 
McKenzie, et al., 2012b). The remainder of this section will focus on TA systems, 
as this is the other main focus of the research presented in this thesis. 
 
1.3.1 Toxin-Antitoxin (TA) Protein Systems 
The TA loci were first discovered in 1986 on prokaryotic plasmids and were 
identified as selfish elements that play a role in the prevention of post 
segregational plasmid loss (Gerdes, Rasmussen, & Molin, 1986). TA systems 
have since been found to be highly abundant in the chromosomes of a range of 
prokaryotes, but have very different proposed functions, including fine tuning the 
physiology of the cell in response to environmental cues (Arcus, McKenzie, 
Robson & Cook, 2011; Buts, Lah, Dao-Thi, Wyns, & Loris, 2005; McKenzie, et 
al., 2012b). TA systems are arranged as a bicistronic operon with the gene 
encoding the antitoxin found upstream of gene encoding the toxin, which typically 
overlap by 2-12 bp. Both the toxin and the antitoxin are co-expressed and form a 
complex that is inactive and binds to the promoter region upstream of its own 
operon to allow autoregulation.  
 
There are five types of TA systems classified by the nature and mode of the 
antitoxin, where the toxin is always a protein. In Type I systems, the antitoxin is 
an un-translated, antisense RNA, which is complementary to the toxin mRNA 
(Fozo, Hemm, & Storz, 2008; Gerdes, 2012). It regulates toxin expression by 
inhibiting the toxin’s translation. In Type II systems, the antitoxin is a protein and 
inhibits toxin activity by binding to the toxin, forming an inactive complex 
(Gerdes, Christensen, & Løbner-Olesen, 2005). In Type III systems, the antitoxin 
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is a small, non-antisense RNA molecule that binds to the toxin to inhibit activity 
(Fineran et al., 2009). In Type IV systems, the antitoxin is a protein that competes 
with the toxin for the same binding target (Dy, Przybilski, Semeijn, Salmond, & 
Fineran, 2014; Masuda, Tan, Awano, Wu, & Inouye, 2012). In Type V systems, 
the antitoxin protein cleaves the toxin encoding mRNA (Fineran et al., 2009; 
Short et al., 2013). Type II TA systems were the first discovered and are the most 
prevalent within the prokaryotic kingdom, and will be the focus of this thesis.  
 
1.3.2 Type II TA Systems 
The Type II TA systems are composed of diverse families, each with 
different modes of action, but ultimately function to induce bacteriostasis in the 
cell in response to specific signals (Arcus et al., 2011; Gerdes et al., 2005; 
Mutschler, Gebhardt, Shoeman, & Meinhart, 2011; Ning, Jiang, Liu, & Xu, 
2013a; Yamaguchi, Park, & Inouye, 2011) (Table 1.1).   
Table 1.1. Summary of Type II TA families and their general mode of action. 
Type II TA Family Mode of Action 
MazEF 
Induces bacteriostasis via translation inhibition by mRNA cleavage in 
response to nutrient stress (Christensen, Pedersen, Hansen, & Gerdes, 
2003) 
RelBE 
Induces bacteriostasis via translation inhibition by mRNA cleavage in 
response to nutrient stress (Pedersen et al., 2003) 
ParDE 
Inhibits DNA replication and transcription by poisoning topoisomerase 
II (Jiang, Pogliano, Helinski, & Konieczny, 2002)  
CcdAB 
Inhibits DNA replication and transcription by poisoning topoisomerase 
II (Afif, Allali, Couturier, & Van Melderen, 2001; Van Melderen, 2002) 
Phd-Doc 
Induces bacteriostasis via translation inhibition by ribosomal 
inactivation (Liu, Zhang, Inouye, & Woychik, 2008) 
HicAB 
Induces bacteriostasis via translation inhibition by mRNA and tmRNA 
cleavage in response to nutrient stress (Jorgensen, Pandey, Jaskolska, & 
Gerdes, 2009) 
HipBA 
Induces bacteriostasis via translation inhibition by inactivation of tRNA 
by phosphorylation (Schumacher et al., 2009) 
MosAT 
Promotes maintenance of an integrative conjugative element that infers 
antibiotic resistance (Wozniak & Waldor, 2009) 
VapBC 
Induces bacteriostasis via translation inhibition by mRNA cleavage 
(Arcus et al., 2011) 
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The majority of Type II toxins function by inhibiting translation which 
leads to growth arrest (Brown & Shaw, 2003; Yamaguchi et al., 2011) (Figure 
1.11). The toxin is inactivated by forming a complex with the antitoxin (Gerdes et 
al., 2005). The high prevalence of Type II systems on chromosomes of bacteria 
led to the proposal that chromosomal Type II TA systems are stress-response 
elements contributing to prokaryote adaptation to stressful environments (Gerdes 
et al., 2005). This proposal has been supported by a series of recent experimental 
findings. For example, in E. coli, activation of Type II TA systems is triggered by 
various stressors (Christensen-Dalsgaard, Jørgensen, & Gerdes, 2010; Hazan, Sat, 
& Engelberg-Kulka, 2004). It is suggested that the general Type II TA system 
mode of action is to induce reversible growth arrest under stressed conditions via 
inhibition of translation.  This allows stressed cells to remain in a dormant or non-
growing stress-tolerant state until more favourable environmental conditions 
return. 
 
Figure 1.11. Generalised schematic of the characteresitics and genetic 
organisation of bacterial TA pairs. Figure modified from Brown & Shaw 
(2003). 
 
1.3.3 VapBC TA Systems 
The VapBC family is defined by their toxic Virulence associated protein 
(VapC), which belongs to the PilT N-terminal domain (PIN domain) family of 
proteins. The VapBC TA family is the largest of the Type II TA systems but they 
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remain the least well characterised, as a consequence of their relatively recent 
identification and diverse functions (Arcus, Bäckbro, Roos, Daniel, & Baker, 
2004; Arcus, Rainey, & Turner, 2005; Clissold & Ponting, 2000; Gerdes et al., 
2005). VapBC TA systems have become a point of interest because of their 
overrepresentation in the genomes of pathogenic and environmentally hazardous 
bacteria, providing a new potential target for controlling these organisms. 
 
1.3.3.1 Expansion of VapBC Systems in Pathogenic and Environmentally 
Hazardous Bacteria 
VapBC TA systems are overrepresented in the genomes of pathogenic and 
environmentally hazardous bacteria such as the human pathogen M. tuberculosis 
and the fresh water toxic bloom-forming cyanobacteria Microcystis aeruginosa 
(Arcus et al., 2011). M. tuberculosis has 47 vapBC operons encoded in its 
genome, where the related non-pathogenic environmental M. smegmatis has just 
one (Arcus et al., 2011; McKenzie, et al., 2012b). M. aeruginosa has 34 vapBC 
operons encoded in their genome, where the related non-toxic Synechocystis sp. 
PCC6803 (Synechocystis) has only 12 (Kaneko et al., 2001; Leplae et al., 2011; 
Makarova, Wolf, & Koonin, 2009). This overexpansion suggests a functional link 
between toxicity and VapBC systems.  
 
1.3.3.2 VapBC Autoregulation 
VapBC pairs are arranged as a bicistronic operon with both the antitoxin 
(VapB) and the toxin (VapC) co-expressed to form an inactive complex (VapBC) 
that binds to the promoter region upstream of its own operon to allow 
autoregulation. The VapB is responsible for binding to inverted repeat (IR) units 
in the promoter region, which is typically enhanced by the interaction of VapB 
and VapC (Figure 1.12) (Arcus et al., 2011).  
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Figure 1.12. Schematic diagram of a generalized VapBC system. The antitoxin 
(VapB) binds to the promoter region of the TA operon. This binding is enhanced 
by the toxin (VapC). The toxin gene encodes a toxic protein that often leads to 
growth arrest via ribonuclease-mediated inhibition of translation. When the toxin 
is bound with the antitoxin, it becomes inactive and forms a benign protein 
complex. The antitoxin is more susceptible to proteolytic degradation. Figure 
from Arcus et al. (2011). 
 
The fast intracellular trafficking locus (fitAB) from the sexually 
transmitted pathogen N. gonorrhoeae is the most well characterised VapBC 
system with a 1 bp overlap between the two genes with fitA upstream of fitB. FitA 
has a DNA binding domain that binds to an IR sequence (TGCTATCA-N12-
TGATAGCA) within the promoter region of the operon to allow autoregulation 
(Figure 1.13) (Mattison, Wilbur, So, & Brennan, 2006; Wilbur et al., 2005). The 
X-ray crystal structure of FitAB bound to DNA shows four FitAB heterodimers 
bound to DNA (Figure 1.13) (Mattison et al., 2006). 
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Figure 1.13. fitAB autoregution. (A) Schematic of the fitAB promoter region that 
is autoregulated by FitAB. The IR sequence that FitA binds to is shown upstream 
of the FitA start codon and is highlights in bold. Figure from Wilbur et al. (2005). 
(B) The structure of FitAB from N. gonorrhoeae bound to IR from its promoter 
DNA. At the top of the figure FitA forms a dimer (two chains coloured pink and 
purple). The dimer binds to one half of the DNA IR. The other FitA dimer is seen 
at the bottom of the figure (two chains coloured blue and light blue) binding to the 
other half of the DNA IR. Each FitA monomer binds to a FitB monomer-the two 
FitB dimers lie to the left and right of the DNA (FitB chains are coloured 
clockwise from top-right - light green, dark green, tan and yellow). Double 
stranded DNA lies behind the hetero-octomeric FitAB structure. Figure from 
Arcus et al. (2011). 
 
FitA binds to this sequence with weak affinity, which is improved when 
FitA forms a complex with FitB (Wilbur et al., 2005). FitAB binds to its promoter 
region when N. gonorrhoeae is extracellular to represses transcription of the fitAB 
operon. Upon invasion into epithelial cells, FitAB is released from the DNA and 
the complex dissociates to release FitB. Active FitB then slows replication by 
inhibiting translation via specific mRNA degradation (Mattison et al., 2006).  
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1.3.3.3 VapC Endonuclease Function to Inhibit Translation 
The VapC mode of action is to inhibit translation by specific mRNA 
degradation, resulting in reversible growth arrest. VapC proteins belong to the 
PilT N-terminal domain (PIN domain) family of proteins. PIN domain containing 
proteins are associated with RNA degradation by virtue of their ribonuclease 
activity (Anantharaman & Aravind, 2003; Clissold & Ponting, 2000; Fatica, 
Tollervey, & Dlakić, 2004; Lamanna & Karbstein, 2009). The PIN domain 
contains four conserved acidic residues (Asp5, Glu42, Asp104 and Asp133) within an 
RNase-H-like fold, which form a negatively charged active site to bind a divalent 
cation (Mg
2+
 or Mn
2+
)
 
and facilitate metal-dependent nuclease activity (Figure 
1.14) (Arcus et al., 2004; Arcus et al., 2011; Mattison et al., 2006; Miallau et al., 
2009).  
 
Figure 1.14. Generalized PIN-domain structure.  (A) A cartoon representation 
of a PIN-domain structure coloured blue-red from N-terminus to C-terminus with 
the central 5-stranded parellel β sheet typical of a PIN-domain. (B) The same 
structure as a C-α trace showing the four conserved acidic residues and Mn2+ 
(black) in the active site. Figure from Arcus et al. (2011). 
 
VapC is inactivated by direct interaction with VapB as shown by the 
structure of the FitAB complex (Figure 1.13). Nucleic acid cleavage by FitB is 
inhibited by binding of the FitA C-terminal Arg68 into the active site of FitB 
where it interacts with three of the acidic residues (Asp5, Glu42, and Asp104), 
forming strong electrostatic interactions that are difficult to disrupt (Figure 1.15). 
The complex is further stabilised by the hydrophobic interaction between the C-
terminal FitA helix α3 and the FitB helices α1, α2 and α4 (Figure 1.15). 
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A 
 
B 
 
Figure 1.15. X-ray structures showing FitA inactivation of FitB. (A) The C-
terminal Arg68 from FitA (monomer peptide shown in orange with Arg68 depicted 
as a stick and coloured by atom) binds into the active site of the FitB monomer 
(shown in grey with acidic active site residues depicted as a stick and coloured by 
atom) (B) FitB depicted as an electrostatic surface to show the acidic properties of 
the active site that Arg68 interacts with and the hydrophobic region formed within 
FitB helices α1, α2 and α4 that the FitA helix α3 interacts with to stabilise the 
complex. PDB co-ordinates from Mattison et al. (2006) (PDB ID 2H10). Figures 
were drawn using PyMol (Delano, 2002). 
 
VapB is susceptible to degradation by cellular proteases, which is induced 
under stress. This causes the cellular levels of antitoxin to drop, subsequently 
inducing activation of the toxin. The mode of action of VapBC indicates that they 
play an important role in growth regulation in response to changing environments 
(Arcus et al., 2005; Arcus et al., 2011; Daines, Wu, & Yuan, 2007; Mattison et al., 
2006; Puskás et al., 2004; Robson, McKenzie, Cursons, Cook, & Arcus, 2009). 
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1.3.3.4 Functions of Characterised VapBC Systems 
Several VapBC systems from a range of bacteria have been shown to 
inhibit translation, and, in some cases, induce growth arrest under stress 
conditions or when overexpressed in vivo. However, cellular targets and specific 
biological roles of these systems are yet to be elucidated (Arcus et al., 2011; 
Bodogai et al., 2006; Cooper, Daugherty, Tachdjian, Blum, & Kelly, 2009; Daines 
et al., 2007; Ning, Jiang, Liu, & Xu, 2013a; Sharp et al., 2012; Winther & Gerdes, 
2009; Y. X. Zhang et al., 2004). 
 
As mentioned earlier, FitAB in N. gonorrhoea is hypothesised to slow 
intracellular trafficking and replication during host infection (Mattison et al., 
2006). The mechanism involves FitAB binding to its promoter region when N. 
gonorrhoeae is extracellular to repress transcription of its operon. Upon invasion 
into epithelial cells, FitAB is released from the DNA and the complex dissociates 
to release FitB. Active FitB then slows replication by inhibiting translation via 
specific mRNA degradation (Mattison et al., 2006).  
 
The nitrogen-fixing symbiont of legumes Sinorhizobium meliloti carries a 
large number of TA modules in its genome. One of these VapBC systems, NtrPR, 
has been implicated in the regulation of a range of metabolic transcripts, and, 
more specifically, is hypothesised to adjust metabolic processes during symbiosis 
and other stress conditions (Puskás et al., 2004). Another VapBC system (VapBC-
5) was shown to affect efficiency of symbiosis and nitrogen fixation capacity 
(Cinege, Bodogai, Oláh, & Kiers, 2014). 
 
M. smegmatis is a relative of the pathogenic bacteria M. tuberculosis. 
Because of its fast growing and non-pathogenic physiology, it is a valuable tool 
for investigating mycobacterial metabolism. As a result, the sole VapBC system 
(VapBC1283/4) has been well characterised. VapC1284 functions as a metal
 
dependent endoribonuclease that specifically binds and cleaves single stranded 
RNA (ssRNA) at the cut sites AUA(U/A) (McKenzie et al., 2012b). This cut site 
was found to be abundant in M. smegmatis mRNA transcripts that were 
downregulated in the response to VapC overexpression in microarray 
experiments. A large proportion of these downregulated genes encode proteins 
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responsible for carbon transport and metabolism indicating that VapBC1283/4 
functions as a post-transcriptional regulator of carbon metabolism (McKenzie et 
al., 2012b).  
 
M. tuberculosis has 47 vapBC operons encoded in their genome. Of the 
systems that have been characterised, all VapC proteins inhibit translation by 
endoribonuclease activity. In some cases, translation inhibition resulted in 
reversible growth arrest (Arcus et al., 2011; Ramage, Connolly, & Cox, 2009; 
Sharp et al., 2012). All functional VapBC systems monitored in vivo under stress 
conditions, in both culture and during infection of macrophages, showed that each 
condition induced different VapBC systems (Ramage et al., 2009). Also, no cross 
talk between VapBC systems was identified (Ramage et al., 2009). Although the 
role of these VapBC systems remains largely unknown, these findings suggest 
that each system may play an individual role in response to different 
environmental cues, suggesting they function as an intricate response system 
during adaptation. For organisms that host a large number of VapBC systems, this 
would provide the capacity for efficient adaption to fluctuating and/or 
inhospitable conditions.  
 
1.3.4  Cyanobacteria VapBC TA Systems 
 Cyanobacteria are capable of autotrophy via oxygenic photosynthesis and 
are the most important photosynthetic bacterial phylum. They are primary 
producers by nature of their autotrophy, which is essential for the existence of all 
higher organisms (Herrero, 2008). They produce organic carbon from CO2, water, 
and light energy with gaseous oxygen being generated as the by-product of water 
splitting (Herrero, 2008). The biological production of oxygen is hypothesised to 
have converted the atmosphere of early Earth from an anaerobic, inhospitable 
environment to an atmosphere that supported aerobic respiration (Dismukes et al., 
2001; Herrero, 2008). Aerobic respiration is the most efficient biological process 
for generating energy from organic carbon and is dependent on oxygen. Aerobic 
respiration supports higher metabolic demands and subsequently more complex 
and larger organisms (Herrero, 2008). Cyanobacteria have been utilized for 
industrial purposes due to their ability to generate renewable energy, 
cyanobacterial based fuels, ethanol, medicinal extracts and health supplements 
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(Deng & Coleman, 1999; Deng & Chow, 2010; Ostensvik, Skulberg, Underdal, & 
Hormazabal, 1998; Quintana, Van der Kooy, Van de Rhee, Voshol, & Verpoorte, 
2011; Rittmann, 2008). It is obvious why understanding the physiology of 
cyanobacteria has become one of the largest fields in biology.   
 
 Members of the cyanobacteria phylum can be found in almost every 
terrestrial and aquatic habitat. Aquatic cyanobacteria can be found in both marine 
and freshwater systems, and terrestrial cyanobacteria form biofilms that can be 
found anywhere from rich temperate soils to rocks in the deserts of Antarctica 
(Thajuddin & Subramanian, 2010). Aquatic cyanobacteria can reproduce 
explosively in certain conditions and are known for their extensive blooms. These 
blooms are detrimental to other species in close proximity and can often be toxic 
to humans and animals because of the cyanotoxins produced (Briand, Jacquet, 
Bernard, & Humbert, 2003; Falconer & Humpage, 2005; Paerl, Fulton, 
Moisander, & Dyble, 2001). Blooms often result in closure of recreational waters 
and the treatments used to eliminate the blooms are expensive and can be fatal to 
livestock and other aquatic organisms (Frangeul et al., 2008; Steffensen, 2008).  
 
 The toxic bloom forming cyanobacteria M. aeruginosa has an 
overrepresentation of TA systems in its genome, compared to its non-toxic 
relatives. For example the M. aeruginosa genome encodes 113 TA systems, where 
its non-toxic relative Synechocystis Sp. PCC6803 (PCC8603) has only 19 (Toxin-
Antitoxin Database). Of the 113 TA systems encoded in the M. aeruginosa 
genome, a large proportion of the TA loci (34) are annotated as vapBC operons 
(Arcus et al., 2011). In comparison, PCC6803 has only 12 vapBC loci (Kaneko et 
al., 2001; Leplae et al., 2011; Makarova et al., 2009). This expansion suggests a 
functional link between toxicity and VapBC systems, however the function of 
VapBC systems in cyanobacteria is not known. In fact, only one of the 12 
PCC6803 VapBC systems has been partially characterised, and none from any 
toxic-forming species (Ning, Liu, Xu, Zhuang, Wen, et al., 2013b).  
 
1.3.4.1 Synechocystis VapBC Systems 
 The Synechocystis genome was the third prokaryote and first 
photosynthetic genome to be sequenced (Kaneko et al., 1995) and is used as the 
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model organism to investigate the physiology of cyanobacteria. Synechocystis has 
12 annotated vapBC loci and until recently none had been characterised. Ning et 
al., (2013) investigated the VapBC10 (ssr2962/slr1767) system of Synechocystis 
using E. coli as the model organism and were able to confirm that the operon 
functions as a typical VapBC system. They showed vapB10 and vapC10 form a 
bicistronic operon and both genes are co-transcribed under normal growth 
conditions. Overexpression of VapBC10 had no effect on growth but 
overexpression of VapC10 caused growth arrest in E. coli, which could be 
reversed by introducing overexpressing VapB10. Because the VapC10 shows the 
characteristic bacteriostatic phenotype of a VapC toxin it is proposed that VapC10 
exerts its growth arrest via translation inhibition, like other characterised VapC 
toxins, however this has not been confirmed experimentally.  
 
 VapBC systems are normally characterised by their repressive 
autoregulation where VapB binds to the promoter region of the operon and 
represses expression. The efficiency of binding is enhanced when VapC is bound 
to VapB and it is proposed that under normal growth conditions the toxin and 
antitoxin are co-expressed to form a non-toxic TA complex which respresses TA 
expression. Under specific stress conditions this repression is lifted by the 
degradation of VapB, which results in activation of VapC (Gerdes et al., 2005). 
This is not the case for Synechocystis VapBC10, which shows an alternative 
mechanism of autoregulation.  
 
 Ning et al. (2013) showed that VapB10 binds to the promoter region of its 
own operon and positively autoregulates transcription. They identified the specific 
DNA sequence that VapB10 recognises: the imperfect IR sequence TTTCCCT-
2N-AGGGTAA present in the promoter region upstream of the ssr2962/slr1767 
operon (Figure 1.16). They also showed VapC10 is unable to bind to the promoter 
region and actually abolishes binding of VapB10 to DNA. These results reveal 
that VapB10 can positively autoregulate the operon, which can be inhibited by 
VapBC10. 
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Figure 1.16. Schematic representation of the genetic structure of the 
Synechocystis VapBC10 operon. The imperfect IR sequence that VapB binds to 
is shown upstream of the VapBC10 operon within the promoter region. Figure 
from Ning et al. (2013). 
 
 Because this is the only VapBC system to be characterised in 
cyanobacteria, and the functional mechanism is still unknown, it is difficult to 
draw any conclusions about the role that these VapBC systems play in growth 
regulation. However, because of the link between the number of VapBC systems 
and the toxicity of some organisms it is a very promising avenue to investigate. 
Obtaining a better understanding of the role that VapBC systems play may also 
provide a novel strategy for bloom control.  
 
1.4 Objectives of this Thesis 
This thesis will investigate bacterial regulation at both (I) the transcription 
level by the structural and functional characterisation of the transcription factor 
AmtR in the actinomycetes M. smegmatis and (II) the post-transcription level with 
preliminary characterisation of three VapBC systems present in the cyanobacteria 
Synechocystis and one VapBC system from the toxic bloom forming M. 
aeruginosa. The M. smegmatis AmtR was initially investigated as a putative 
regulator of the M. smegmatis VapBC1283/4 system, with initial characterisation by 
X-ray crystallography. Functional characterisation of AmtR revealed that it has no 
regulatory control over VapBC1283/4, however it does play an instrumental role in 
regulation of alternative nitrogen metabolism in response to nitrogen limitation. 
The cyanobacteria VapBC systems investigated in this thesis were previously 
unexplored and through a combination of in vitro and in vivo analyses I present 
the preliminary characterisation and putative function of these poorly understood 
systems.  
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2 Characterisation of Mycobacterium smegmatis 
Transcription Factor AmtR 
 
2.1 Introduction 
Nitrogen and carbon are essential for bacterial growth and survival, and, as 
a consequence, bacteria have evolved processes for efficient uptake and 
metabolism of these nutrients in response to their environment. Soil bacteria are 
subjected to environments with consistent nitrogen limitation and carbon surplus. 
This has implications for the necessity of regulation and diversification of 
nitrogen metabolism in these organisms. Transcription factors play an essential 
role in these processes.  
 
A well studied example of transcriptional regulation of nitrogen metabolism 
in bacteria is the global nitrogen regulatory system (NtrBC), which is responsible 
for response to nitrogen limitation (see Figure 1.4 in Chapter 1) (Arcondéguy et 
al., 2001; Chubukov et al., 2014 Morett & Segovia, 1993). NtrC is activated by 
phosphorylation in response to nitrogen limitation, which results in the 
upregulation of its regulon (Austin & Dixon, 1992; Kern et al., 1999). The 
phosphorylation of NtrC is dependent on the PII proteins GlnB and GlnK 
(Arcondéguy et al., 2001; Atkinson & Ninfa, 1998; Kamberov et al., 1995). The 
NtrC regulon is composed of genes that encode for ammonium transport and 
assimilation, alternative nitrogen uptake and metabolism, and nitrogen fixation 
(Arcondéguy et al., 2001; Atkinson & Ninfa, 1998; Claverie-Martin & 
Magasanik, 1991; Schneider et al., 1998).  
 
In bacteria that do not have an NtrBC system, including a number of 
actinobacteria, the global transcription factors GlnR, TnR and AmtR function as 
the major players in nitrogen-limiting response (Arcondéguy et al., 2001; Jakoby 
et al., 2000; Schreier et al., 1989; Tiffert et al., 2008). The regulation of nitrogen 
metabolism is very diverse in actinomycetes and has been intensively studied in 
the organisms Corynebacterium glutamicum, Streptomyces coelicolor and 
Streptomyces avermitilis (Chen et al., 2013; Jakoby et al., 2000; Tiffert et al., 
2008).  
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In C. glutamicum the response to nitrogen limitation is regulated via the 
global nitrogen transcription regulator AmtR, which acts as a repressor of at least 
35 genes under nitrogen surplus (Beckers et al., 2005; Jakoby et al., 2000). AmtR 
directly interacts with the PII protein GlnK, under nitrogen limiting conditions, 
leading to the release of AmtR from its target DNA and upregulation of its 
regulon (Beckers et al., 2005). The C. glutamicum AmtR regulon is composed of 
genes that encode proteins responsible for responding to nitrogen limitation, 
including ammonia uptake and assimilation, and alternative nitrogen uptake and 
metabolism (Beckers et al., 2001; 2004; Bendt et al., 2004; Jakoby et al., 2000; 
Muhl et al., 2009; Nolden et al., 2001a). This system of nitrogen regulation has 
been observed only in C. glutamicum and introduces a new player to the intricate 
network of prokaryotic nitrogen regulation. In S. coelicolor, the transcription of 
genes involved in response to nitrogen limitation is mediated by the 
transcriptional regulator GlnR (Tiffert et al., 2008). S. avermitilis contains both 
GlnR and AmtR, and GlnR is suggested to work as a crucial nitrogen regulator, 
although functional studies have not confirmed this (Chen et al., 2013). AmtR has 
been identified as a regulator involved in alternative urea metabolism and amino 
acid transport, playing an important role in nitrogen metabolism (Chen et al., 
2013).   
 
Although these studies have provided insight into nitrogen regulation of 
members of the actinobacteria phylum, there is limited understanding of nitrogen 
regulation in the genus mycobacteria. Mycobacterium smegmatis is a soil bacteria 
that belongs to the fast-growing mycobacterial group and is commonly used as a 
model organism to study pathogenic species like M. tuberculosis. The preferred 
nitrogen source of M. smegmatis is ammonium but it is capable of using different 
nitrogenous compounds under changing environmental conditions. This 
scavenging ability allows M. smegmatis to utilize a broader range of nitrogenous 
sources compared to its pathogenic relatives (Amon, Titgemeyer, & Burkovski, 
2009). 
 
M. smegmatis lacks a NtrBC system for global nitrogen response and, like 
S. avermitilis, encodes both GlnR and AmtR proteins. GlnR has been identified as 
an important nitrogen regulator, as it controls the genes that encode ammonia 
Chapter Two 
 
 34 
uptake and assimilation, alternative nitrogen uptake and metabolism, and the 
signal transduction PII proteins (Amon et al., 2008; Fink et al., 2002; Jenkins et 
al., 2012; 2013; Jessberger et al., 2012). A number of genes that encode proteins 
involved in critical nitrogen metabolic processes are not under the control of GlnR 
and it has been suggested that these genes are under control of AmtR (Amon et 
al., 2008).  
 
Bioinformatic analyses of the M. smegmatis genome revealed a number of 
genes homologous to the S. avermitilis regulon that are putatively under AmtR 
control (Jessberger et al., 2012). This was confirmed by transcriptome analysis of 
the M. smegmatis amtR deletion strain, which also showed that AmtR repression 
is lifted only under nitrogen limitation. Co-factor independent binding of AmtR to 
the upstream promoter region of the genes was also confirmed and no putative 
signalling molecules were identified (Jessberger et al., 2012). This study indicates 
that the M. smegmatis AmtR controls a regulon of genes involved in alternative 
nitrogen uptake and metabolism, and the expression of this regulon is induced 
under nitrogen limiting conditions when AmtR repression is lifted. Like GlnR, the 
signal to lift repression in mycobacteria is not known. Elucidating the signal for 
these transcription factors to lift repression is critical to improve our 
understanding of nitrogen metabolic regulation. 
 
These initial findings suggest M. smegmatis AmtR may have a unique role 
in metabolic adaptation to nitrogen limitation, and further investigation into the 
structure and function of AmtR will provide greater understanding of the 
regulatory mechanisms functioning in mycobacteria.  In this chapter, I present my 
work on the structural and functional characterisation of the M. smegmatis AmtR. 
Firstly, I have solved the X-ray crystallographic structure of both the truncated C-
terminal regulatory domain of AmtR and the full structure including both the C-
terminal regulatory domain and the N-terminal DNA binding domain. This is the 
first AmtR structure to be solved: it reveals the regulatory domain contains a deep 
binding pocket and the DNA binding domain is defined by a helix-turn-helix 
(HTH) motif. Secondly, in collaboration with the Cook Laboratory at Otago 
University, we have confirmed the M. smegmatis AmtR regulon and determined 
the DNA recognition sequence. Subsequently, I have determined a modified 
actinobacteria AmtR binding motif using representative actinobacteria AmtR 
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DNA recognition sequences and mutation work done in this thesis. Finally, we 
have identified two potential signalling molecules specific to AmtR that appear to 
function via a co-repressor mechanism of regulation that has not been observed in 
the TetR protein family until now.  
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2.2 Methods 
2.2.1 DNA Manipulation and Cloning 
2.2.1.1 Gene, Primer and Oligonucleotide Design  
2.2.1.1.1 M. smegmatis amtR Gene Design 
The M. smegmatis amtR gene (msmeg_4300) was ordered from GeneArt 
(Life Technologies, Carslbad CA) with a 5’ Ncol restriction site and a 3’ HindIII 
restriction site with the stop codon removed to allow for ligation into pYUB28b 
with a C-terminal His tag.  The amtR gene was extracted from the GeneArt 
plasmid by restriction digest as per Section 2.2.1.6 using NcoI and HindIII and 
inserted into the pYUB28b expression vector (Bashiri, Rehan, Greenwood, 
Dickson, & Baker, 2010). The vector was transformed into E. coli TOP10 cells 
prior to transformation and protein expression in the M. smegmatis 4517 
expression strain.  
 
2.2.1.1.2 M. smegmatis Primer Design 
Primers for amplification of the glnK gene (msmeg_2426) from the M. 
smegmatis mc
2
155 genomic DNA for cloning were initially designed to include 
the 5’ restriction site NdeI and the 3’ restriction site HindIII necessary for ligation 
into PYUB28b with a N-terminal His tag. An extra 3-6 bases were included to 
allow for efficient cleavage, depending on the restriction enzyme used. These 
primers failed to amplify glnK so a new set of primers were made without the 
restriction enzyme sites, which successfully amplified glnK. The PCR product of 
the second set of primers was used as the template for PCR with the first set of 
primers to add the restriction sites to the glnK gene. The gene was then digested as 
per Section 2.2.1.6 with Ndel and HindIII and inserted into the pYUB28b 
expression vector. The vector was then transformed into E. coli TOP10 cells prior 
to transformation and protein expression in the M. smegmatis 4517 expression 
strain. All putative sequences were cloned in silico into the pYUB28b vector 
using Geneious R6 to ensure the protein sequence was correct and the His tags 
were in frame.  
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Primers for generation of DNA fragments for electrophoretic mobility 
shift assays (EMSA) were designed to amplify specific regions from the promoter 
sites of putative AmtR regulated genes in the M. smegmatis genome. Primers were 
also designed to amplify a non-specific region of the genome that contained no 
putative binding site, which were used as the non-specific control. All primers 
were supplied by IDT (Coralville IA) and resuspended in 1 x TE.  
 
2.2.1.1.3 M. smegmatis Oligonucleotide Design 
DNA oligonucleotides required for AmtR DNA EMSA assays and 
AmtR:DNA co-crystallisation trials were designed as complementary single 
stranded sequences of recognition regions, or variations of recognition regions, 
from the promoter sites of putative AmtR regulated genes. All oligonucleotides 
were supplied by IDT and resuspended in 1 x TE. The oligonucleotides were 
annealed by mixing with annealing buffer (1 x TE + 150 mM NaCl) in a 1:4 
annealing buffer to DNA ratio. The mixture was incubated at 95 °C for 10 
minutes and brought down to room temperature to incubate overnight. DNA 
quantification was conducted as per Section 2.2.1.5.  
 
For recognition regions that were too large to order as oligonucleotides, 
primers were designed (Section 2.2.1.1.2). The recognition regions were PCR 
amplified from the M. smegmatis mc
2
155 genome as per Section 2.2.1.3.1 with 
subsequent agarose gel electrophoresis analysis (Section 2.2.1.4.1), and 
purification and quantification as per Section 2.2.1.5.   
 
A list of all genes, primers and oligonucleotides ordered are presented in 
Table A.1 in the Appendices.  
 
2.2.1.2 DNA Digoxigenin-II-ddUTP (DIG) Labelling for EMSA Assays 
DNA was 3’-end labelled with digoxigenin-11-ddUTP (DIG) using the 
DIG Gel Shift kit, 2
nd
 Generation (Roche, Germany) as per manufactures 
instructions. The labelling reaction was as follows: 
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100ng   DNA 
1 x   labelling buffer 
1.25 mM  CoCl2 
1 mM  DIG ddUTPs 
400 U  Terminal transferase 
 
The reaction mixture was incubated at 37 °C for 15 min and enzyme 
actitvity was stopped by the addition of 0.11 mM EDTA (pH 8). DNA was diluted 
to 0.4 ng/μl for all gel shift assays. 
 
2.2.1.3 Polymerase Chain Reactions (PCR) 
2.2.1.3.1 PCR Amplification from M. smegmatis mc2155 Genomic DNA 
PCR reactions were carried out with the proofreading enzyme KAPA HiFi 
DNA polymerase (Kapa Biosystems, Wilmington MA). The annealing 
temperature was 60 °C unless otherwise stated. PCR reactions were carried out in 
25 μl volumes using the following concentrations: 1 x High GC amplification 
buffer, 0.3 mM deoxynucleotide mix (dATP, dCTP, dTTP & dGTP), 2 mM 
MgSO4, 5% DMSO, 1 U 2G DNA polymerase, 0.3 μM of each primer and 10 ng 
template DNA (M. smegmatis mc
2
155 genomic DNA). The following cycling 
conditions were used for amplification: 
  95 °C   2.00  (min:sec) 
  98 °C   0.20 
  55 °C   0.15 
  72 °C   0.45 
  72 °C   5.00 
 
2.2.1.3.2 PCR Screening of pYUB28b + amtR Transformants 
pYUB28b plasmids purified from E. coli (Section 2.2.1.11.), were checked 
for the presence of the amtR gene insert prior to sequencing by performing a PCR 
using T7 primers. PCR reactions were carried out with Taq DNA polymerase 
(Invitrogen, Carlsbad CA) in 25 μl volumes using the following concentrations: 1 
x PCR buffer, 0.2 mM dNTP mix (dATP, dCTP, dTTP & dGTP), 1.5 mM 
x 29 
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MgSO4, 2.5 U Taq DNA polymerase, 1 μM of each primer and 30-60 ng template 
DNA. The following cycling conditions were used for amplification: 
  94 °C   2.00  (min:sec) 
  94 °C   0.30 
  55 °C   0.30 
  72 °C   0.45 
  72 °C   5.00 
PCR reactions were visualised as in Section 2.2.1.4 below. 
 
2.2.1.4 DNA Gel Electrophoresis 
2.2.1.4.1 Agarose Gel Electrophoresis 
DNA fragments were separated via agarose gel electrophoresis. Samples 
were mixed with 10 x DNA loading dye prior to loading, and run on a 1% TAE 
gel. Agarose gels were made with 1x SYBR safe
TM
 DNA gel stain (Invitrogen). 
Gels were visualised by blue light and band sizes were determined by visual 
comparison against a 1kb-Plus DNA ladder (Invitrogen). 
 
2.2.1.4.2 Native Acrylamide TBE Gel Electrophoresis 
Digoxigenin-11-ddUTP (DIG) labelled DNA from EMSA was run on 6 % 
native acrylamide (19:1) TBE (Tris-borate-EDTA) gels. Gels were pre-run at 70 
V for 30 min in 1 x TBE before loading DNA. Gels were then run at 150 V for 45 
min-1 hr until the dye front reached the bottom of the gel.  
 
2.2.1.5 DNA Purification and Quantification 
DNA from agarose gels was separated and visualised with SYBR safe
TM
 
DNA dye as described in Section 2.2.1.4.1. The desired bands were extracted 
using a sterile scalpel blade and DNA purified using the QIAquick Gel Extraction 
Kit (Qiagen, Netherlands) according to the manufacturer’s instructions. DNA was 
eluted in 30 μl of elution buffer. PCR products from solution were purified using a 
Qiaquick PCR Product Purification Kit (Qiagen) according to the manufacturer’s 
instructions. DNA purity and concentration was estimated by measuring A260/A230 
x 29 
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nm and A260/A280 nm ratios using a NanoDrop®ND-1000 Spectrophotometer 
(Thermo Fisher Scientific, Waltham MA).  
 
2.2.1.6 Restriction Enzyme Digestion 
Restriction enzymes were purchased from Invitrogen, and digests were 
performed on purified PCR products or plasmid DNA either singly, due to buffer 
incompatibilities, or as double digests if buffers were compatible. 1 μl of 
restriction enzyme was added to 28-38 μl of DNA along with the appropriate 
amount of buffer, BSA and water for a 40-100 μl reaction according to the 
manufacturer’s instructions. Digests were incubated at 37 °C for 3 hrs, with 
subsequent purification as per Section 2.2.1.5.  
 
2.2.1.7 DNA Ligation 
DNA ligations were set up using 1 U of T4 DNA ligase (Invitrogen), and a 
vector to insert molar ratio of 1:3, where possible, in a total volume of 10-50 μl. 
Ligations were incubated overnight at 14 °C.  
 
2.2.1.8 Preparation of Electrocompetent E. coli TOP10 Cells 
A glycerol stock of E. coli TOP10 cells was streaked onto a low salt LB 
agar plate and incubated at 37 °C overnight. A 10 ml starter culture of low salt LB 
was inoculated with a single colony and grown overnight at 37 °C, shaking at 200 
rpm. The overnight culture was used to inoculate 1 L of low salt LB, which was 
grown in the same conditions as the starter culture until it reached OD600 0.5-0.7. 
All subsequent steps were performed with ice-cold 10 % glycerol, in pre-chilled, 
sterile containers. The cells were chilled on ice for at least 20 min, centrifuged 
(4,000 g, 15 min, 4 °C), the supernatant removed and the pellet resuspended in 
500 ml 10 % glycerol. The spin and wash step was repeated three further times, 
resuspending in 250 ml, 20 ml then 2 ml respectively. 50 μl aliquots were flash 
frozen in liquid nitrogen and stored at -80 °C.  
 
Chapter Two 
 
 41 
2.2.1.9 Electroporation of E. coli 
Ligation reactions (10-50 μl) or plasmid DNA (1 μl) was added to 50 μl 
freshly thawed electrocompetent E. coli TOP10 cells. The mixture was placed in a 
2 mm electroporation cuvette (BioRad Laboratories, Hercules CA) and 
electroporated with a BioRad Gene Pulser
TM 
(BioRad Laboratories) at 2.5 kV, 25 
μF capacitance and 200 Ω resistance. Transformed cells were recovered 
immediately in 0.9 ml of SOC media and incubated at 37 °C, shaking at 200 rpm 
for 30 min. Aliquots of the cells (50 & 100 μl) were plated into low salt LB agar 
plates containing hygromycin (50 μg/ml) for selection and incubated at 37 °C 
overnight. Single colonies from these plates were used to inoculate 5 ml low salt 
LB cultures containing hygromycin and incubated at 37 °C, shaking at 200 rpm 
overnight. These cultures were used to isolate plasmid DNA according to the 
method in Section 2.2.1.11 below and to make glycerol stocks as per Section 
2.2.1.15.  
 
2.2.1.10 Cloning of amtR and glnK into pYUB28b 
pYUB28b is an E. coli-mycobacterial shuttle vector with hygromycin 
resistance. The M. smegmatis amtR and glnK genes were digested (Section 
2.2.1.6), purified (Section 2.2.1.5.) and ligated (Section 2.2.1.7) into pYUB28b 
between the selected restriction sites within the multiple cloning site (MCS), 
allowing for the appropriate N- or C-terminal His tag.  Vectors containing the 
inserted gene were transformed into electrocompetent E. coli TOP10 cells 
(Section 2.2.1.9) and plated onto low salt LB agar plates containing hygromycin 
for selection. The plasmid constructs were purified then sequenced (Section 
2.2.1.11 and Section 2.2.1.12) to confirm correct insertion before being 
transformed into electrocompetent M. smegmatis 4517 (Section 2.2.1.14).  
 
2.2.1.11 E. coli Plasmid DNA Extraction 
E. coli plasmid DNA was extracted from 5 ml overnight cultures using the 
QIAprep Spin Miniprep Kit (Qiagen, Netherlands) according to manufacturer’s 
instructions, and eluted in 50 μl elution buffer. 
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2.2.1.12 DNA Sequencing 
DNA was sequenced by Massey Genome Service (MGS) using Sanger 
sequencing on an ABI3730 DNA Analyzer (Applied Biosystems, Foster City CA) 
at Massey University. 
 
2.2.1.13 Preparation of Electrocompetent M. smegmatis 4517 Cells 
A glycerol stock of M. smegmatis mc
2
 4517 cells was streaked onto a low 
salt LB agar plate supplemented with 0.05 % (w/v) tween 80 (LBT) + kanamycin 
(50 μg/ml) and incubated in a humidity chamber at 37 °C for three days. A culture 
of 5 ml low salt LBT + kanamycin was inoculated with a single colony and grown 
for 48 hrs at 37 °C at 200 rpm. The 5 ml culture was used to inoculate 500 ml of 
7H9 media + ADC + Tween 80 + Kanamycin, which was grown at 37 °C at 200 
rpm until it reached an OD600 of 0.6-0.7. All subsequent steps were performed 
with ice-cold 10 % glycerol, in pre-chilled, sterile 50 ml falcon tubes. The cells 
were chilled on ice for 1.5 hrs, centrifuged (4,000 g, 20 min, 4 °C), the 
supernatant removed and the pellet resuspended in 50 ml 10 % glycerol. The spin 
and wash step was repeated two more times, resuspending in 50 ml then 5 ml 
respectively. The cells were pooled and transferred to a single 50 ml falcon tube 
and centrifuged (as above) one final time before resuspending in 500 μl 10 % 
glycerol, flash freezing 40 μl aliquots in liquid nitrogen and storing at -80 °C.  
 
2.2.1.14 Electroporation of M. smegmatis 
Plasmid DNA (1 μl) was added to 40 μl freshly thawed electrocompetent 
M. smegmatis mc
2
 4517 cells and 40 μl of sterile 10 % glycerol. The mixture was 
placed in a 2 mm electroporation cuvette (BioRad Laboratories) and 
electroporated with a BioRad Gene Pulser
TM 
(BioRad Laboratories) at 2.5 kV, 25 
μF capacitance and 1000 Ω resistance. Transformed cells were recovered 
immediately in 0.9 ml of 7H9 media and incubated at 37 °C, shaking at 200 rpm 
for 3 hrs. Aliquots of the cells (50 μl and 100 μl) were plated onto 7H10 + ADC + 
Tween 80 agar plates containing hygromycin (50 μg/ml) and kanamycin (50 
μg/ml) for selection and incubated at 37 °C for three days in a humidity chamber. 
These cultures were used to make glycerol stocks as per Section 2.2.1.15 and to 
conduct small scale expression trials (Section 2.2.2.6). 
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2.2.1.15 Glycerol Stocks 
Glycerol stocks for long term storage of transformed bacteria at -80 °C 
were made by adding 0.5 ml of overnight culture (LB + hygromycin for E. coli + 
pYUB28b transformants or LBT + hygromycin + Kanamycin for M. smegmatis + 
pYUB28b transformants) to 0.5 ml of 50 % sterile glycerol. 
 
2.2.2 Protein Expression and Purification 
2.2.2.1 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) Protein 
Analysis 
SDS-PAGE gels were cast in a Hoefer mini gel casting system. SDS-
PAGE gels consisted of a 5 % acrylamide stacking gel overlaid on a 16.5 % 
acrylamide resolving gel. All SDS-PAGE gels were made up with 30 % 
acrylamide with an acrylamide:bisacrylamide ratio of 37.5:1 (v/v) (BioRad 
Laboratories), including 0.1 % filtered SDS, and were polymerised by the addition 
of 0.05 % ammonium persulphate (APS) and TEMED. 
 
Protein samples were mixed in a 3:1 ratio with 4 x SDS loading buffer and 
denatured for 5 min at 95 °C prior to loading onto the gel. Gels were run with 1 x 
SDS-PAGE running buffer at 70 V until the samples entered the resolving gel, 
then at 150 V until the dye front reached the end of the gel. For protein molecular 
weight estimation 10 μl of Precision Plus ProteinTM Unstained Standard (BioRad 
Laboratories) was run alongside each gel.  
 
2.2.2.2 Native Polyacrylamide Gel Electrophoresis (Native-PAGE) Protein 
Analysis 
12 % Native-PAGE gels were cast and run as for SDS-PAGE gels (Section 
2.2.2.1), with the exception of no SDS in the gel, running buffer or loading dye.  
 
2.2.2.3 Coomassie Blue Stain for Protein Gel Electrophoresis 
Gels were stained by colloidal coomassie staining using the quick stain 
method (Wong, Sridhara, Bardwell, & Jakob, 2000) with Fairbanks staining 
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solutions A-D. Gels were microwaved for 30 s in 50 ml Fairbanks staining 
solution A, cooled to room temperature while shaking gently, the stain removed, 
and then repeated as above with stains B, C and lastly D (de-stain).  
 
2.2.2.4 Quantification of Protein Concentration 
A NanoDrop ND-1000 Spectrophotometer (Thermo Fisher Scientific) was 
used to measure absorbance at 280 nm and the Beer-Lambert equation (A=ε.c.l) 
applied to correlate absorbance with concentration. Here A= absorbance at 280 
nm, ε= the theoretical extinction coefficient of the protein, c= concentration, and 
l= pathlength. Theoretical extinction coefficients were calculated based on the 
amino acid composition using Geneious Pro (Version 6.1.7 Biomatters Ltd, NZ) 
and the ExPASy ProtParam tool (Wilkins et al., 1998).  
 
2.2.2.5 Concentration of Protein Samples 
Vivaspin concentrators (10 kDa molecular weight cut off) (Sartorius AG, 
Germany) were used to concentrate protein samples. Protein samples were added 
to the upper reservoir of 20 ml or 500 μl concentrators and spun at 3,900 g at 4 °C 
until the desired volume or concentration was obtained.  
 
2.2.2.6 Small Scale Protein Expression and Purification from M. smegmatis 
All M. smegmatis expression cultures included kanamycin and 
hygromycin at 50 μg/ml for selection. Expression of M. smegmatis AmtR and 
GlnK were initially confirmed with small scale His tag binding tests using Ni 
Sepharose beads. A single transformed colony either from the freshly transformed 
plate or streaked from a glycerol stock was used to inoculate a 5 ml defined media 
PA-0.5G + 0.05 % Tween 80 seeder culture. This culture was grown for 48 hr at 
37 °C, shaking at 200 rpm, then 100 μl was used to seed a 10 ml ZYP-5052 + 0.05 
% Tween 80 expression culture, which was grown for 90 hr at 37 °C, shaking at 
200 rpm. Cultures were centrifuged (4,600 g, 20 min, 4 °C) and cell pellets were 
resuspended in 1 ml lysis buffer (50 mM phosphate buffer, 200 mM NaCl, 20 mM 
imidazole, pH 7.4) before 5 μl was removed and added to 10 μl lysis buffer and 5 
μl 4 x SDS loading dye (named whole-cell sample).  
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The remainder of the cells were sonicated on ice using a fine tip probe for 
15 s bursts at setting 3.5 with a Misonix Sonicator (Misonix Inc., Farmingdale 
NY) until cells were lysed. The lysate was centrifuged at 13,000 g for 20 min at 4 
°C. 10 μl of the supernatant, containing the soluble protein, was added to 5 μl of 
lysis buffer and 5 μl of 4 x SDS loading dye (named soluble sample). The 
remainder of the supernatant was transferred to a 1.5 ml eppendorf tube 
containing 50 μl of lysis buffer pre-equilibrated Ni Sepharose beads. The pellet, 
containing the insoluble protein, was resuspended in 250 μl of lysis buffer and 5 
μl was added to 10 μl of lysis buffer and 5 μl of 4 x SDS loading dye (named 
insoluble sample). The supernatant and beads were incubated at room temperature 
for 15 min at 1,000 rpm and then left to settle for 5 min. The beads were then 
centrifuged at 3,000 g for 1 min and 10 μl of the supernatant was added to 5 μl of 
lysis buffer and 5 μl of 4 x SDS loading dye (named flow-though sample). The 
remainder of the supernatant was removed. The beads were then washed with 1 
ml of lysis buffer, left to settle for 5 min and then centrifuged (3,000 g for 1 min). 
15 μl of the supernatant was added to 5 μl of 4 x SDS loading dye (named wash 
sample). The remainder of the supernatant was removed and the wash step was 
repeated with no aliquots taken for sampling. 50 μl of 4 x SDS loading buffer was 
added to the beads, then 20 μl from all six samples were analysed by SDS-PAGE.  
 
2.2.2.7 Large Scale Protein Expression and Sonication from M. smegmatis 
2.2.2.7.1 Large Scale Autoinduction Protein Expression 
Large scale protein expression cultures were grown as for small scale 
protein expression cultures in Section 2.2.2.6, with the exception that 10 ml seeder 
cultures were used to inoculate 1 L expression cultures to maintain the 1:100 ratio. 
Cultures were centrifuged (4,600 rpm, 20 min, 4 °C) and cell pellets either frozen 
at -80 °C or resuspended in 25 ml lysis buffer (50 mM Phosphate buffer, 200 mM 
NaCl, 20 mM imidazole, pH 7.4) for sonication.  
 
2.2.2.7.2 In vivo Large Scale Nitrogen Limiting Induced GlnK Adenylylation 
For in vivo nitrogen limiting induced adenylylation of GlnK, M. smegmatis 
containing the vector pYUB28b+glnK was streaked out on a low salt LBT agar 
plate + kanamycin and hygromycin (50 μg/ml) and grown at 37 °C in a humidity 
Chapter Two 
 
 46 
chamber for 3-5 days. A single colony from the plate was used to inoculate a 10 
ml seeder culture of LBT broth + kanamycin and hygromycin (50 μg/ml). The 
culture was incubated at 37 °C, shaking at 200 rpm for 24 hrs. The seeder (0.2 ml) 
was used to inoculate a 10 ml seeder culture of modified Sauton’s minimal media 
(Williams et al., 2013)  + 30 mM NH4Cl2 which was incubated at 37 °C, shaking 
at 200 rpm for 24 hrs. The Sauton’s seeder (5 ml) was used to inoculate 1 L of 
modified Sauton’s media + 30 mM NH4Cl2 which was incubated at 37 °C, 
shaking at 200 rpm until they reached OD600 0.5-0.7 and were induced with 0.1 M 
IPTG. Cells were further incubated until they reached late log phase and harvested 
by centrifugation at 4,600 g for 20 min, 4 °C.  The supernatant was removed and 
cells were washed by resuspension in modified Sauton’s media without NH4Cl2. 
The wash step was repeated and cells were transferred to 1 L of modified Sauton’s 
+ 1 mM NH4Cl2. The cells were incubated for another 12 hours to allow all 
available nitrogen to be metabolised and induce GlnK adenylylation as per 
Williams et al. (2013). Cultures were centrifuged (4,600 g, 20 min, 4 °C) and cell 
pellets either frozen at -80 °C or resuspended in 25 ml lysis buffer (50 mM 
Phosphate buffer, 200 mM NaCl, 20 mM imidazole, pH 7.4) for sonication.  
 
All media recipes are presented in the Appendices. 
 
2.2.2.8 M. smegmatis Large Scale Protein Purification 
Cells were sonicated on ice using a large probe for 30 s bursts at setting 7-
8.5 with 1 min rests in between using a Misonix Sonicator (Misonix Inc.) until 
cells were lysed (3-8 min). The lysate was centrifuged at 13, 000 rpm for 20 min 
at 4 °C. The supernatent was filtered through 1.2 μm and 0.45 μm Minisart filters 
(Sartorius AG) and 5 μl was added to 10 μl lysis buffer and 5 μl 4 x SDS loading 
buffer for later SDS-PAGE analysis. The pellet was resuspended in approximately 
10 ml of lysis buffer and 5 μl of this was added to 10 μl lysis buffer and 5 μl 4 x 
SDS loading buffer for later SDS-PAGE analysis. The protein in the remainder of 
the supernatant was initially run through a HisTrap HP column (GE Healthcare, 
UK) and purified via Immobilised Metal Affinity Chromatography (IMAC) on an 
ÄKTA FPLC system (Section 2.2.2.8.1). Fractions containing the protein of 
interest were purified further by size exclusion chromatography (SEC) using a 
Superdex column (GE Healthcare) (Section 2.2.2.8.2). Aliquots of fractions (15 
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μl) containing the protein of interest from both IMAC and SEC were added to 5 μl 
of 4 x SDS loading buffer for analysis with SDS-PAGE. 
 
2.2.2.8.1 Purification of His Tagged Proteins via Immobilised Metal Affinity 
Chromatography (IMAC) 
A 5 ml HiTrap
TM 
chelating HP column (GE Healthcare) was pre-
equilibrated with lysis buffer (50 mM phosphate buffer, 200 mM NaCl, 20 mM 
imidazole, pH 7.4) at a flow rate of 1 ml/min. The supernatant from the post-
sonicated cell lysate was loaded onto the IMAC column which was then attached 
to an ÄKTA Basic
TM 
or ÄKTA Purifier
TM 
FPLC system (GE Healthcare). 
Unbound proteins were removed by washing the column with 15-25 ml of lysis 
buffer at a flow rate of 1 ml/min, before bound protein was removed using a 
gradient of 0-50% elution buffer (lysis buffer + 1 M imidazole) over 50 ml at a 
flow rate of 1 ml/min. The IMAC column was stripped of Ni
2+ 
ions using 10 ml 
100 mM EDTA pH 8.0, washed with 20 ml water and re-primed with 5 ml 100 
mM NiCl2 between purifications of different proteins.  
 
2.2.2.8.2 Size Exclusion Chromatography (SEC) 
Proteins were purified by size exclusion chromatography (SEC) using 
either a preparative HiLoad
™
 16/60 Superdex™ 200 pg (S200 16/60) or analytical 
Superdex™ 200 10/300 (S200 10/300) column (GE Healthcare), which have a 
separation range of 10-600 kDa. Proteins were concentrated to 5 ml or 0.5 ml 
respectively, and filtered with a Nanosep® MF 0.2 μm filter (Pall Corporation, 
New York NY) before loading and running on a pre-equilibrated (50 mM 
phosphate buffer, 200 mM NaCl, pH 7.4) column.  
 
SEC of proteins bound to co-purified genomic DNA was performed using 
the S200 10/300 column as above but in high salt (2 M NaCl) buffer to dissociate 
the co-purified genomic DNA. The protein was combined at 1:1 volume ratio with 
high salt PBS buffer (4 M NaCl), concentrated down to 0.5 ml and filtered with a 
Nanosep® MF 0.2 μm filter (Pall Corporation) before loading and running on a 
pre-equilibrated (50 mM phosphate buffer, 2M NaCl, pH 7.4) column.  
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2.2.3 Dialysis of Protein Samples 
To remove the high salt concentration and any co-purified ligands, the 
protein was dialysed into a low salt buffer (20 mM phosphate, 200 mM NaCl, pH 
7.4) using 6-8 kDa molecular cut off Spectra Por® dialysis tubing (Spectrum 
Laboratories, Rancho Dominguez CA). Samples were loaded into pre-wet tubing 
and the ends were sealed using dialysis clips before dialysing into 1 L of gently 
stirring buffer. The buffer was replaced four times over a period of 15 hrs. 
 
2.2.4 Crystallography 
2.2.4.1 Initial Crystallisation Trials of AmtR 
Initial crystallisation trials for AmtR employed sitting-drop vapour 
diffusion and were set up using the high throughput Mosquito® crystal robotic 
system (TTP Labtech Ltd, UK), using PEGRx HT, Crystal Screen HT, Index HT 
and SaltRx Ht crystallisation screens (Hampton Research, Aliso Viejo CA). 
Aliquots of each screen condition (100 μl) were manually pipetted into 96 well 
Intelli-plate reservoirs (Hampton Research) before 100 nl of protein and reservoir 
solutions were robotically added into the crystallisation well. All plates were 
sealed with ClearSeal™ Film (Hampton Research) and stored at 18 °C.  
 
Initial trials used AmtR purified protein and subsequent trials used AmtR 
co-purified with up to 5 mM of a co-repressor xanthine or allantoin and 400-500 
μg of a 26 bp DNA oligonucleotide containing the recognition sequence.  
 
2.2.4.2 Optimisation of Crystallisation Conditions (Fine Screening) 
Once promising crystallisation conditions had been identified, a variety of 
optimisation steps were employed to produce crystals of the highest possible 
quality suitable for X-ray analysis as follows. 
 
2.2.4.2.1 Hanging Drops 
Crystallization fine-screens employed hanging-drop vapour diffusion in 
24-well plates (Hampton Research) at 18 °C. Plates were pre-greased with 
Glisseal N then 0.5 ml of fine screen ‘mother liquor’ (ML) was transferred into 
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the well. In general, the fine screen ML trialled contained a variation of the 
original concentration of the macromolecule, precipitant, or pH. 1 μl of protein 
and ML was pipetted onto a 22 mm square siliconised coverslip (Hampton 
Research), which was then inverted over the reservoir of ML and sealed by the 
grease.  
 
2.2.4.2.2 Protein Concentration and Age Trials 
A combination of AmtR concentration and age was trialled to determine 
the optimal conditions for quality crystal formation. Protein concentrations ranged 
from 5 mg/ml to 15 mg/ml and protein age ranged from 1 hr to 1 week post 
purification.  
 
2.2.4.2.3 Tryptic Digest of Protein 
Purified AmtR was subjected to tryptic digestion to preferentially digest 
away the N-terminal DNA binding domain, in order to crystallise only the C-
terminal regulatory domain. Trypsin from bovine pancreas (Sigma Aldrich, St. 
Louis MO) was added to AmtR at ratios of 1 mg:100 mg, 1 mg:500 mg , and 1 
mg:1,000 mg respectively. All further trypsin crystallization fine-screens used 
trypsin at a ratio of 1 mg:100 mg. Trypsin was added to the protein, which was 
immediately used to lay down crystal fine screens to limit the activity of the 
trypsin on the protein prior to beginning the crystallisation process. 
 
2.2.4.2.4 DNase Treatment of Protein 
Purified AmtR was subjected to DNA removal by DNase l (from bovine 
pancreas) (Sigma Aldrich) to remove co-purified DNA. DNase l was added to 
protein to give 1 mg:800 mg ratio respectively. DNase l was added to AmtR and 
incubated at 37 °C overnight, before being used to lay down crystallisation fine 
screens. 
 
2.2.4.2.5 Heavy Metal Soaks 
A post-soak with mercury was performed on crystals to incorporate the 
heavy metal into the crystal at cysteine positions. ML (250 μl) containing 5 mM 
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mercury(II) chloride was transferred into a pre-greased well. 2 μl of the 
ML/mercury(II) chloride was pipetted onto a coverslip and a crystal was added to 
this drop. The coverslip was inverted above the well and sealed overnight before 
looping the crystal and freezing it for testing.  
 
2.2.4.2.6 Ligand-Additive Screens 
For co-crystallisation crystals were grown in hanging drops (Section 
2.2.4.2.1) with the ML containing 0.1 mM – 100 mM of an additive. Additives 
were selected from the AmtR ligand library (Table 2.1. in Section 2.2.6.2.). For 
post soaking, AmtR crystals grown in non-additive ML conditions were 
transferred to a new hanging drop containing 0.1 mM-100 mM of an additive and 
left overnight.  
 
2.2.4.2.7 DNA Co-Crystallisation  
Crystals were grown in hanging drops (Section 2.2.4.2.1) with AmtR 
protein that was co-purified with a co-repressor and a 26 bp DNA oligonucleotide 
containing the AmtR recognition sequence.  The ML contained up to 10 mM of 
co-repressor. 
 
2.2.4.3 Testing Crystal X-Ray Diffraction 
Protein crystals were tested for X-ray diffraction on an Agilent Supernova 
X-ray Diffractometer (Agilent Technologies, Liberty Lake WA) at the University 
of Waikato using a Titan S2 CCD detector, or at the Australian Synchrotron using 
an ADSC Quantum 210r detector. 
 
2.2.4.4 X-Ray Data Collection 
AmtR protein crystals were flash-frozen in liquid nitrogen with up to 30% 
glycerol prior to data collection. For data collection, crystals were mounted in a 
stream of cold N2 gas at 100 K. Data was collected at the macromolecular 
crystallography beamline (MX1) at the Australian Synchrotron, Melbourne, 
Australia using an ADSC Quantum 210r detector.  
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2.2.5 AmtR DNA Electrophoretic Mobility Shift Assays (EMSA) 
Purified AmtR that had been treated for co-purified DNA removal by high 
salt SEC (Section 2.2.2.8.2) and subsequent dialysis (Section 2.2.3) was used in 
electrophoretic mobility shift assays (EMSA) using the DIG Gel Shift kit, 2
nd
 
Generation (Roche). The target DNA fragments were labelled as described in 
Section 2.2.1.2.  
 
2.2.5.1 EMSA Reactions 
The protein:DNA ratio was based on the molarity of AmtR (24.330 g/mol) 
calculated by ProtParam (web.expasy.org/proparam/) and DNA which was 
calculated using the Promega BioMath Calculator 
(http://www.promega.com/a/apps/biomath/index.html?calc=ugpmols). Assay 
protein:DNA ratios began at equal molar and subsequent higher ratios of protein 
to DNA. Assays were conducted as per manufacturer’s instructions with each 
reaction containing 1.5 x Binding Buffer, 0.5 μg of Poly dI-dC, 0.4 ng of DIG 
labelled DNA and various concentrations of AmtR. To confirm positive shifts 
were a result of protein binding to DNA and not to the DIG label, assays were set 
up with unlabelled target DNA added in 120 X excess at the highest labelled 
DNA:protein ratio. This assay was labelled specific control. To determine the 
specificity of protein binding, assays were set up with unlabelled non-specific 
DNA (the promoter region of the M. smegmatis phoH2 gene which contains no 
putative AmtR recognition sequence) added in 103 X excess (to account for size 
difference of the DNA fragments). This assay was labelled the non-specific 
control.  
 
Assays were prepared on ice and incubated at room temperature for 20 
min. Loading dye was added to each assay and then run on a 6 % native 
acrylamide TBE gel (Section 2.2.1.4.2)  
 
2.2.5.2 DNA Southern Blotting and Cross Linking 
DNA was transferred from the 6 % native acrylamide TBE gel to a 
Biodyne
® 
nylon transfer membrane (Pall Corporation) by southern blotting.  The 
membrane was placed over the gel and several pieces of blotting paper were 
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placed on top of the membrane and weighted by a 150 ml schott bottle filled with 
water to increased capillary movement. Blotting was done at room temperature for 
30 min. DNA was fixed to the membrane by UV crosslinking using a Gibco BRL 
UV Crosslinker (Life Technologies).  
 
2.2.5.3 Membrane Washing and Blocking 
The membrane was rinsed in 50 ml washing buffer (0.1 M maleic acid, 
0.15 M NaCl, pH 7.5, 0.3 % Tween 20) for 5 min and blocked for 30 min in 1 X 
blocking solution (Roche). The membrane was then incubated in 1 X blocking 
solution + antibody (Roche) for 30 min followed by two 15 min wash steps with 
washing buffer. The membrane was equilibrated in detection buffer (0.1 M Tris, 
0.1 M NaCl, pH 9.5) for 5 min before doing the chemiluminescent immunoassay.  
 
2.2.5.4 Chemiluminescence Immunoassay 
A chemiluminesence reaction using the alkaline phosphatase-conjugated antibody 
bound to the DIG labelled DNA and Disodium 3-(4-methoxyspiro {1, 2-
dioxetane-3, 2′-(5′-chloro) tricyclodecan}-4-yl) phenyl phosphate (CSPD) was 
done as per the manufacturer’s instructions. The reaction was incubated at room 
temperature for 5 min, followed by a 10 min incubation at 37 °C to enhance the 
reaction. The alkaline phosphatase dephosphorylates the CSPD resulting in light 
emission. The light emission was captured by exposing the membrane to 
Amersham Hyperflim X-ray film (GE Healthcare) in a light protective cassette for 
a minimum of 1 hr. The film was then developed in Kodak developer (Sigma 
Aldrich) for 2 min and fixed using Kodak fixer (Sigma Aldrich) for 30 sec. The 
film was visualised and captured using white light.  
 
2.2.6 AmtR Signalling Molecule Identification 
To determine the signalling molecule required for the regulation of the 
AmtR regulon a variety of techniques were implemented including protein pull 
down assays, fluorescence binding assays, AmtR + msmeg_2184 promoter region 
gel shift assays, crystallization by additive screens and high throughput thermal 
melt assays.  
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2.2.6.1 AmtR-GlnK Pull Down Experiments 
To test for protein interaction between AmtR and GlnK, both proteins 
were overexpressed into M. smegmatis overexpression culture conditions (Section 
2.2.2.8) and purified by IMAC (Section 2.2.2.8.1.). To test for protein interaction 
between AmtR and adenylyated GlnK (GlnK-AMP), AmtR was expressed as 
above and M. smegmatis pYUB28b+glnK was grown in modified Sautons media 
+ 1 mM NH4Cl2 (Section 2.2.2.7.2.) To confirm adenylylation of GlnK (Glnk-
AMP) the protein was purified by IMAC and SDS-PAGE analysed (Section 
2.2.2.1.). 
 
2.2.6.1.1 Incubation of AmtR and GlnK 
IMAC purified AmtR and GlnK, and AmtR and GlnK-AMP were 
incubated together at equal monomeric molar ratios for 20 min at room 
temperature then moved to 4 °C overnight. The solution was then run through a 
pre-equilibrated (50 mM phosphate buffer, 200 mM NaCl, pH 7.4) analytical 
Superdex™ S200 10/300 SEC column (GE Healthcare). A SEC pull down was 
implemented over a traditional IMAC pull down as both proteins included a 
terminal His tag. Protein peaks from the elution traces were analysed for 
interactions by a change in size of the protein complex coming off the column, 
which was verified by different band profiles in both SDS-PAGE and native-
PAGE (Section 2.2.2.1 and Section 2.2.2.2.). 
 
2.2.6.2 Ligand Library Generation 
The M. smegmatis AmtR regulon is primarily composed of genes involved 
in alternative nitrogen metabolism. As a result the ligand library was generated by 
selecting biological molecules that were (I) substrates or metabolites in nitrogen 
metabolism (II) general cellular signalling molecules and (III) compatible with the 
chemistry of the AmtR binding pocket in the regulatory domain (based on the 
structure we solved) (Table 2.1).  
 
 
 
 
Chapter Two 
 
 54 
Table 2.1. AmtR ligand library containing a list of molecules tested as 
putative AmtR ligands.  
Ligand group Example Reasoning 
Amino acids (a.a) 
 
Lysine 
 
 Nitrogen substrate and/or metabolite 
 
 AmtR binding site chemistry 
 
Glutamate 
 
Arginine 
 
Metabolic signaling 
molecules 
 
2-Oxoglutaric acid (2-OG) 
 
 Key intermediate in Krebs cycle 
 
 Metabolite of a.a metabolism and 
synthesis 
 
 AmtR binding chemistry 
 
 Intracellular nitrogen transportation 
 
 Signal of intracellular nutrient levels  
 
 
 
Adenosine monophosphate 
(AMP) 
 
Cyclic AMP  
  
Ammonia 
metabolism 
Guanidine 
 
 AmtR binding chemistry 
 
 Nitrogen metabolism 
 
 AmtR regulon 
Creatine 
 
Urea 
 
Agmatine 
 
Ammonia 
 
Chapter Two 
 
 55 
The molecules were screened as putative AmtR ligands with purified and 
extensively dialysed AmtR by a range or methods including (1) fluorescence 
binding assays, (2) EMSA of AmtR bound to the msmeg_2184 promoter region to 
test if putative ligands disrupted the protein-DNA interaction, (3) co-crystalization 
and post-soaking of AmtR crystals with putative ligands for X-ray 
crystallography, (4) high throughput differential scanning fluorimetry and (5) 
modelling of putative ligands into the binding pocket of the AmtR regulatory 
domain.  
 
2.2.6.3 Fluorescence Binding Assays 
The intrinsic fluorescence excitation and emission of AmtR was determined 
by a 3D wavelength scan using a F-7000 fluorescence spectrophotometer (Hitachi 
HTA, USA). Binding assays were conducted using a 280 nm excitation 
wavelength scan with peak emission of AmtR at approximately 330 nm. 
Molecules from the ligand library were screened for binding to AmtR with 
concentrations of ligand from 0 mM-100mM. Binding of ligand was represented 
by a change is AmtR emission wavelength or intensity proportional to the amount 
of ligand added to the assay.  
 
2.2.6.4 Ligand Screening via AmtR + DNA Complex Disruption by EMSA 
The binding of AmtR to its recognition sequence 
ATCTGTCATCTGACAG was used as a screen for ligand binding. The TetR 
protein family that AmtR belongs to is characterised by signalling molecule 
induced disruption of protein:DNA complexes.  To test if ligands from the library 
caused disruption of the AmtR:DNA, complex EMSA shifts were conducted 
(Section 2.2.5.1) with the addition of ligands ( 0 mM-100 mM). 
 
2.2.6.5 AmtR Co-Crystallisation and Post Soaking Additive Screens  
AmtR co-crystallisation fine screens and post soaking were set up (Section 
2.2.4.2) with the addition of 0 mM-100 mM ligand from the library to the ML. 
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2.2.6.6 High Throughput Differential Scanning Fluorimetry 
A differential scanning fluorimetry assay was performed at the University 
of Waikato by collaborating PhD student Michael Petridu to detect ligand 
interactions that promote protein stability (Niesen, Berglund, & Vedadi, 2007). 
Experiments were performed with final concentrations of 5 µM  purified AmtR 
protein and 5 x SYPRO® Orange Dye (Thermo Fisher Scientific) in single wells 
of an opaque 96-well plate. When started, DNA was added at a molar ratio of 30:1 
(AmtR:DNA). To detect ligand interactions, compounds were obtained from the 
nitrogen substrate PM3 Biolog Plate (Biolog Inc., Hayward CA), resuspended in 
50 µL PBS buffer to make final ligand concentrations of 2 mM. The melting 
temperature of AmtR was determined using a LightCycler®480 (Roche). Samples 
were equilibrated for 5 minutes at 25 °C and then the temperature was increased 
to 90 °C at a rate of 1 °C/min, taking a fluorescence reading every 0.07 °C. The 
melting point of the protein was calculated by the LightCycler®480 software 
v1.5.1.62. 
 
2.2.6.7 ParDOCK Modelling of Xanthine into AmtR Binding Pocket 
Xanthine was manually modeled into the AmtR binding site in a position 
where there was unresolved density that could not be satisfied by the model 
during molecular replacement. The structure was then run through a series of 
refmac5 refinements to optimize ligand positioning. To further optimize ligand 
positioning the structure was run through the ParDOCK program (Gupta, 
Gandhimathi, Sharma, & Jayaram, 2007). ParDOCK is an all-atom energy based 
Monte Carlo, rigid protein ligand docking program, which predicts the binding 
mode of the ligand in receptor target sites.  The ParDOCK output file was 
visualized in PyMOL (Delano, 2002) to identify the predicted hydrogen bonding 
interactions between the residues in the binding site and xanthine.  
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2.3 Results 
2.3.1 Expression and Protein Purification of AmtR in M. smegmatis 
Cloning and small scale expression trials were previously conducted and 
optimized by Jo McKenzie, a Post Doctoral fellow in the Arcus Lab. Protein 
expression cultures were scaled up (Section 2.2.2.7) and protein was initially 
purified by IMAC (Section 2.2.8.1) and analysed by SDS-PAGE (Section 
2.2.2.1). The chromatogram and corresponding SDS-PAGE gel (Figure 2.1) 
depict the column load, flow through and purification fractions. The AmtR 
monomer is 24.3 kDa, as shown by the SDS-PAGE gel. Non-specifically bound 
protein eluted early off the column at a low concentration of imidazole (100-250 
mM), whereas AmtR-His tagged protein eluted later in the gradient with a greater 
concentration of imidazole (400-650 mM). 
 
 
Figure 2.1. IMAC purification and corresponding SDS-PAGE analysis of 
AmtR. The chromatogram depicts the UV absorbance and elution profile and the 
corresponding SDS-PAGE gels depict the insoluble fraction after cell lysis (I), 
soluble fraction loaded onto the column (L) and the flow through fraction 
containing unbound non-specific protein (FT). Fractions and their elution position 
are shown by the coloured bars. The blue line represents the fractions containing 
the non His tagged protein and the red represents the fractions containing AmtR-
His tagged.  
 
AmtR was further purified by SEC (Section 2.2.2.8.2) (Figure 2.2).  
Proteins belonging to the TetR family generally function as dimers and AmtR 
eluted off the column as a single peak within the size range of 35-67 kDa, 
suggesting it is in a dimeric state (48.6 kDa).  
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Figure 2.2. SEC of AmtR and corresponding SDS-PAGE gel. The 
chromatogram depicts the UV absorbance profile of protein elution and the gel 
depicts the load and elution fractions. The position of the AmtR elution peak and 
approximate size is shown by the red bar.  
 
SEC purified protein was subjected to subsequent high salt (2 M NaCl) 
induced dissociation of any AmtR:DNA complexes that were present due to co-
purified genomic DNA, which may inhibit downstream in vitro analyses. The 
protein was then purified again by SEC in high salt buffer to ensure complete 
removal of contaminating DNA. To remove the high salt concentration and any 
co-purified ligands the protein was exhaustively dialysed into a low salt buffer 
(200 mM NaCl). The purified and dialysed AmtR was used for crystallisation 
trials, electrophoretic mobility DNA shift assays (EMSA) and ligand binding 
experiments. 
 
2.3.2 AmtR X-ray Crystallographic Structures 
2.3.2.1 AmtR C-terminal LBD Domain Structure 
2.3.2.1.1 Trypsin Treatment of Protein and Crystallisation  
Initial attempts to produce high quality crystals of the non truncated AmtR 
protein proved unsuccessful. Purified AmtR was then subjected to tryptic 
digestion to preferentially digest away the N-terminal DNA binding domain in 
order to crystallise only the C-terminal regulatory domain. AmtR trypsin treated 
crystals grew after 14 days in the crystallisation condtion 100 mM Na acetate pH 
5.0, 2.2 M Na formate with protein at 10 mg/ml. Crystals diffracted to 3 Å but the 
structure could not be solved by molecular replacement.  
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2.3.2.1.2 Heavy Metal Post Soaking of Trypsin Treated AmtR Crystals 
Trypsin treated crystals (Figure 2.3) were soaked overnight in the same 
conditions as Section 2.3.2.1.1 with the addition of mercury (5 mM HgCl2). These 
crystals showed significantly better diffraction (1.84 Å), and data was collected on 
these crystals to solve the AmtR structure. 
 
Figure 2.3. Crystal of M. smegmatis trypsin treated 
mercury soaked AmtR. Crystals grew after 14 days in 
100 mM Na acetate pH 5.0, 2.2 M Na formate with 
protein at 10 mg/ml. Crystal diffracted to 1.84 Å and a 
dataset was collected with 100 % completeness in space 
group I 2 3.  
 
 
2.3.2.1.3 Data Collection 
Data was collected on the above trypsin treated crystal soaked in mercury 
to 1.84 Å with 100% completeness at the wavelength 12290.0 eV (6 eV above the 
LIII edge of mercury) (Table 2.2). The data set was indexed and integrated using 
iMosflm 7.0.9 (Leslie & Powell, 2007) then scaled and truncated using Aimless 
(Evans & Murshudov, 2013) in the CCP4 platform suite 6.4.0 (Collaborative 
Computational Project, Number 4, 1994). The resolution limit of 1.84 Å for the C-
terminal domain dataset gives a very high R-merge value 0.201 (1.662) (Table 
2.2). This is possibly the result of the very high redundancy. This resolution limit 
of 1.84 Å can be justified by the CC½ of 0.859 in the outer shell and the mean 
I/σ(I) 2.9 in outer shell (Table 2.2).  
 
2.3.2.1.4 Structure Solution and Refinement 
Phasing was achieved using the Single-wavelength Anomalous Diffraction 
(SAD) technique to solve the C-terminal AmtR structure. Initial mercury sites 
were identified and refined using SHELX (Sheldrick, 2007) and the solution was 
autosolved in space group I 2 3 using autorickshaw (Panjikar, Parthasarathy, 
Lamzin, Weiss, & Tucker, 2005) (Table 2.2). The structure was refined by initial 
restrained refinement in refmac5 (Murshudov et al., 2011; Murshudov, Vagin, & 
Dodson, 1997) in the CCP4 suite 6.4.0. Subsequent cycles of manual refinement 
using COOT 0.7 (Emsley, Lohkamp, Scott, & Cowtan, 2010) followed by 
refinement in Refmac5 on the CCP4 suite 6.4.0 were done (Table 2.2).  
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Table 2.2. Data Collection and Refinement Statistics. 
 SAD/Truncated structure MR/Full Structure 
Data collection   
Wavelength 1.0072  Å 0.95370 Å 
Space group I 2 3  C 2  
Unit cell dimensions (Å) 111.1, 111.1, 111.1 181.8, 105.8, 39.57 
Unit cell dimensions (°) 90, 90, 90 90, 94.5, 90 
Resolution (Å) 32.07-1.84, (1.88-1.84) 37.25-1.98 (2.03-1.98) 
R-merge 0.201 (1.662) 0.100 (0.694) 
CC (1/2) 0.999 (0.859) 0.997 (0.769) 
Completeness (%) 100 (100) 97.1 (90.5) 
Redundancy 42.7  (39.7) 6.7 (5.7) 
No. of observations 856794   (48790) 336413   (18392) 
No. of unique reflections 20068 (1230) 50329 (3241) 
Mean I/σ(I) 69.1 (2.9)  9.6 (2.1) 
Phasing Statistics 
Anomalous completeness 99.9 - 
Anomalous multiplicity 22.1 - 
DelAnom correlation between half sets 0.764 (0.035) - 
Refinement   
R-factor 0.183 0.212 
R-free 0.210 0.252 
Protein atoms 1097 4549 
Metal atoms 9 Hg - 
Solvent atoms 147 126 
Average B value (Å
2
) 25.7 28.8 
RMSD   
Bond angles (°) 2.670 1.851 
Bond lengths (Å) 0.028 0.018 
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2.3.2.1.5 Structural Analysis 
The crystal structure showed trypsin had cleaved off the N-terminal 3-
helical DNA binding domain (DBD), leaving the larger 7 α-helical C-terminal 
ligand binding domain (LBD) (Figure 2.4). The structure crystalised as a 
homodimer with one molecule in the asymmetric unit. 
 
Figure 2.4. A cartoon diagram of the X-ray crystal structure of the C-
terminal ligand binding domain of M. smegmatis AmtR.  The structure was 
solved using SAD on a mercury soaked crystal. The structure resolved to 1.84 Å 
in 1 2 3 symmetry. The structure is solved as a homodimer with each monomer 
composed of a 7-α helical domain. The N-terminus is helix α4 and is coloured 
dark blue. The C-terminus is helix α10 and is coloured red. This figure and all 
other structural figures have been drawn using PyMOL (Delano, 2002). 
 
The structure of the LBD begins at the N-terminal helix α4 which is a long 
helix composed of 24 residues (Asp66-Gly89) that runs parallel with helix α7 
(Figure 2.4). Helix α4 is responsible for connecting the DBD to the LBD. Helix 
α4 is followed by a short loop region before the start of helix α5. The LBD 
domain is built around a central triangle composed of helices α5, α6 and α7, with 
helix α5 and helix α7 running antiparallel with each other so that the start of helix 
α5 and the end of helix α7 are close to each other (Figure 2.5).  Helix α6 curves 
around helix α4 (Figure 2.5) and is composed of 9 residues but has only one full 
turn of a helix. Helix α8 runs at an angle that is nearly parallel with helix α5. 
Helix α9 is positioned behind the central triangle and runs antiparallel with helix 
α8. (Figure 2.5) Helix α8 and helix α9 constitute the dimerization interface 
Chapter Two 
 
 62 
forming an orthogonally packed four-helix bundle with the same helices (helix 
α8’ and helix α9’) from the other monomer (Figure 2.4).  
 
Figure 2.5. Cartoon diagram of AmtR monomer showing the central triangle 
of the LBD made up of helices α5, α6 and α7. Helices α5 and α7 run antiparallel 
to each other with the N-terminus of helix α5 interacting with the C-terminus of 
helix α7. Helix α6 forms the base of the triangle by wrapping around helix α4 and 
is the most disordered region of the structure. Helices α8 and α9 sit at the back of 
the triangle and run antiparallel to each other. Helices α4, α8, α9 and α10 have 
been shown in ribbon form to highlight the conserved triangle of helices α5, α6 
and α7. 
 
The LBD forms a large binding pocket in the centre of each monomer, 
which is accessed by a long entrance tunnel (Figure 2.6). The AmtR binding 
pocket sits in the lower section of the triangle in the space between helices α4 and 
α5 with a volume of approximately 125.70 Å3 (Figure 2.6). The pocket consists of 
11 residues from helices α4 α5, α6, α7 and α8: 7 polar residues (Thr76 Asp105, 
Tyr104, Glu108, Tyr144, Arg167 and Glu170) and 5 non-polar residues (Pro80, Leu101, 
Leu109, Leu140 and Phen166) (Figure 2.6). Glu170 on helix α8 shows density for 
alternative conformations and sits at the entrance of the binding pocket. It is 
speculated that this residue may act as a gate to the binding pocket that can 
change position based on the conformation of AmtR and help stabilise ligand 
binding. 
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A 
 
 
 
B 
 
Figure 2.6. The M. smegmatis LBD (A) A mesh lined space filling model of the 
AmtR LBD monomer structure showing the long entrance tunnel along the grey 
surface with three water molecules (in blue) sitting in it. The binding site is shown 
in black with a mesh surface. (B) The AmtR LBD flipped 90 ° to illustrate the 
putative interacting residues in binding pocket as sticks from helices α5, α6, α7 
and α8. Glu170 is shown with its alternate confirmations illustrating its potential 
role as a gate to the binding pocket. 
 
2.3.2.2 AmtR Full Structure  
2.3.2.2.1  DNAse Treatment of Protein and Crystallisation 
A good quality non-trypsin treated AmtR crystal (Figure 2.7) was obtained 
only from fresh (1 hr post-purification) AmtR that had been DNase treated in the 
same crystallisation condition as trypsin treated crystals (100 mM Na acetate pH 
5.0, 2.2 M Na formate with protein at 10 mg/ml). The crystal diffracted to 1.98 Å 
and data was collected on this crystal for structure solution by molecular 
replacement (MR). 
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Figure 2.7. M. smegmatis AmtR non-trypsin 
treated crystal. The crystal grew only from fresh (1 
hr post-purification) AmtR that had been DNase 
treated in 100 mM Na acetate pH 5.0, 2.2 M Na 
formate with protein at 10 mg/ml. The crystal 
diffracted to 1.98 Å and a dataset was collected with 
97.1 % completeness in space group C2. 
 
 
2.3.2.2.2 Data Collection 
Data was collected on the above crystal to 1.98 Å and a dataset was 
collected with 97.1 % completeness in space group C2 at the wavelength 12669.5 
eV (Table 2.2). The data set was indexed and integrated using iMosflm 7.0.9 
(Leslie & Powell, 2007) then scaled and truncated using Aimless (Evans & 
Murshudov, 2013) in the CCP4 platform suite 6.4.0 (Collaborative Computational 
Project, Number 4, 1994).  
 
2.3.2.2.3 Structure Solution and Refinement 
The structure solution was determined by molecular replacement (MR) 
using the truncated AmtR structure solved by SAD as a model.  MR was done in 
Phaser (McCoy et al., 2007) in the CCP4 suite 6.4.0. The N-terminal domain was 
then built in using Buccaneer (Cowtan, 2006; Cowtan, 2007). The structure was 
refined by initial restrained refinement in refmac5 (Murshudov et al., 1997; 
Murshudov et al., 2011) refinement in the CCP4 suite 6.4.0. Subsequent cycles of 
manual refinement using COOT 0.7 (Emsley et al., 2010) followed by refinement 
in Refmac5 on the CCP4 suite 6.4.0 were done (Table 2.2). The Coordinate files 
and structure factors for the full structure has been deposited in the Protein Data 
Bank with PDB code 5E57. 
 
2.3.2.2.4 Structural Analysis 
The structure crystalized as a homodimer with each monomer composed 
of 10 α-helices with connecting turns and loops that constitute two domains 
(Figure 2.8). The N-terminal domain is a Helix-Turn-Helix (HTH) DNA binding 
motif and is composed of helices α1, α2, and α3. The C-terminal domain is the 
LBD as described in Section 2.3.1.1. 
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Figure 2.8. Cartoon diagram of the full X-ray crystallographic structure 
of M. smegmatis AmtR. The structure was solved by molecular replacement to 
1.98 Å with C2 symmetry. The structure solved as a homodimer with each 
monomer composed of 10 α helices constituting a N-terminal HTH DNA binding 
domain and a C-terminal LBD domain.  
 
Alignment of the SAD LBD structure with the full structure of AmtR 
showed a Root Mean Standard Deviation (RMSD) of 0.36 Å. The main area of 
disparity is at the N-terminus where the full structure has the DBD present and the 
SAD structure does not. There is a difference of 5.8 Å at the N-terminus of the 
helix α4 between the structures, as a result of the DBD changing the orientation of 
this region in the full structure (Figure 2.9).  Helices α6 of both structures are 
variable in both secondary structure and position and also align poorly. There is a 
difference of 12.2 Å between the last turn of the helix in both structures (Figure 
2.9). This observed variability is important for the signal transduction to be 
transferred from the ligand binding site to the DBD.  The N-terminal region of 
helix α7 has a difference of 3.2 Å, as a result of the full structure having a more 
significant kink in the helical structure (Figure 2.9).  Helices α5, α8, α9 and α10 
align well. Helix α10 in the full structure has an extension containing a disordered 
region followed by a small helix that is composed of the C-terminal 6-His tag.  
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Figure 2.9. Alignment of the SAD and full structure of AmtR. The SAD 
structure is coloured grey and the full structure is coloured cyan. The SAD 
structure is composed of the C-terminus LBD and the full structure is composed 
of both the N-terminus DBD and the C-terminus LBD with an extension to the 
helix α10 containing a 6-His tag. (A) Good alignment for the LBD with the 
exceptions in the N-terminus of helices α4 and α7. (B) Rotation of structures by 
90 ° to show the poor alignment in variable region of helix α6. 
 
2.3.2.2.5 The N-Terminal DNA Binding Domain (DBD) of AmtR 
The AmtR DBD domain is 46 residues and is composed of a long helix α1 
(14 residues (Arg23-Thr36)), followed by a HTH motif composed of helices α2 and 
α3 which are orientated to insert into the major groove of DNA (Figure 2.10). 
Helix α2 is composed of 6 residues (Arg54-His60) and forms a small helix. Helices 
α2 and α3 are at an 80.5 ° angle and joined by a 5 residue turn. Helix α3 is 
composed of 5 residues (Ala56-His60) and forms a short helix that constitutes the 
recognition helix of the HTH motif  (Figure 2.10).  
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Figure 2.10. Cartoon diagram of the AmtR dimer DBD. Helix α1 is the longest 
helix shown in dark blue followed by helix α2 shown in lighter blue and then the 
recognition helix α3 shown in aqua blue. Helix α4 is shown in cyan and is 
represented in ribbon form to help illustrate the helices that compose only in the 
DBD. The 80.5 ° angle between the helices that compose the HTH motif, α2 and 
α3, is shown in yellow.  
 
The DBD has a positively charged surface (Figure 2.11), with the residues 
responsible for this charge from helices α1 (Arg23), α2 (Arg45 & Arg46) and α3 
(His60) and the loops between helices α1-α2 (His37), α2-α3 (Arg54) and α3-α4 
(His61 & Lys65).   
 
Figure 2.11. Electrostatic image of the AmtR dimer. (A) Full structure showing 
electrostatic properties of the AmtR dimer surface. (B) AmtR dimer rotated 90 ° 
to show the positive charge of the DBD. 
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2.3.2.2.6 Comparison of AmtR to Characterised TetR Structures 
Although there are over 100 TetR structures in the PDB, no pair of any 
solved TetR shares more than 36 % sequence identity and less than 20 have been 
functionally characterized (Yu, Reichheld, Savchenko, Parkinson, & Davidson, 
2010). The lack of conservation is seen in the ligand binding domain with the 
average pairwise identity at only 9 % (Yu et al., 2010). The structures range from 
177 to 237 residues in length and all possess nine conserved helices where helix 1 
to helix 3 comprises the DBD domain and helix 4 to helix 9 comprises the LBD 
domain (Yu et al., 2010).  
 
The M. smegmatis AmtR structure was compared with structures in the 
PDB using the PDBeFOLD server. The closest structure was a putative TetR from 
Rhodococcus jostii RHA1, a close relative of mycobacteria (McLeod et al., 2006) 
(PDB code 3HIM; Z = 6.64; RMSD, 2.40 Å; number of matched residues, 168; 
sequence identity, 23 %). The structure was solved with C2 symmetry to 2.2 Å. 
No functional work has been done on this protein so no further comparisons were 
made. The second alignment was with the TetR protein, phenylacetic acid and 
fatty acid metabolism regulator (PfmR), from the extremely thermophilic 
bacterium, Thermus thermophilus HB8 (Agari, Sakamoto, Kuramitsu, & Shinkai, 
2012) (PDB code 3VPR; Z = 7.0; RMSD, 2.31 Å; number of matched residues, 
159; sequence identity, 18 %) (Figure 2.12). Other alignments included another 
putative transcriptional regulatory protein also from R. jostii RHA1 (PDB code 
2IBD; Z = 6.71; RMSD, 2.49 Å; number of matched residues, 163; sequence 
identity, 21 %), the nucleoid occlusion factor SlnA protein from E. coli (PDB 
code 4GCL; Z = 6.30; RMSD, 2.87 Å; number of matched residues, 162; 
sequence identity, 19 %), the nucleoid occlusion factor SlnA protein from 
Klebsiella pneumonia (PDB code 4GCK; Z = 5.91; RMSD, 2.93 Å; number of 
matched residues, 161; sequence identity, 1 8%) and the transcriptional regulator 
HlyllR from Bacillus cereus (PDB code 2JK3; Z = 5.45; RMSD, 2.46 Å; number 
of matched residues, 145; sequence identity, 15 %). 
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Figure 2.12. Alignment of the AmtR monomer with the PfmR monomer 
using PDBeFOLD. AmtR is coloured dark cyan and PfrmR is coloured light 
cyan. Areas of no alignment are coloured grey. Areas of the poorest alignment are 
observed in the C-terminal LBD. 
 
PfrmR is characterised as a transcriptional repressor of the operons 
involved in phenylacetic acid and fatty acid metabolism. The N-terminal domain 
of PfmR resembles that of the DNA-binding domain from the QacR family of 
TetR transcription factors (Agari et al., 2012). QacR transcription factors are 
unique in their DNA binding mechanisms, as they generally recognise a longer 
sequence of DNA and involve the binding of a pair of QacR dimers (Schumacher 
et al., 2002). TetR DNA binding is generally by one dimer to a 15 bp DNA 
sequence upstream of the gene or promoter that it regulates (Orth et al., 2000).  
 
The AmtR HTH motif aligns well with the QacR HTH motif (RMSD, 
0.818 Å; number of matched residues, 49) (Figure 2.13).  It also contains 4 (Thr44, 
Tyr59, His61 & Lys65) of the 7 QacR DBD residues (Thr25, Ser34, Ser35, Tyr40, 
Tyr41, His42, & Lys46), which form hydrogen bonds with the backbone of the 
major groove of DNA in the QacR-DNA complex. The alignment shows that like 
QacR, the AmtR helix α2 is orientated to insert into the major groove of DNA and 
the N-terminus of the α3 points towards the centre of the DNA major groove, 
while the helix axes runs parallel to the major groove. This alignment suggests 
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that AmtR binds DNA in the same mechanism as QacR. Interestingly the residues 
responsible for binding to specific nucleotides in QacR are absent in AmtR, 
suggesting that binding to the major groove of DNA by AmtR is achieved by the 
QacR mechanism but the specificity in DNA recognition is not shared.  
 
Figure 2.13. AmtR DBD superimposed over QacR DBD bound to DNA. 
AmtR is in cyan and QacR is in grey. (A) Cartoon diagram of interaction of 
QacR DBD bound to DNA with AmtR DBD superimposed over QacR. (B) 
Ribbon diagram of alignment rotated 90 ° to show conserved DNA binding 
residues Thr44, Tyr59, His61 and Lys65. 
 
As mentioned earlier, it is common for TetR proteins to be disparate in the 
LBD, as a result of the difference in ligand binding and regulatory control. This is 
the case for AmtR and PfmR. Although the DBD regions align relatively well, the 
LBD regions show poor alignment and diverge significantly in their binding 
pocket volume and composition. Interestingly, PfmR appears to have a glutamate 
gate (Glu123) at the entrance site to the binding pocket, similar to the Glu170 
observed in AmtR (Figure 2.14).  
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A 
 
B 
 
Figure 2.14. Comparison of (A) PfmR (Agari et al, 2012) and (B) AmtR 
binding pockets. Both pockets are composed of aromatic residues, hydrophobic 
residues and polar residues characteristic of TetR binding pockets. Both structures 
show a glutamate residue at the entrance of the binding pocket that may act as a 
gate for ligand binding. In PfmR, the glutamate bridge is labelled E123 and sits at 
the entrance of the cavity. In AmtR, the glutamate bridge is labelled Glu170 and 
also sits at the entrance of the cavity. Direction of ligand movement into binding 
pocket is indicated by green arrow in both figures. 
 
2.3.2.2.7 Conserved Structural Features of AmtR 
The DBD domain is the most structurally conserved region of TetR 
structures (Yu et al., 2010), which is composed of a typical HTH motif (Yu et al., 
2010). The AmtR DBD domain shares this conservation with the two short 
helices, α2 and α3 composing the HTH motif. Generally, there is a water molecule 
bound to a threonine that sits in the turn between helices α1 and α2, two residues 
beside the start of helix α2, and to the arginine in the first position of helix α2. The 
binding of these water molecules help orientate the residues in the HTH motif for 
binding to DNA (Orth et al., 2000). In the AmtR structure the threonine is 
substituted to a serine (Ser43) and the arginine (Arg45) is conserved as the first 
position in helix α2 (Figure 2.15). Interestingly, the residue in between Ser43 and 
Arg45 is a threonine (Thr44), and, from the structure, appears to be the only residue 
in this region that has a water molecule bound to it (Figure 2.15).  Helices α2 and 
α3 are normally at a 120 ° angle and joined by a tight 4 residue turn with glycine 
found in the second position. The AmtR structure varies in that the angle of the 
turn between helices α2 and α3 is 80.5 ° and the turn is 5 residues long instead of 
4 (Figure 2.15).   
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Figure 2.15. Conserved 
features of AmtR HTH 
motif (A) AmtR HTH 
motif amino acid sequence 
with conserved residues 
annotated. Helices α2, α3 
and the N-terminus of α4 
are shown above the 
sequence in magenta. The 
conserved turn between 
helices α2 and α3 is shown 
above the sequence in 
blue. The conserved 
amino acid residues are 
highlighted below the 
sequences in dark blue. 
(B) AmtR Thr44 bound to 
water. The bound water 
molecule is shown as a 
blue sphere with the 
interaction shown as a 
yellow dotted line.  
 
Helix α3 of TetR structures is the most conserved helix, with each 
subfamily having high conservation, indicating that closely related TetR proteins 
within subfamilies recognise similar DNA sequences (Yu et al., 2010). This helix 
is termed the recognition helix and is responsible for inserting into the major 
groove of the DNA and interacting with the nucleotides of the palindromic 
sequence, with the exception of the 3 central base pairs. Upon binding, the major 
groove is widened at recognition half sites and narrowed at the central base pairs 
of the palindromic sequence due to partial unwinding (Orth et al., 2000).  
 
The core residues responsible for binding DNA are highly conserved in 
TetR proteins and are located either in helix α3 or in the loop between helices α3 
and α4 (Yu et al., 2010). Figure 2.16 shows the sequence alignment of the AmtR 
DBD domain with representative DBD domains of the TetR family (PfmR, TetR 
& QacR) illustrating the conserved residues Leu58, Tyr59, His61 and Lys65. 
Residues Tyr59, His61 and Lys65 are responsible for hydrogen bonding to the 
phosphate groups in the major groove containing the recognition sites of the 
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palindromic DNA. The side chain of Lys65 also forms hydrogen bonds with 
oxygen atoms in residues in the loop between helices α1 and α2, which are 
thought to stabilise the region (Yu et al., 2010). Lys65 also forms salt bridges with 
the DNA phosphate backbone, showing that it is a critical residue for DNA 
binding and functions to both stabilize the DBD domain and interact with DNA. 
 
Figure 2.16. AmtR DBD domain alignment with PfmR, TetR and QacR 
illustrating the conserved residues Leu58, Tyr59, His61 and Lys65. Residues 
Tyr59, His61 and Lys65 are responsible for interacting with nucleotides in the major 
groove of DNA containing the recognition sites of palindromic sequence. Lys65 
plays an instrumental role in both DBD stabilisation and DNA binding. 
 
The LBD domains of TetR structures are inherently disparate because of 
the diversity of regulatory functions played by the TetR family, however there are 
a small number of conserved structural features. The LBD is built around a central 
triangle composed of helices α5, α6 and α7. Helices α5 and α7 generally run 
antiparallel with each other so that the start of helix α5 and the end of helix α7 are 
close to each other. This structure is also observed in AmtR as mentioned earlier. 
The variable region of the helix α6 seen in AmtR is conserved in all TetR 
structures. This is a result of the requirement of helix α6 a to be displaced when 
the ligand is bound into the binding site (Orth et al., 2000). The movement of 
helix α6 displaces helix α4 causing the HTH motif to swing in a pendulum-like 
motion by about 5 ° (Orth et al., 2000). This movement shifts the recognition 
helix α3 along the major groove of the DNA to disrupt the protein-DNA complex 
(Orth et al., 2000).  
 
There is only one position in the LBD of TetR structures where there is a 
strongly conserved residue and it is a glycine that is found in the loop between 
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helices α7 and α8, and the angle between these helices is generally conserved at 
58 ° with a standard deviation of 6 ° (Yu et al., 2010). The conserved glycine has 
been shown to play a critical role in maintaining the angle and stabilization of the 
LBD (Yu et al., 2010). This is also observed in AmtR, which actually has two 
glycines (Gly156 & Gly157) present in the loop and the angle between helices α7 
and α8 is 59 ° (Figure 2.17). Helices α8 and α9 constitute the dimerization 
interface forming an orthogonally packed four-helix bundle with the same helices 
(helix α8’ and helix α9’) from the other monomer.  
 
Figure 2.17. Cartoon diagram of AmtR LBD showing 59 ° angle of helices α7 
and α8. Helix α7 is coloured yellow and helix α8 is coloured rust. The two 
conserved glycine residues Gly156 and Gly157 are also shown in the loop between 
helices α7 and α8. 
 
The size of TetR ligand binding cavities range from 25 to 5278 Å
3
. Each 
monomer possesses one cavity so that each dimer can bind two identical ligands 
simultaneously (Yu et al., 2010). The binding cavities are generally characterised 
as hydrophobic with an enrichment of aromatic residues (Phe, Trp and Tyr). The 
hydrophobic binding cavities have been shown to bind to small hydrophobic 
molecules or ring-containing molecules, which allow favourable stacking and van 
der Waals interactions with the aromatic residues (Yu et al., 2010). The AmtR 
binding cavity is approximately 125.7 Å
3
 and consists of 11 residues containing 7 
polar residues and 5 non-polar residues including 4 aromatic residues. Glu170 on 
α9 forms a potential gate of the pocket that extends into a well-defined entrance 
site that is formed by helices α6- α9. The similarity of the AmtR binding pocket to 
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that of other TetR structures indicates that AmtR likely binds a small hydrophobic 
molecule or a ring containing ligand.  
 
In summary, the AmtR structure is a homodimer, with each monomer 
containing a N-terminal DBD and a C-terminal LBD. The DBD shares conserved 
residues and structural characteristics with the transcription factor QacR, 
suggesting that it binds DNA as a pair of dimers in the same mechanism as QacR. 
Like all TetR structures, the AmtR LBD is unique and forms a large binding 
pocket in the lower centre of each monomer, which is accessed by a long entrance 
site. The pocket has an enrichment of aromatic residues and both hydrophobic and 
hydrophilic residues, suggesting that it binds a ring containing signalling 
molecule. The residue Glu170 on helix α8 sits at the entrance of the pocket and 
shows density for alternative conformations indicating that it may act as a gate 
that can change position based on the conformation of AmtR and help stabilise 
ligand binding.  
 
2.3.3  Identification of AmtR Regulated Genes and Recognition Sequence 
2.3.3.1 AmtR Regulon 
To determine the genes under the control of M. smegmatis AmtR an initial 
search of the M. smegmatis genome using variations of the C. glutamicum AmtR 
recognition motif was conducted and one putative semi-palindromic sequence in 
the promoter region upstream of the vapBCmsmeg_1283/4 operon was identified. The 
C. glutamicum AmtR binding motif is ATCTATAGn1-4ATAG (Figure 2.18), 
which is present in the promoter region of the vapBCmsmeg_1283/4 operon at -29 to -
47 upstream of the operon start site; however, the interspacing region between the 
two half sites is 9 bp compared to the 1-4 bp seen in C. glutamicum.  
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Figure 2.18. The C. glutamicum AmtR recognition motif identified in the 
upstream promoter region of the M. smegmatis vapBC operon msmeg_1283/4 
(A) The AmtR recognition motif of C. glutamicum. The height of letters 
represents the frequency of corresponding nucleotides in the motif. Figure from 
Beckers et al. (2005). (B) The M. smegmatis vapBC operon (msmeg_1283/4) 
promoter region showing C. glutamicum AmtR bind motif upstream of the start 
codon for the msmeg_1283 gene. 
 
Additionally, microarray analysis of the M. smegmatis AmtR deletion (M. 
smegmatis Δamtr) strain by our collaborators at Otago University identified a 
number of genes found to be differentially expressed in the absence of AmtR. The 
main genes found to be regulated by AmtR were msmeg_2184, msmeg_2185, 
msmeg_2186, msmeg_2187 and msmeg_2189. These appear to form an operon 
and are annotated to encode an amino acid permease, two hypothetical proteins, a 
urea carboxylase (UC), and an allophanate hydrolase (AH) respectively (Figure 
2.19).  
 
Figure 2.19. Genomic and chemical schematic of the putative metabolic 
pathway encoded by the urea carboxylase and allophanate hydrolase 
(UC/AH) operon in the M smegmatis AmtR regulon. The AmtR protein 
functions as transcriptional repressor of the UC/AH encoding operon under 
nitrogen surplus. When nitrogen levels drop, AmtR is released from the 
msmeg_2184 promotor region, which activates transcription of the genes encoding 
UC/AH, an energy-dependent urea degradation pathway (Petridis, 2015). 
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None of the genes identified in the above operon have been functionally 
characterised in M. smegmatis and their function remains hypothetical; however, 
in other organisms, the UC and AH proteins are known to form an enzyme 
complex that converts urea to ammonium via an ATP-dependent process (Figure 
2.19) (Whitney, Cooper & Magasanik, 1973). This indicates that in M.smegmatis, 
AmtR controls a regulon of genes involved in alternative nitrogen uptake (amino 
acid permease) and urea metabolism (UC and AH), confirming that AmtR 
functions as a nitrogen regulator in mycobacteria. The results of the microarray 
analysis and subsequent confirmation of the M. smegmatis AmtR regulon are 
elaborated in Michael Petridu’s PhD thesis (Petridis, 2015).  
 
2.3.3.2 AmtR Recognition DNA Sequence 
The upstream regions of all differentially expressed genes in the M. 
smegmatis Δamtr strain were analysed and a 16 bp consensus sequence of 
TCTGTn4-6ACAG was identified as a putative AmtR recognition motif. Promoter 
regions from the differentially expressed genes msmeg_2184 (Pmsmeg_2184) and 
msmeg_2185 (Pmsmeg_2185) were selected as representative binding sites and tested 
for AmtR binding by electrophoretic mobility shift assays (EMSA) using purified 
and exhaustively dialysed AmtR protein from M. smegmatis (Sections 2.2.2.8 and 
2.2.3). 
 
AmtR caused a mobility shift only when incubated with Pmsmeg_2184 at a 
DNA:protein molar ratio of 1:50 (Figure 2.20). To determine specificity of 
binding, unlabelled specific DNA was added in 120 x excess resulting in complete 
abolition of the shift (Figure 2.20). Non-specific DNA (promoter region of 
msmeg_phoH2 gene) was added in 103 x excess (accounting for size difference 
between specific and non-specific DNA) and did not affect the mobility shift 
(Figure 2.20). This demonstrates that AmtR binds specifically to the upstream 
promoter region of msmeg_2184, albeit with low affinity.  
 
To identify the M. smegmatis AmtR binding motif, Pmsmeg_2184 was mutated 
and the EMSA was repeated. Using the consensus sequence TCTGTn4-6ACAG 
determined by the microarray experiment, we mutated six nucleotides to adenine 
in the 40 bp DNA fragment (Figure 2.20). The shift was not observed when the 
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EMSA DNA fragment was replaced by the mutated sequence (Figure 2.20). This 
result demonstrates that the specificity of the nucleotides present in the two half 
sites of the recognition sequence are critical for binding. To test for ligand-
dependent binding, we repeated the above assays in the presence of various 
concentrations of putative ligands, however no conclusive results were obtained. 
A 
 
B 
 
C  
 
Figure 2.20. In vitro DNA binding of M. smegmatis AmtR to msmeg_2184 
promoter DNA. (A) EMSA with AmtR protein and unmutated vs mutated DIG-
labelled 40-bp DNA fragment including the putative AmtR-binding site in 
Pmsmeg_2184. The molar ratios of DNA to protein are shown above. Controls for 
binding specificity (lane S) using 103-fold excess of unlabelled Pmsmeg_2184 (lane S) 
and using 103-fold excess of unlabelled promoter region of the unspecific phoH2 
gene (lane U) are shown. EMSA using a mutated promoter region of Pmsmeg_2184 is 
shown in lane M. (B) Pmsmeg_2184 containing the AmtR binding recognition 
sequence at -42 bp to -56 bp. (C) Unmutated vs mutated AmtR-binding region in 
Pmsmeg_2184. Nucleotides in the inverted repeats were mutated (shown in red) using 
site-directed mutagenesis. 
 
The alignment of all the putative M. smegmatis AmtR recognition sites 
used in this study (Figure 2.21) shows that the Pmsmeg_2184 and Pmsmeg_2185 
sequences are very similar, sharing 11 nucleotides, including 9 nucleotides in the 
two half sites. The main difference between the two sequences is that the spacing 
region between the two half sites is 6 bp in Pmsmeg_2184 and 4 bp in Pmsmeg_2185. 
Although both sequences are very similar, M. smegmatis AmtR only recognised 
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and bound the Pmsmeg_2184 sequence. The specificity of AmtR for Pmsmeg_2184 and 
not Pmsmeg_2185, in combination with the microarray analysis and the location of 
each gene to each other in the genome suggests that msmeg_2184, msmeg_2185, 
msmeg_2186, msmeg_2187 and msmeg_2189 form an operon, which is controlled 
by AmtR at the promoter region of msmeg_2184. The vapBCmsmeg_1283/4 promoter 
region sequence, which AmtR does not recognise, also shares 11 nucleotides with 
the msmeg_2184 recognition motif (Figure 2.21). Similar to msmeg_2185, the 
main difference between msmeg_2184 and vapBCmsmeg_1283/4 is the spacing 
between the two half sites, where it is 6 bp in msmeg_2184 and 9 bp in 
vapBCmsmeg_1283/4. This indicates that the spacing region between each half site of 
the recognition sequence is critical for binding.  
msmeg_2184 A  T C T G T C A T C T G _ _ _ A C A G 
msmeg_2185 G T C T G T G A C C _ _ _ _ _ A C A G 
msmeg_1283/4 A T C T A T C A A G G T C G T A T A G 
Figure 2.21. Alignment of all M. smegmatis putative AmtR recognition motifs 
used in EMSA. AmtR bound to msmeg_2184 but not msmeg_2185 or 
vapBCmsmeg_1283/4. Nucleotides in red represent shared conservation with the 
msmeg_2184 AmtR recognition motif.  
 
Recent characterisation of AmtR from the actinomycetes family member, 
Streptomyces avermitilis, has revealed another organism specific AmtR 
recognition motif and a putative actinomycetes consensus semi-palindromic 22 bp 
AmtR recognition motif:  n4CTnTCn4GACnGn4 (Figure 2.22) (Chen et al., 2013). 
 
Figure 2.22. MEME-derived consensus sequence from the upstream regions 
of all AmtR regulated genes. The height of each letter in the logo is proportional 
to the frequency of the nucleotide appearance.  Figure from Chen et al., (2013). 
 
To determine the new consensus sequence for the actinomycetes AmtR 
recognition motif, given that we determined the M. smegmatis AmtR binding 
sequence as ATCTGTCATCTGACAG, the actinomycetes representative AmtR 
recognition sequences were aligned to look for conserved nucleotides (Figure 
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2.23). The first half site of the M. smegmatis recognition motif is similar to the 
first half site of the C. glutamicum AmtR recognition motif, with the exception of 
the 5
th
 bp being guanine instead of adenine, respectively. The spacing region 
between the two half sites is 6 bp in both the M. smegmatis and C. glutamicum 
AmtR recognition motifs. The second half site of the AmtR motif in both 
organisms varies only at the 16
th 
bp, where it is a cytosine in M. smegmatis and a 
thymine in C. glutamicum. In S. avermitilis, there are conserved nucleotides in 
both of the half sites, with the second half site being identical to the M. smegmatis 
second half site. The main difference between S. avermitilis and the two other 
motifs is the spacing region, which is extended by 2 bp. Based on the alignments 
of these representative AmtR recognition motifs the new actinomycetes AmtR 
consensus sequence for binding is the semi-palindromic 16-18 bp sequence 
ATnTnTn6-8AnAG (Figure 2.23). 
Organism 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
M. smegmatis 
 
A T C T G T C A T C T G _ _ A C A G 
C. glutamicum 
 
A T C T A T A G N N N N _ _ A T A G 
S. avermitilis 
 
A T T T C T G T C G C C C G A C A G 
Actinomycetes 
consensus 
A T N T N T N N N N N N N N A N A G 
Figure 2.23. Actinomycetes consensus AmtR recognition motif. Alignment of 
the actinomycetes representative AmtR recognition sequences from M. 
smegmatis, C. glutamicum and S.avermitilis show the conserved regions of the 
motif. Red nucleotides represent nucleotides shared between the motifs (positions 
1, 2, 4, 6, 15, 17 and 18). 
 
Using a combination of microarray analysis and EMSA, this study has 
revealed the M. smegmatis AmtR regulon and the recognition sequence required 
for AmtR binding. The AmtR regulon is composed of genes that form an operon, 
which encode for proteins involved in alternative nitrogen uptake and urea 
metabolism. By testing native and mutated putative AmtR recognition sequences 
by EMSA, it was possible to determine the M. smegmatis AmtR recognition 
sequence, which is very similar to the C. glutamicum AmtR recognition motif. 
This study also revealed that both the specificity of nucleotides present in the two 
half sites and the spacing between these two half sites of the recognition sequence 
are crucial for AmtR binding. By comparing the M. smegmatis AmtR recognition 
sequence and all other representative AmtR DNA binding motifs, it was possible 
to generate a modified actinomycetes AmtR consensus recognition motif.  
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2.3.4 AmtR Signalling Molecules 
AmtR, like all TetR transcription factors, is known to act as a repressor of 
gene expression when bound to DNA in the promoter region of the genes under its 
regulation. In C. glutamicum, AmtR repression is lifted as a result of direct 
interaction with the adenylylated PII signalling protein GlnK, which only occurs 
under nitrogen limiting conditions (Beckers et al., 2005). To investigate GlnK as a 
signalling protein for M. smegmatis AmtR, both proteins (AmtR and GlnK in both 
the native (GlnK) and adenylylated (GlnK-AMP) form) (Figure 2.24) were 
purified and subjected to Size Exclusion Chromatography (SEC) pull down 
assays. To produce GlnK-AMP M. smegmatis overexpression cultures were 
grown in nitrogen limiting conditions to induce the post-translational 
adenylylation of GlnK. Adenylylation was confirmed by the enrichment of a band 
at 15 kDa which only appeared under nitrogen limiting growth conditions (Figure 
2.24).  The results were validated with both denaturing and native protein gel 
electrophoresis (PAGE) analysis, however mass spectrometry is required to 
confirm accurate protein composition. 
 
Figure 2.24. Protein purification and 16% SDS-PAGE analysis of AmtR, 
Glnk and Glnk-AMP. (A) A band at approximately 25 kDa representing AmtR 
was purified from an M. smegmatis overexpression culture. (B) A band at 
approximately 14 kDa shows GlnK purified from an M. smegmatis 
overexpression culture grown in nitrogen sufficient conditions. (C) Two bands 
showing GlnK and GlnK-AMP purified from M. smegmatis overexpression 
cultures grown in nitrogen limiting conditions. The band at 15 kDa represents 
GlnK-AMP and the band at approximately 14 kDa represents GlnK.  
 
For the SEC pull down assays, initially the purified GlnK, GlnK-AMP and 
AmtR were run individually on a SEC column to determine the size and elution 
trace of each protein unbound (Figure 2.25). GlnK proteins are generally trimeric 
with each monomer approximately 14 kDa. The M. smegmatis GlnK monomer is 
14.4 kDa and eluted off the SEC column as a trimer of approximately 43 kDa 
(Figure 2.25). GlnK-AMP is also generally a trimer with each monomer able to be 
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adenylylated. The M. smegmatis GlnK-AMP also eluted off the SEC column as a 
trimer of approximately 44 kDa (Figure 2.25). AmtR is generally dimeric with 
each monomer approximately 25 kDa in size. The M. smegmatis AmtR monomer 
is 24.3 kDa and the purified protein elutes off the column as a dimer of 
approximately 49 kDa (Figure 2.25).  
 
Purified AmtR was then incubated with either purified GlnK or GlnK-AMP 
and then run on a SEC column. If an AmtR-GlnK interaction did occur, with the 
possibility of each GlnK monomer interacting with one AmtR dimer, the SEC 
elution trace should have a peak from approximately 91 kDa (1 AmtR dimer : 1 
GlnK trimer) to 135 kDa (1 AmtR dimer : 2 GlnK trimers). No new peaks in this 
size range were observed and an increased peak in the size range 43-48 kDa was 
observed (Figure 2.25), which suggested that no interaction was observed between 
AmtR and GlnK or AmtR and GlnK-AMP in this pull down experiment.  
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Figure 2.25. AmtR and GlnK SEC pull down assays. (A) SEC elution trace of 
purified GlnK and GlnK-AMP showing both proteins eluted off the column as 
trimers of approximately 43-48 kDa. (B) SEC elution trace of purified AmtR 
showing the protein eluted off the column as a dimer of approximately 49 kDa. 
(C) AmtR + GlnK (native & adenylylated) pull down assay SEC elution trace. 
The trace showed that both proteins come off in the same size range as the control 
elutions and there is no interaction between the proteins, which would have been 
represented by a peak within the size range 91-189 kDa. The numbering on the 
trace represents where samples of elution fractions were used for PAGE 
verification.  
 
To validate this observation, elution fractions from each peak were 
analysed by both 16 % SDS and native-PAGE to determine the protein 
composition of each peak (Figure 2.26). The native-PAGE gel analysis shows that 
in the load containing AmtR and GlnK-AMP the proteins are unbound. Fraction 1, 
which represents the size range from 91-135 kDa where the bound proteins were 
expected to elute, contained no protein. Fractions 2, 3 and 4 of the single peak in 
the elution trace had both AmtR and GlnK-AMP present, with AmtR in higher 
abundance in the left side and GlnK-AMP in higher abundance on the right side of 
the peak, as expected due to their size differences. The native-PAGE analysis of 
the same fractions in the peak showed there was no interaction between the 
proteins (Figure 2.26). The results of the pull down assay demonstrate that AmtR 
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and GlnK (in its native or modified form) do not interact. This suggests that GlnK 
is not a signalling protein for AmtR to lift repression, and, therefore, the M. 
smegmatis AmtR regulation is not controlled by the same signalling mechanism 
as the C. glutamicum AmtR. 
 
 
Figure 2.26. PAGE analysis of AmtR and GlnK SEC pull down assays. (A) 16 
% SDS PAGE of AmtR shown in the monomeric state at ~24 kDa. (B) 16 % SDS 
PAGE of GlnK-AMP, represented as the upper band in its monomeric state at ~15 
kDa (C) Native PAGE of AmtR in its dimeric state. Ladder is provided for 
comparative value only as sizes are inaccurate in non-denaturing conditions (D) 
Native gel electrophoresis of GlnK-AMP in its trimeric state. (E) 16 % PAGE of 
AmtR + GlnK-AMP SEC pull down assay elution peaks. The load is AmtR + 
GlnK-AMP before being run through the SEC. Fraction 1 represents the fractions 
within the size range 91-135 kDa. Fraction 2 represents the left side, fraction 3 
represents the centre and fraction 4 represents the right side of the only peak 
observed. (F) Native gel electrophoresis of AmtR and GlnK-AMP SEC pull down 
assay elution peaks with the same lanes as (E).  
 
AmtR belongs to the TetR protein family, which is characterised by their 
regulatory control being mediated by the binding of small signalling molecules. 
The signalling molecule induces a conformational change in the TetR structure, 
which disrupts the protein-DNA interaction and results in expression of the genes. 
To test if M. smegmatis AmtR controlled its regulon in this manner, we generated 
a ligand library of potential molecules that could act as signalling molecules for 
AmtR. Because the microarray analysis showed that the AmtR regulon is 
primarily composed of genes involved in alternative nitrogen metabolism, the 
ligand library (Table 2.1 in Methods Section 2.2.6.2) was generated by selecting 
biological molecules that were (I) substrates or metabolites in nitrogen 
metabolism (II) general cellular signalling molecules and (III) had compatible 
chemistry with the AmtR binding pocket.  
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All putative signalling molecules were screened against purified and 
extensively dialysed AmtR by a range or methods, including (1) Fluorescence 
binding assays, (2) electrophoretic mobility shift assays (EMSA) of AmtR bound 
to the msmeg_2184 promoter region to test if putative ligands disrupted the 
protein-DNA interaction, (3) co-crystalization and post-soaking of AmtR crystals 
with putative ligands for X-ray crystallography and (4) modelling of putative 
ligands into the binding pocket of the AmtR regulatory domain. Using this multi-
technique approach, no conclusive results were obtained to confidently identify 
any of the above molecules as a ligand for AmtR.  
 
Next, high throughput differential scanning fluorimetry utilizing Biolog 
plates containing 96 different nitrogenous sources or metabolites per plate were 
used to screen for signalling molecules (Petridis, 2015). Purified and extensively 
dialysed AmtR in both the presence and absence of Pmsmeg_1283/4 were used for this 
screen. An increase in the melting temperature (Tm) of AmtR was observed in 
presence of DNA showing that AmtR is stabilised when it is bound to DNA 
(Figure 2.27). The effect of each of the 96 molecules on the AmtR and AmtR + 
DNA Tm was then tested. Only two of the 96 molecules, xanthine and allantoin, 
showed a change in the Tm of the AmtR protein. Interestingly, these molecules 
both caused an increase in the AmtR Tm and the shift was only observed in the 
presence of DNA (Figure 2.27). This suggests that AmtR stability is further 
increased when bound to both DNA and either of these molecules.  
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Figure 2.27. Thermal stability of the AmtR protein. (A) Increase in melting 
temperature (Tm) of the AmtR protein in the presence of DNA (solid grey: AmtR 
+ DNA; dashed grey: AmtR – DNA). The effect of various exemplary compounds 
is shown (solid yellow: AmtR + DNA + nitrate; solid green: AmtR + DNA + urea; 
solid blue: AmtR + DNA + glutamate). DNA only (dashed black) has no 
effect. (B) Increase in the Tm of the AmtR protein after addition of xanthine and 
allantoin in presence, but not in absence of DNA (solid grey: AmtR + DNA; 
dashed grey: AmtR – DNA; solid purple: AmtR + DNA + xanthine; dashed 
purple: AmtR – DNA + xanthine; solid orange: AmtR + DNA + allantoin; dashed 
orange: AmtR – DNA + allantoin) (Petridis, 2015). 
 
To validate this unexpected result, xanthine was modelled into the AmtR 
binding pocket (Figure 2.28) using ParDOCK software. Xanthine was manually 
modeled into the AmtR binding site in a position where there was unresolved 
density that could not be satisfied by the model during molecular replacement  
and ligand positioning was optimized using ParDOCK. The modelling shows that 
xanthine hydrogen bonds with four of the residues that line the binding pocket 
(Thr76, Asp105, Arg137 and Phen166). Xanthine interacts with the carbonyl group on 
Phen166 and the side chains of Thr76, Asp105, and Arg137. The strongest interacting 
residue in the binding pocket is Asp105 which interacts with both the nitrogen in 
the amide group and the nitrogen in the adjacent amine group within xanthine.  
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Figure 2.28. Xanthine modeled into the AmtR binding site using the 
ParDOCK software. The AmtR structure is coloured grey with interacting 
residues represented as sticks and coloured by atom to show hydrogen bonding. 
Xanthine is coloured by atom with carbon represented in green. Hydrogen 
bonding is represented by yellow dotted lines.  
 
In summary, screening for signalling molecules of AmtR has revealed that 
the M. smegmatis AmtR does not have the same PII protein-protein signalling 
mechanism as its close relative C. glutamicum. Small molecule screening has 
revealed that AmtR may use the nitrogenous molecules xanthine and allantoin as 
signalling molecules, however not in the same manner as other TetR structures. In 
fact, these molecules appear to stabilise the AmtR:DNA complex. Using this high 
throughput screening technique, we have identified two putative ligands that 
appear to be functioning via a co-repressor mode of regulation to control AmtR 
regulation.  
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2.4 Discussion 
M. smegmatis is a soil bacteria that is exposed to fluctuating nutrient levels 
and in particular, limited nitrogen availability. It is characterised by its scavenging 
ability to transport and utilise a range of nitrogenous compounds in the absence of 
ammonia (Amon et al., 2009). The genome has a high prevalence of genes 
involved in urea transport and metabolism, suggesting that urea is an important 
alternative nitrogen source during nitrogen limitation (Amon et al., 2008). M. 
smegmatis is also one of the members of the actinomycetes that lacks a NtrBC 
system, which is utilised in most organisms for global nitrogen response. Instead, 
it has both transcription factors GlnR and AmtR, which are responsible for global 
nitrogen regulation. GlnR has been identified as an important regulator of nitrogen 
metabolism, however a number of the genes involved in urea transport and 
metabolism are not under the control of GlnR. The role of AmtR remained largely 
unknown but has been indicated as a regulator of these alternative urea metabolic 
pathways under nitrogen limitation.  
 
Based on the work presented in this thesis and through collaborative 
efforts with the Cook Laboratory at Otago University, we have structurally and 
functionally characterised the M. smegmatis AmtR. The X-ray crystallographic 
structure of M. smegmatis AmtR is the first AmtR structure of the TetR family to 
be solved and forms a homodimer with each monomer composed of 10 α-helices 
that constitute two domains. The C-terminal domain is the ligand binding domain 
(LBD) defined by helices α5-α10 that has a deep central binding pocket. The N-
terminal domain is the DNA binding domain (DBD) composed of helices α1- α3 
that is defined by the Helix-Turn-Helix (HTH). The AmtR regulon has been 
identified as a cohort of genes including an operon involved in alternative 
nitrogen uptake and urea metabolism via a two-step energy dependent process. 
Subsequently, the AmtR DNA recognition sequence was identified and used to 
generate a modified actinobacteria AmtR binding motif. The signalling 
mechanism used to lift M. smegmatis AmtR repression has been identified with 
two co-repressor signalling molecules that appear to function via a mechanism of 
regulation that has not been observed in the TetR protein family until now.  
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The N-terminal domain of the AmtR structure is defined by the HTH motif 
and contains conserved residues and a positively charged surface that allows 
interaction with DNA. The AmtR DBD aligns best with PfmR, a transcriptional 
repressor from Thermus thermophilus HB8 that also belongs to the TetR protein 
family. The DBD of PfmR resembles the QacR family of TetR transcription 
factors. QacR transcription factors are unique in their DNA binding mechanisms 
mainly because they bind DNA as pairs of dimers, where TetR DNA binding is 
generally by one dimer.  The similarities of AmtR and QacR suggest that AmtR 
may bind DNA as a pair of dimers in the same mechanism as QacR. 
 
The M. smegmatis AmtR recognition sequence has been identified as the 
16 bp semi-palindromic ATCTGTCATCTGACAG, which shares similarities to 
its close relative, the C. glutamicum AmtR recognition motif. Both the nucleotide 
specificity and the size of the spacing regions between the two half sites of the 
recognition sequence region are critical for binding. The specificity of AmtR for 
msmeg_2184 over msmeg_2185 supports the microarray analysis that 
msmeg_2184, msmeg_2185, msmeg_2186, msmeg_2187 and msmeg_2189 form 
an operon which is controlled by AmtR at the promoter region of msmeg_2184. 
Using the M. smegmatis AmtR binding sequence, a new actinomycetes AmtR 
consensus sequence was generated: the semi-palindromic 16-18 bp sequence 
ATnTnTn6-8AnAG. 
 
The M. smegmatis AmtR LBD forms a large binding pocket in the centre 
of each monomer, which is accessed by a long entrance site. It is built around a 
central triangle composed of helices α5, α6 and α7 with a disordered helix α6. The 
disorder is a result of the requirement of helix α6 a to be displaced when the 
ligand is bound into the binding pocket. The movement of helix α6 induces a 
conformational change that results in the disruption the protein-DNA complex. 
The binding cavity is approximately 125.70 Å
3 
and consists of both hydrophobic 
and hydrophilic residues, with an enrichment of aromatic residues, similar to other 
TetR binding pockets, suggesting AmtR binds a ring containing signalling 
molecule. The residue Glu170 on α8 forms a potential gate at the entrance site of 
the pocket that may influence the stability or efficiency of ligand binding.   
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AmtR, like all TetR transcription factors, acts as a repressor of gene 
expression when bound to DNA in the promoter region of the genes that it 
regulates. Conservation of the general structural features of the LBD and the 
presence of a large binding pocket suggested that ligand binding is a likely 
scenario to lift AmtR repression of its regulon. However, in C. glutamicum the 
AmtR is known to lift repression as a result of direct interaction with the 
adenylylated form of the PII signalling protein GlnK, which only occurs under 
nitrogen limiting conditions. SEC pull down assays showed that AmtR and Glnk 
(in its native or adenylylated form) do not interact, suggesting that GlnK is not a 
signalling protein for AmtR. We conclude that the M. smegmatis AmtR regulation 
is not controlled by the same signalling mechanism as the C. glutamicum AmtR.  
 
To test if small molecule binding is a likely scenario to lift AmtR 
repression we screened a library of potential ligands and identified two molecules, 
xanthine and allantoin, as potential ligands for AmtR. Interestingly, the interaction 
was only observed when AmtR was bound to the msmeg_2184 promoter region. 
This unexpected result suggests that the AmtR-DNA interaction is actually 
stabilised by the presence of either of these molecules. All characterised TetR 
regulators have shown the opposite effect in the presence of their ligands i.e. 
when the ligand is bound to the protein it induces a conformational change that 
results in the disruption of the protein-DNA interaction. This is the first example 
where the repression of a TetR protein is potentially enhanced by the presence of 
a ligand, which appears to be functioning as a co-repressor. Although this has not 
been observed in the TetR protein family, it is a common regulatory mechanism 
present in other transcription factor protein families. An interesting example is the 
transcriptional repressor PurR, a member of the Lac1 family, which regulates 
purine biosynthesis (Schumacher, Choi, Zalkin, & Brennan, 1994). The PurR-
DNA complex is dependant on a co-repressor, which can be either hypoxanthine 
or guanine. Based on these findings we suggest that AmtR functions in the same 
regulatory manner as PurR, where the absence of the co-repressor releases AmtR 
from the DNA and lifts the repression of its regulon. One can speculate that the 
dissipation of xanthine and allantoin is directly related to a decrease in 
intracellular nitrogen levels. The result would be the release of AmtR repression 
and subsequent expression of the proteins involved in alternative nitrogen uptake 
and urea metabolism to respond the limiting nitrogen levels.  
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By structurally and functionally characterising the M. smegmatis AmtR 
transcription factor we have begun to elucidate a novel co-repressor mechanism of 
nutrient signalling that allows the AmtR regulon to provide alternative nitrogen 
metabolism in the form of urea metabolism. This is of significance as M. 
smegmatis inhabits an environment of constant nitrogen limitation, so the ability 
to respond with alternative ammonia production in the form of urea metabolism 
provides a strong adaptive advantage. These results support findings that AmtR 
functions as an important nitrogen regulator in mycobacteria.   
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3 Preliminary Characterisation of Cyanobacteria 
VapBC Systems 
 
3.1 Introduction 
Regulation in bacteria is essential for adaptation. For regulation to be 
effective bacteria must be able to fine tune metabolism by modulating processes at 
multiple levels of gene expression for efficient energy expenditure in response to 
nutrient status. The regulatory response occurs at three levels: transcription, post-
transcription and post-translation. The process of transcription transposes genetic 
information from DNA to mRNA, which can then be translated to a functional 
protein. Transcription of genes into mRNA is regulated by transcription factors 
(as mentioned in Chapter 2). Post-translational regulation is where the synthesised 
protein is modified by a range of post-translational regulators to alter the proteins 
active state. Post-transcriptional regulation is where the population of mRNA is 
modulated in response to environmental signals by a range of regulators. The 
importance of post-transcriptional regulation has become increasingly evident 
over recent years and there is now overwhelming evidence that it plays a much 
larger role in cellular adaption than previously thought (Hammarlöf et al., 2015).  
 
mRNA is relatively unstable with half lives in the order of minutes, 
allowing prokaryotic cells to rapidly alter their transcript pool in response to 
environmental changes  (Picard et al., 2009). The instability of mRNA is 
attributed to the post-transcriptional regulators with which it interacts to determine 
its fate. These regulators function by recognising specific characteristics of the 
target RNA, including sequence and/or secondary structure to alter subsequent 
translation efficiency. An interesting example of this form of regulation is the 
toxin-antitoxin (TA) protein system. A number of toxin families in the TA 
systems function as selective mRNA interferases which result in the inhibition of 
translation (Inouye, 2006). These systems are well documented as stress-response 
elements and have also been shown to target mRNA transcripts involved in 
metabolism (Bodogai et al., 2006; Inouye, 2006; McKenzie et al., 2012b). 
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There are five types of TA systems, however the Type II TA systems are the 
most prevalent within the prokaryotic kingdom. They are classified by having a 
protein antitoxin and toxin. The antitoxin inhibits the toxin activity by binding to 
the toxin, forming an inactive complex (Gerdes et al., 2005). The majority of 
Type II toxins are mRNA endoribonucleases that target specific mRNA 
transcripts to inhibit translation (Yamaguchi et al., 2011). The VapBC family is 
the largest family by number of the Type II systems. They are defined by their 
toxic virulence associated protein (VapC), which belongs to the PilT N-terminal 
domain (PIN domain) family of proteins.  
 
The VapBC TA system is arranged as a bicistronic operon (Figure 1.12 in 
Chapter 1) with the gene encoding the antitoxin found upstream of the gene 
encoding the toxin, which typically overlaps by 2-12 bp (Mattison et al., 2006; 
Ning, Jiang, Liu, & Xu, 2013a; Robson et al., 2009). Both proteins are co-
expressed and form an inactive complex that binds to the promoter region 
upstream of its own operon to allow autoregulation (Figure 1.12). The VapB 
contains a DNA binding domain that is responsible for binding to inverted repeat 
(IR) units in the promoter region, which is typically enhanced by the interaction of 
VapC (Arcus et al., 2011). VapC inhibits translation by specific mRNA 
degradation via metal dependant ribonuclease activity (Anantharaman & Aravind, 
2003; Arcus et al., 2004; Arcus et al., 2011; Clissold & Ponting, 2000; Fatica et 
al., 2004; Lamanna & Karbstein, 2009; Mattison et al., 2006; Miallau et al., 
2009). Under normal growth conditions VapC and VapB are co-expressed 
forming a non-toxic complex which autorepresses VapBC expression. Under 
specific stress conditions this repression is lifted by the degradation of VapB and 
results in activation of VapC and subsequent growth arrest via translation 
inhibition (Gerdes et al., 2005). This allows stressed cells to remain in a dormant 
or in a non-growing stress-tolerant state until more favourable environmental 
conditions return. The mode of action of VapBC indicates that they play an 
important role in growth regulation in response to adaptation (Arcus et al., 2005; 
Arcus et al., 2011; Daines et al., 2007; Mattison et al., 2006; Puskás et al., 2004; 
Robson et al., 2009).  
 
Several VapBC systems from a range of bacteria have been shown to 
inhibit translation, and, in some cases, induce growth arrest under stress 
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conditions or when overexpressed in vivo. However, cellular targets and specific 
biological roles of these systems are yet to be elucidated (Arcus et al., 2011; 
Bodogai et al., 2006; Cooper et al., 2009; Daines et al., 2007; Ning, Jiang, Liu, & 
Xu, 2013a; Sharp et al., 2012; Winther & Gerdes, 2009; Zhang et al., 2004). For 
example, FitAB in N. gonorrhoea is hypothesised to slow intracellular trafficking 
and replication during host infection (Mattison et al., 2006). NtrPR in the 
nitrogen-fixing symbiont of legumes Sinorhizobium meliloti is hypothesised to 
adjust metabolic processes during symbiosis and other stress conditions (Puskás et 
al., 2004). VapBC-5 (also in S. meliloti) affects efficiency of symbiosis and 
nitrogen fixation capacity (Cinege et al., 2014). Several VapBC systems in the 
pathogenic Mycobacterium tuberculosis have been implicated in the stress 
response to different environmental cues, suggesting they function as an intricate 
response system during adaptation. The sole VapBC system in M. smegmatis, the 
non-pathogenic relative of M. tuberculosis, has been characterised extensively 
with the cellular targets and biological role identified: VapBC1283/4 acts as a post-
transcriptional regulator of carbon metabolism (McKenzie et al., 2012b). 
 
VapBC TA systems have become a point of interest because of their 
overrepresentation in the genomes of pathogenic and environmentally hazardous 
bacteria. For example, M. tuberculosis has 47 vapBC operons encoded in its 
genome, where the non-pathogenic environmental M. smegmatis has just one 
(Arcus et al., 2011; McKenzie et al., 2012b). The toxic bloom-forming 
cyanobacteria M. aeruginosa has 34 vapBC operons encoded in the genome, 
where the non-toxic Synechocystis sp. PCC6803 (Synechocystis) has only 12 
(Kaneko et al., 2001; Leplae et al., 2011; Makarova et al., 2009). This expansion 
suggests a functional link between toxicity and VapBC systems. As mentioned 
earlier, several VapBC systems in M. tuberculosis have been implicated in stress 
response to different environmental cues, suggesting they function as an intricate 
response system during adaptation. For organisms that host a large number of 
VapBC systems this would provide the capacity for efficient adaption to 
fluctuating and/or inhospitable conditions. The function of VapBC systems in 
cyanobacteria is not known. In fact, only one of the 12 Synechocystis VapBC 
systems have been characterised, and none from any toxin-forming species (Ning, 
Liu, Xu, Zhuang, Wen, et al., 2013b). 
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 Cyanobacteria are primary producers by nature of their autotrophy, which 
is essential for the existence of all higher organisms (Herrero, 2008). Members of 
the cyanobacteria phylum can be found in almost every terrestrial and aquatic 
habitat. Aquatic cyanobacteria can reproduce explosively in certain conditions and 
are known for their extensive blooms. These blooms are detrimental to other 
species in close proximity and can often be toxic to humans and animals because 
of the cyanotoxins produced (Briand et al., 2003; Falconer & Humpage, 2005; 
Paerl et al., 2001). Blooms often result in closure of recreational waters and the 
treatments used to eliminate the blooms are expensive and can be fatal to 
livestock and other aquatic organisms (Frangeul et al., 2008; Steffensen, 2008).  
 
 Synechocystis is used as the model organism to investigate the physiology 
of cyanobacteria. It has 12 annotated vapBC loci, and, until recently, none were 
characterised. Ning et al. (2013) investigated VapBC10 (ssr2962/slr1767 where 
the first letter “s” stands for Synechocystis, the second letters indicate gene length 
with “s” indicating less than 100 codons and“l” indicating longer than 100 
codons, and the last letter “r” indicating direction of transcription on the circular 
genome is in the right direction) of Synechocystis. They were able to confirm that 
the operon functions as a typical VapBC system, with the exception of its mode of 
autoregulation. vapB10 and vapC10 form a bicistronic operon and both genes are 
co-transcribed under normal growth conditions. Expression of VapBC10 has no 
effect on growth but expression of VapC10 caused growth arrest in E. coli, which 
could be reversed by expressing VapB10. Because VapC10 shows the 
characteristic bacteriostatic phenotype of a VapC toxin, it is proposed that 
VapC10 exerts its growth arrest via translation inhibition, like other characterised 
VapC toxins, however this has not been confirmed experimentally.  
 
 VapBC systems are normally characterised by their repressive 
autoregulation, where VapB binds to the promoter region of the operon and 
represses expression. The efficiency of binding is enhanced when VapC is bound 
to VapB. Ning et al. (2013) showed, firstly, that VapB10 binds to the promoter 
region of its own operon and positively autoregulates transcription. They 
identified the specific DNA sequence that VapB10 recognises: the imperfect IR 
sequence TTTCCCT-2N-AGGGTAA present in the promoter region upstream of 
the ssr2962/slr1767 operon (Figure 1.16 in Chapter 1). Secondly, they showed 
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that VapC10 abolishes binding of VapB10 to DNA. These results reveal that 
VapB10 can positively autoregulate the operon, which can be inhibited by 
VapBC10. 
 
 Because this is the only characterised VapBC system in cyanobacteria and 
the functional mechanism is still unknown, it is difficult to draw any conclusions 
about the biological role of these VapBC systems. However, because of the link 
between the number of VapBC systems and the toxicity of the organism it is a 
very promising avenue to investigate. Obtaining a better understanding of the role 
that VapBC systems play may also provide a novel strategy for bloom control.  
This chapter presents research on the preliminary characterisation of both M. 
aeruginosa and Synechocystis VapBC systems. 
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3.2 Methods 
3.2.1 DNA Manipulation and Cloning 
3.2.1.1 Gene, Primer and Oligonucleotide Design  
3.2.1.1.1 M. aeruginosa NIES-843 Gene Design 
The M. aeruginosa NIES-843 vapBC operons MAE49640/50 and 
MAE43230/20 were ordered from GeneArt (Life Technologies) with a 5’ PstI 
restriction site and a 3’ HindIII restriction site with the stop codon removed to 
allow for ligation into pET28b-PstI with a C-terminal His tag.  The operons were 
extracted from the GeneArt plasmid by restriction digest as per (Section 2.2.1.6) 
using PstI and HindIII and inserted into the pET28b-PstI expression vector and 
the vector was transformed into E. coli DH5α cells prior to transformation and 
protein expression in E. coli BL21 (DE3) cells.  
 
3.2.1.1.2 M. aeruginosa NIES – 843 Primer Design 
Primers were designed to amplify vapC genes from GeneArt vapBC 
plasmids with a 5’ PstI restriction site and a 3’ HindIII restriction site with the 
stop codon removed to allow for ligation into pET28b-PstI with a C-terminal His 
tag. An extra 3-6 bases were included to allow for efficient cleavage, depending 
on the restriction enzyme used. The PCR products were then digested as per 
Section 2.2.1.6 with the corresponding restriction enzymes, and inserted into the 
expression vector. The vector was transformed into E. coli DH5α cells prior to 
transformation and protein expression in E. coli Bl21 cells. 
 
Primers were designed for cloning M. aeruginosa NIES-843 vapBC 
operons MAE49640/50 and MAE43230/20 into alternative E. coli expression 
vectors when pET28b-pstI cloning failed. Primers were designed to amplify the 
vapBC operons from GeneArt plasmids and include the appropriate 5’ and 3’ 
restriction sites for ligation with either an N-terminal or C terminal His tag, 
depending on the plasmid. An extra 3-6 bases were included to allow for efficient 
cleavage, depending on the restriction enzyme used. Where only a N-terminal His 
tag was possible a stop codon was re-inserted into vapC. The operons were then 
digested as per Section 2.2.1.6 with the corresponding restriction enzymes and 
Chapter Three 
 98 
inserted into the expression vector, and the vector was transformed into E. coli 
DH5α cells prior to transformation and protein expression in E. coli BL21 (DE3) 
cells. Table A.3 in the Appendices shows the plasmids used for expression 
attempts. 
 
Primers were also designed for cloning M. aeruginosa NIES-843 vapBC 
operons MAE49640/50 and MAE43230/20 using the In-Fusion Ready pOPIN 
vector Suite (Berrow et al., 2007) when pET28b-pstI and alternative plasmid 
cloning failed. Primers were designed to amplify the vapBC operons from 
GeneArt plasmids and include the 5’ and 3’ 15 bp extensions homologous with 
the sites of linearization of the pOPIN vectors to enable successful In-Fusion 
cloning. The operons were inserted for expression with an N-terminal His tag (a 
stop codon was re-inserted into vapC) and, depending on the plasmid, an N-
terminal fusion protein to reduce VapC toxicity. The operons were inserted into 
the expression vector and the vector was transformed into E. coli DH5α cells prior 
to transformation and protein expression in E. coli BL21 (DE3) cells. Table A.3 in 
the Appendices shows all plasmids used for expression trials. All putative 
sequences were cloned in silico into the vector using Geneious R6 to ensure the 
protein sequence was correct and the His tags were in frame. Successful 
transformant plasmids containing the insert were confirmed by sequencing.   
 
3.2.1.1.3 Synechocystis Primer Design 
Primers for amplification of Synechocystis vapBC operons from the 
Synechocystis genomic DNA for cloning were initially designed to include the 5’ 
restriction site PstI and the 3’ restriction site HindIII with the stop codon removed 
for ligation into pET28b-PstI with a C-terminal His tag. An extra 3-6 bases were 
included to allow for efficient cleavage, depending on the restriction enzyme used. 
The operons were then digested as per Section 2.2.1.6 with PstI and HindIII and 
inserted into the pET28b-PstI expression vector, and the vector was transformed 
into E. coli DH5α cells prior to transformation and protein expression in E. coli 
Bl21 cells. All putative sequences were cloned insilico into the pET28b-PstI 
vector using Geneious R6 to ensure the protein sequence was correct and the His 
tags were in frame.  
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Primers for generation of ‘left’ and ‘right’ DNA fragments were designed 
to be cloned into pUC19 plasmids for generation of unmarked Synechocystis 
vapBC deletion strains (Synechocystis ΔvapBC) via homologous chromosomal 
DNA exchange.  The primers to construct the ‘left’ fragment were designed to 
amplify up to 200 bp of the 5’ end of vapB with 0.7-1.0 kb of 5’ upstream non-
protein coding DNA with a 5’ EcoRI restriction site and a 3’ SacI restriction site. 
The primers to construct the ‘right’ fragment were designed to amplify up to 200 
bp of the 3’ end of vapC with 0.7-1.0 kb of 3’ downstream non-protein coding 
DNA with a 5’ BamHI restriction site and a 3’ XbaI restriction site. An extra 1-2 
bases were included to allow for efficient cleavage, depending on the restriction 
enzyme used. The fragments were then digested (Section 2.2.1.6) with the 
respective enzymes and inserted into the pUC19 vector, which was transformed 
into E. coli DH5α cells prior to transformation into Synechocystis for the 
generation of the knock out strains. All putative sequences were cloned in silico 
into the pUC19 vector using Geneious R6 to ensure the sequence was correct.  
 
Primers for generation of DNA fragments for electrophoretic mobility 
shift assays (EMSA) were designed to amplify specific regions from the promoter 
site of the Synechocystis vapBCslr1209/1210 operon in the Synechocystis genome. The 
PCR products were 3’-end labelled with digoxigenin-11-ddUTP (DIG) (Section 
2.2.1.2).  
 
All primers were supplied by IDT and resuspended in 1 x TE. A list of all 
genes, primers and oligonucleotides ordered are present in Table A.1 in the 
Appendices.  
 
3.2.1.2 Polymerase Chain Reactions (PCR) 
3.2.1.2.1 PCR Amplification from Synechocystis Genomic DNA and GeneArt 
Plasmids 
PCR reactions were carried out with the proofreading enzyme KAPA HiFi 
DNA polymerase (Kapa Biosystems).  The annealing temperature was 55 °C 
unless otherwise stated. PCR reactions were carried out in 25 μl volumes using 
the following concentrations: 1 x High GC amplification buffer, 0.3 mM 
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deoxynucleotide mix (dATP, dCTP, dTTP & dGTP), 2 mM MgSO4, 1 x Enhancer 
buffer, 1 U 2G DNA polymerase, 0.3 μM of each primer and 10 ng template 
DNA. The following cycling conditions were used for amplification: 
  95 °C   2.00  (min:sec) 
  98 °C   0.20 
  55 °C   0.15 
  72 °C   0.45 
  72 °C   5.00 
 
Ligation, preparation of E. coli DH5α and Bl21 cells and electroporation 
of E. coli cells were done as per Section 2.2.1.7 and 2.2.1.9 in Chapter 2. 
 
3.2.1.2.2 PCR Screening of Transformants. 
Plasmids purified from E. coli (Section 2.2.1.11), were checked for the 
presence of the target DNA insert prior to sequencing by performing a PCR using 
either target specific or T7 primers. PCR reactions were carried out with Taq 
DNA polymerase as per Section 2.2.13. PCR reactions were visualised as in 
Section 2.2.1.4.1. Alternatively E. coli transformants were confirmed by colony 
PCR where a colony was taken from the transformant plate and used to inoculate 
a Taq PCR reaction.  
 
3.2.1.3 DNA Purification and Quantification 
DNA from agarose gels were separated and visualised with SYBR safe
TM
 
DNA dye as described in Section 2.2.1.5. The desired bands were extracted using 
a sterile scalpel blade and DNA purified using the QIAquick Gel Extraction Kit 
(Qiagen) according to the manufacturer’s instructions. DNA was eluted in 30 μl of 
elution buffer. PCR products from solution were purified using a Qiaquick PCR 
Product Purification Kit (Qiagen) according to the manufacturer’s instructions. 
DNA purity and concentration were estimated by measuring A260/A230 nm and 
A260/A280 nm ratios using a NanoDrop®ND-1000 Spectrophotometer (Thermo 
Fisher Scientific).  
x 29 
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3.2.1.4 Cloning of vapBC Operons into E. coli Expression Plasmids 
3.2.1.4.1 pET28b-pstI Cloning 
pET28b-pstI is an E. coli expression vector with kanamycin resistance. 
The vapBC operons and vapC genes were digested as per Section 2.2.1.6, purified 
(Section 2.2.15) and ligated (Section 2.2.1.7) into pET28b-pstI between the 
selected restriction sites within the multiple cloning site (MCS) allowing for the 
C-terminal His tag.  Vectors containing the inserted gene or operon were 
transformed into electrocompetent E. coli DH5α cells (Section 2.2.1.9) and plated 
onto LB agar plates containing kanamycin for selection. The plasmid constructs 
were purified, then sequenced (Section 2.2.1.12) to confirm correct insertion 
before being transformed into electrocompetent E. coli BL21 (DE3) (Section 
2.2.1.9).  
 
3.2.1.4.2 pETDUET and pPROEX – Htb 
pETDUET is an E. coli expression vector with ampicillin resistance that 
allows co-expression of two proteins from difference cloning sites with a variation 
of terminal His tags. pPROEX HTb is an E. coli expression vector with ampillicin 
resistance that allows expression of proteins with a N-terminal His tag. Vectors 
containing the inserted gene or operon were transformed into electrocompetent E. 
coli DH5α cells (Section 2.2.1.9) and plated onto LB agar plates containing the 
appropriate antibiotic for selection. The plasmid constructs were purified then 
sequenced (Section 2.2.1.12) to confirm correct insertion before being 
transformed into electrocompetent E. coli Bl21 (Section 2.2.1.9).  
 
3.2.1.4.3 pOPIN Cloning 
The pOPIN vector suite in combination with the In-Fusion enzyme 
(Clontech Laboratories, Mountain View CA) is a one step, high-throughput 
cloning system for problematic protein expression. Primer extensions are used to 
flank the 5’ and 3’ of each insert to allow a single PCR product to be inserted into 
multiple vectors containing different fusion partners and ampicillin resistance. 
vapBC operons were amplified with primers that incorporated the homologous 
extensions and then ligated as per the manufacturers instructions into pOPIN 
plasmids. Vectors containing the inserted operon were transformed into 
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electrocompetent E. coli DH5α cells (Section 2.2.1.9) and plated onto LB agar 
plates + ampicillin for selection. The plasmid constructs were purified, then 
sequenced (Section 2.2.1.12) to confirm correct insertion before being 
transformed into electrocompetent E. coli Bl21 (Section 2.2.1.9).  
 
3.2.1.5 Preparation of  pUC19 Mutant Constructs 
pUC19 is an E. coli vector with ampicillin resistance. The fragments were 
digested as per Section 2.2.1.6, purified (Section 2.2.15) and ligated (Section 
2.2.1.7) into pUC19 between the selected restriction sites within the MCS. 
Vectors containing the inserted fragments were transformed into electrocompetent 
E. coli DH5α cells (Section 2.2.1.9) and plated onto LB agar plates containing 
kanamycin for selection. The plasmid constructs were purified then sequenced 
(Section 2.2.1.12) to confirm correct insertion before subsequent cloning of the 
next fragment into the MCS. The end result was a pUC19 plasmid with both the 
5’ left and 3’ right fragments cloned into the MCS. When both fragments were 
successfully cloned into pUC19 (pUC19 + L&R construct), a sucrose sensitive 
and kanamycin resistance cassette (sacRB/Kan(R)) was excised from the pUM24 
plasmid by BamH1 digestion and cloned into the BamH1 site in the pUC19 L&R 
between the left and right fragments (pUC19 + L&R + sacRB/Kan(R) construct). 
 
Plasmid DNA extraction was done as per Section 2.2.1.11 and DNA 
sequencing was done as per Section 2.2.1.12 in Chapter 2. 
 
3.2.1.6 Preparation of Synechocystis Unmarked ΔvapBC Strains 
3.2.1.6.1 Generation of Marked ΔvapBC Strains 
A Synechocystis wild type (WT) glycerol stock was streaked onto BG-11 
agar plates and grown under low light (approximately 5-20 μmol photons m-2 s-1) 
at 30 °C for 4-5 days. Colonies from the plate were used to inoculate a 50 ml BG-
11 culture which was incubated for 3-4 days under normal light (40 μmol photons 
m
-2
 s
-1
) at 30 °C, shaking at 150 rpm. Multiple colonies were required for 
inoculation to prevent photo-inhibition of cells, which occurs when initial biomass 
is too low. 1-2 ml of culture was centrifuged at 5000 g for 5 min at room 
temperature. The supernatant was discarded and the cell pellet was washed by 
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resuspending in 1 ml of BG-11 media and centrifugation at 5000 g for 5 min at 
room temperature. The supernatant was removed and fresh BG-11 was added to a 
final volume of 100-150 μl. The cells were transferred to a 15 ml falcon tube and 
2 μg of pUC19 + L&R + sacRB/kan(R) construct was added. The solution was 
mixed and the cells were incubated, with the tube horizontal, for 4-5 hrs under 
low light at 30 °C and mixed every 1-2 hrs.  
 
Aliquots of both 20 μl and the remaining cells were plated out onto BG-11 
agar plates and incubated at 30 °C under low light for 24 hrs. Post-incubation, 2.5-
3 ml of 0.6% agar solution containing kanamycin at 5 μg/ml, cooled to ~ 42 °C, 
was added on top of the plates to form an even surface layer being careful not to 
disrupt colonies. When the agar surface set, the plates were further incubated for 
5-7 days under normal light at 30 °C or until colonies appeared. Up to 6 colonies 
were streaked out on a BG-11 + kanamycin agar plate (30 μg/ml) and incubated 
for 7 days under normal light at 30 °C. Confirmation of deletions was done by 
PCR diagnostic tests (Section 3.2.1.6.3). 
 
3.2.1.6.2 Generation of Unmarked ΔvapBC Strains 
Colonies from the deletion strain agar plate were used to inoculate a 30-50 
ml BG-11 media, which was incubated for 3-4 days under low light (5-20 μmol 
photons m
-2
 s
-1
) to induce DNA uptake at 30 °C, shaking at 150 rpm. 2-10 ml of 
the culture was centrifuged at 4000 g for 5 min at room temperature. The 
supernatant was removed and the cells were washed as in Section 3.2.1.6.1. Fresh 
BG-11 was added to get a final volume of 100-200 μl, depending on cell density 
and 2 μg of pUC19 + L&R construct was added. The cells were mixed gently and 
transferred to a 10-20 ml flask and incubated for 4-5 hrs under low light at 30 °C, 
shaking at 150 rpm and mixed every 1-2 hrs. 900 ul of BG-11 media was added 
and the culture was incubated for a further 4 days at 30 °C, 150 rpm under normal 
light. 
 
Aliquots of 20 μl, 50 μl, 100 μl and the remaining cells were plated on 
BG-11 + 5 % (w/v) sucrose plates and incubated under low light at 30 °C for 7 
days or until colonies appeared. Colonies were then patched out onto both BG-11 
+ kanamycin and BG-11 + sucrose agar plates to detect unmarked deletion strains. 
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Colonies that grew only on BG-11 + sucrose agar plates were then tested by 
colony PCR (Section 3.2.1.6.3) to confirm deletion and cassette removal. 
Successful deletion strains were streaked out onto BG-11 + sucrose agar plates to 
ensure all chromosomes had the unmarked deletion present.  
 
3.2.1.6.3 Colony PCR Confirmation of ΔvapBC Strains 
To confirm marked deletion strains a small proportion of cells from each 
initial colony of marked ΔvapBC, transformants and WT were subjected to cell 
lysis via bead beating: cells were mixed with 50 μl sterile water containing 0.3 g 
of 0.1 mm and 2.5 mm zirconia beads and shaken in a bead beater for 2 min. Cells 
were centrifuged at 13000 g for 5 min and 5 ul of the supernatant was used as the 
DNA template for a Taq PCR (Section 2.2.13) using the forward left fragment 
primer and the reverse right fragment primer for each operon. Transformants 
produced a band >5 kb containing the flanking regions (2-2.5 kb) of the operon 
and the 3.7 kb cassette that replaced the operon, which is too large to be visualised 
by gel electrophoresis. The absence of a band represented a successful marked 
deletion. The WT band was approximately 2.5 kb (operon + flanking regions). 
Successful deletion colonies were streaked onto a new BG-11 + kanamycin agar 
plate to ensure all chromosomes had the deletion present. 
 
To confirm unmarked deletion strains, the above procedure was done with 
cells from each initial colony of unmarked ΔvapBC transformants and WT. The 
PCR was done with primers designed to amplify only the operon. Successful 
deletion strains showed a region of the operon removed, which was represented 
by a smaller band on the gel compared to the WT PCR product.  
 
3.2.1.7 Glycerol Stocks 
Glycerol stocks for long term storage of transformed or mutated bacteria at 
-80 °C were made by adding 0.5 ml of cells to 0.5 ml of 50 % sterile glycerol. 
 
3.2.2 Protein Expression and Purification 
SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) protein analysis 
and quantification was done as per Section 2.2.2 in Chapter 2.  
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3.2.2.1 Concentration of Protein Samples 
Vivaspin concentrators (10 kDa molecular weight cut off) (Sartorius AG) 
were used to concentrate protein samples. Protein samples were added to the 
upper reservoir of 20 ml or 500 μl concentrators and centrifuged at 3,900 g at 4 °C 
until the desired volume or concentration was obtained.  
 
3.2.2.2 Small Scale Protein Expression and Purification from E. coli 
All E. coli expression cultures included kanamycin at 50 μg/ml for 
selection. Expression of VapBC complexes were initially confirmed with small 
scale His tag binding tests using Ni Sepharose beads. A single transformed colony 
either from the freshly transformed plate or streaked from a glycerol stock was 
used to inoculate a 5 ml LB seeder culture. This culture was grown overnight at 
37 °C, shaking at 200 rpm then 100 μl was used to seed a 10 ml LB expression 
culture which was grown for approximately 2 hrs until the cells reached OD600 
0.5-0.7. Cells were then induced with 1 mM IPTG and incubated overnight at 37 
°C (unless otherwise stated), shaking at 200 rpm. Cultures were then centrifuged 
(4,600 g, 20 min, 4 °C). The rest of the expression trial was done as per Section 
2.2.2.6 in Chapter 2. 
 
3.2.2.3 Large Scale Protein Expression and Sonication from E. coli 
3.2.2.3.1 Large Scale Protein Expression 
Large scale protein expression cultures were grown as for small scale 
protein expression cultures in Section 3.2.2.2 with the exception that 10 ml seeder 
cultures were used to inoculate 1 L expression cultures to maintain the 1:100 ratio. 
Cultures were centrifuged (4,600 g, 20 min, 4 °C) and cell pellets either frozen at -
80 °C or resuspended in 25 ml lysis buffer (50 mM sodium phosphate buffer, 200 
mM NaCl, 20 mM imidazole, pH 7.4) for sonication.  
 
All media recipes are presented in the Appendices. 
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3.2.2.4 E. coli Large Scale Purification 
Cells were sonicated on ice using a small probe for 20 s bursts at setting 3-
5 with 20 sec rests in between using a Misonix Sonicator (Misonix Inc.) until cells 
were lysed (1-2 min). The lysate was centrifuged, filtered and SDS-PAGE 
analysed as per Section 2.2.2.7. The supernatant containing the protein was 
initially run through a HisTrap HP column (GE Healthcare) and purified via 
Immobilised Metal Affinity Chromatography (IMAC) on an ÄKTA FPLC system 
(GE Healthcare) as in Section 2.2.2.8.1. Fractions containing the protein of 
interest were purified further by size exclusion chromatography (SEC) using a 
Superdex column (GE Healthcare) as in Section 2.2.2.8.2. Aliquots of fractions 
(15 μl) containing the protein of interest from both IMAC and SEC were added to 
5 μl of 4 x SDS loading buffer for analysis with SDS-PAGE. 
 
3.2.2.4.1 Acid SEC for VapBslr1209 Removal and VapCslr1210 Purification 
VapBCslr1209/1210 protein from IMAC purification was concentrated to 0.5 
ml using vivaspin concentrators (10 kDa molecular weight cut off) (Sartorius AG) 
and then diluted to 10 ml with SEC buffer (50 mM phosphate buffer, 200 mM 
NaCl, pH 3.0) to bring protein solution to pH 3. Protein was then concentrated 
using vivaspin concentrators (10 kDa molecular weight cut off) to 0.5 ml and 
filtered with a Nanosep® MF 0.2 μm filter (Pall Corporation) before loading and 
running on a pre-equilibrated (50 mM phosphate buffer, 200 mM NaCl, pH 3.0) 
SEC column as per Section 2.2.2.8.2. Fractions containing purified VapC were 
pooled, bought to pH 7.4, and concentrated before being tested for ribonuclease 
activity.  
 
3.2.3 Crystallisation Trials for X-ray Crystallography of Synechocystis 
VapBCslr1209/1210 
Initial crystallisation trials for VapBCslr1209/1210 employed sitting-drop 
vapour diffusion as per Section 2.2.4.1 using protein concentrated to 10 mg/ml. 
Once promising crystallisation conditions had been identified, hanging drop 
vapour diffusion fine-screens were employed as per Section 2.2.4.2.1 to produce 
crystals suitable for X-ray analysis. Crystals were tested for X-ray diffraction on 
an Agilent Supernova X-ray Diffractometer (Agilent Technologies, Liberty Lake 
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WA) at the University of Waikato using a Titan S2 CCD detector or at the 
Australian Synchrotron using an ADSC Quantum 210r detector. All Crystals 
tested for xray diffraction were identified as non protein salt crystals. 
 
3.2.4 VapCslr1210  Ribonuclease Activity 
An assay to test for ribonuclease activity of VapC proteins was used, 
which was originally developed by Jo McKenzie from the Proteins and Microbes 
Laboratory at the University of Waikato (McKenzie et al., 2012a). 
 
3.2.4.1 Urea Denaturing Polyacrylamide Gel Electrophoresis (Urea 
Denaturing-PAGE) 
Urea denaturing-PAGE gels were cast in a Hoefer mini gel casting system 
and consisted of a 10 % acrylamide resolving gel. Gels were made with 30 % 
acrylamide with an acrylamide:bisacrylamide ratio of 37.5:1 (Bio-Rad 
Laboratories), including 6 M urea, and polymerised with 0.05 % ammonium 
persulphate (APS) and TEMED. RNA samples were mixed in a 1:1 ratio with 2 x 
formamide loading dye and denatured for 5 min at 70 °C prior to loading onto the 
gel. Gels were pre-run in 1 x TBE buffer at 70 V for 30 min and wells flushed to 
remove any leached urea before samples were loaded. Gels were run at 150 V 
until the xylene dye front reached the end of the gel. For RNA band size 
estimation, 10 μl of prepared Low Range ssRNA ladder (New England Biolabs, 
Ipswich MA) was run on each gel. Gels were post-stained with 1x SYBR safe
TM
 
DNA gel stain (Invitrogen), and visualised by blue light. 
 
3.2.4.2 The Pentaprobe System 
The pentaprobe system is made of six overlapping dsDNA plasmid 
molecules and covers every combination of five bases (Kwan, Czolij, Mackay, & 
Crossley, 2003). Each single strand of pentaprobe was cloned under a T7 
promoter in pcDNA3 in Joel McKay’s laboratory, School of Molecular 
Bioscience, University of Sydney. The plasmids containing pentaprobe strands in 
the forward direction are termed A922, A923, A924, A925, A926 and A927 and 
in the reverse direction A928, A929, A930, A931, A932 and A933. A922 is 
complementary to A928, A923 to A929 etc. RNA fragments covering every 
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combination of five bases were transcribed from this set of 12 plasmids 
(sequences are presented in Appendices). 
 
The set of 12 pentaprobe inserts were produced by Jo McKenzie (Proteins 
and Microbes Laboratory, University of Waikato) from plasmids obtained from 
Joel MckKay, School of Molecular Bioscience, University of Sydney. Pentaprobe 
inserts were then amplified using the Pfx® DNApolymerase system (Invitrogen) 
with the forward primer flanking the T7 promoter in pcDNA3 and reverse 
flanking the end if the pentaprobe insert, and gel purified.  
 
3.2.4.2.1 In vitro Transcription of Pentaprobe Inserts 
RNA was transcribed from Jo McKenzie’s pentaprobe PCR products using 
the Ambion T7 MEGAscript® kit (Thermo Fisher Scientific). Reactions of 1 μg 
DNA template, 2 μl each rNTP (75 mM stock), 2 μl T7 polymerase enzyme mix, 
2 μl 10 x reaction buffer and nuclease free water in a total volume of 20 μl were 
incubated at 37 °C for 4 hrs, then DNase treated with 1 μl TURBO™ DNase for 
15 min at 37 °C, shaking at 600 rpm. Transcribed RNA was purified by 
ammonium acetate and ethanol precipitation. RNA was precipitated on ice for 1 
hr or at -20 °C overnight, with 8 μl 5 M ammonium acetate and three times the 
volume (54 μl) of 100 % ethanol. Samples were centrifuged (13,000 g, 20 min, 4 
°C) and supernatant was removed. The pellet was washed with 50 μl 70 % ethanol 
and centrifuged as above. The supernatant was removed and the pellet was air 
dried and then resuspended in 5 μl nuclease free water, and stored at -80 °C. 
Secondary structure of RNA molecules were predicted using RNAfold (Gruber, 
Lorenz, Bernhart, Neuböck, & Hofacker, 2008). 
 
3.2.4.3 VapC Ribonuclease Activity Assay 
Ribonuclease activity of VapC against pentaprobe RNA was measured 
over 1 hr with 3 different negative controls: 1) RNA only, to ensure there is no 
RNase contamination of the assay buffer; 2) with EDTA included in the buffer, to 
rule out the possibility of contaminating metal-independant RNAse that co-
purified with VapC, and 3) with the VapBC complex, to show lack of VapC 
ribonuclease activity when in complex with VapB.  
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3.2.4.3.1 Assay Reactions 
10 μl reactions containing 1 μg purified VapC protein, 1 μg RNA, 6 μl 
assay buffer (20 mM phosphate buffer pH 7.4, 20 mM NaCl, 10 mM MgCl2) and 
nuclease free water were incubated at 37 °C for 1 hr. For the RNA only negative 
controls, assay reactions were set up as above but no VapC was added to the 
reaction. Two reactions were set up, 0 hr (which was stopped immediately) and 1 
hr.  For the EDTA negative control, an assay was set up as per the normal assays 
but using assay buffer containing 20 mM EDTA. For the VapBC control, the 
assay was set as per the normal assay but purified VapBC was added to the 
reaction instead of VapC. All assay reactions were stopped by the addition of 10 
μl 2 x formamide loading dye.  
 
3.2.5 Synechocystis VapBCslr1209/1210 DNA Electrophoretic Mobility Shift 
Assays (EMSA) 
Purified VapBC was used in electrophoretic mobility shift assays (EMSA) 
using the DIG Gel Shift kit, 2
nd
 Generation (Roche). The target DNA fragments 
were labelled as described in Section 2.2.1.2. 
 
3.2.5.1 EMSA Reactions 
The protein:DNA ratio was based on the molarity of the VapBC complex 
(tetrameric 115.24 g/mol) calculated by ProtParam (web.expasy.org/proparam/) 
and DNA, which was calculated using the Promega BioMath Calculator 
(http://www.promega.com/a/apps/biomath/index.html?calc=ugpmols). Assay 
Protein:DNA ratios began at equal molar and subsequent higher ratios of protein 
to DNA. Assays were conducted as per manufacturer’s instructions with each 
reaction containing 1.5 x Binding Buffer, 0.5 μg of Poly dI-dC, 0.4 ng of DIG 
labelled DNA and various concentrations of protein. To confirm positive shifts 
were a result of protein binding to DNA and not to the DIG label, assays were set 
up with unlabelled target DNA added in 120 x excess at the highest labelled 
DNA: protein ratio. This assay was labelled specific control. To determine 
specificity of the protein binding assays were set up with unlabelled non-specific 
DNA (pET28bpstI_vapBCslr1209/1210 with no promoter region) added in 120 x 
excess. This assay was labelled the non-specific control.  
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Assays were prepared on ice and incubated at room temperature for 20 
min. Loading dye was added to each assay and then run on a 6 % native 
acrylamide TBE gel as per Section 2.2.1.4.2. DNA southern blotting and cross 
linking was done as per Section 2.2.5.2. Membrane washing and blocking was 
done as per Section 2.2.5.3. The chemiluminescence immunoassay and 
visualisation was done as per Section 2.2.5.4. 
 
3.2.6 Synechocystis ΔvapBC Phenotypic Characterisation 
3.2.6.1 Synechocystis WT vs PCC6803 ΔvapBC Unmarked Growth 
Experiments 
Synechocystis WT and ΔvapBC glycerol stocks were streaked onto BG-11 
agar plates and grown under low light (approximately 5-20 μmol photons m-2 s-1) 
at 30 °C for 4-5 days. Colonies from the plate were used to inoculate 3 x 200 ml 
BG-11 starter cultures per strain. Starter cultures were incubated under low to 
moderate light (20-40 μmol photons m-2 s-1) at 30 °C, shaking at 150 rpm for 5 
days or until they reached OD750 0.2-0.7. Multiple colonies were required for 
inoculation to prevent photo-inhibition of cells, which occurs when initial biomass 
is too low. Each starter culture was used to inoculate 1 x 100 ml growth culture at 
OD750 0.1, for the full light condition, and 1 x 100 ml growth culture OD750 0.1, 
for the 12 hrs light-dark cycling condition.  Each growth condition was run 
simultaneously. Each culture was sampled every 12 hrs for 9 days with OD600 
(contamination), OD680 (chlorophyll) and OD750 (cell density) recorded. Cultures 
were visualised under microscope to check for culture health, morphology and 
contamination.   
 
3.2.6.2 Isolation of Total RNA from Synechocystis  
Total RNA was isolated based on the Acidic Guanidinium 
Isothyocynate/Phenol/Chloroform (AP-GITC) procedure (Chomczynski & Sacchi, 
1987) with a few modifications, namely, 1-bromo-3-chloropropane (BCP) was 
used instead of chloroform and two successive phenol-BCP extractions were 
performed instead of one. A 50 ml sample of Synechocystis WT and 
Synechocystis ΔvapBC cultures were taken at 84 hrs (late-exponential phase for 
full light experiment and early exponential phase for light-dark experiment). 
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Samples were restricted to this late time point as a result of low biomass at earlier 
stages of growth. Cells were centrifuged at 4,000 g for 15 min at 4 °C and the 
supernatant was removed. The pellet was resuspended in 5 ml of 5 M GITC, pH 7, 
and centrifuged as above. The pellet was then resuspended in 0.5 ml GITC, pH 7 
and transferred to a sterile tube containing 0.3 g of 0.1 mm and 2.5 mm zirconia 
beads and stored at -80 °C until use. Cells were disrupted by bead beating four 
times for 20, 25, 30 and 35 s respectively with 1 min rests in between, then 
centrifuged to remove the resulting foam. 50 μl of 2 M, pH 4 Sodium acetate 
(NaOAc) and 0.5 ml water saturated phenol were added, vortexed for 15 s, then 
rotated for 10 min at room temperature. After addition of 100 μl BCP, the sample 
was shaken vigorously for 1 min, incubated for 5 min on ice and centrifuged 
(13,000 g, 15 min, 4 °C). The aqueous phase was re-extracted by repeating the 
two previous steps in a new tube, scaling up the volumes accordingly to account 
for any increase in aqueous phase volume. The RNA contained in the aqueous 
phase was transferred to a new tube and precipitated with an equal volume of 
isopropanol before being incubated at -40 °C overnight. The RNA was pelleted by 
centrifugation (13,000 g, 30 min, 4 °C), washed in 1 ml 70 % ethanol and 
centrifuged again (13,000 g, 15 min, 4 °C). Finally the RNA was washed in 1 ml 
100 % ethanol, centrifuged (13,000 g, 15 min, 4 °C), briefly air-dried and then 
solubilised in 20 μl nuclease free water. Isolated RNA was stored at -80 °C until 
use.  
 
3.2.6.3 RNA-seq Processing and Data Analysis 
 Total RNA purity and concentration was estimated by measuring A260/A230 
and A260/A280 ratios using a NanoDrop® ND-1000 Spectrophotometer (Thermo 
Fisher Scientific). 23s and 16s band representation and further quality control tests 
were done at BGI, China (http://www.genomics.cn/en/index). DNA removal, 
cDNA library construction, RNAseq and bioinformatics analysis (Quantification) 
was also done at BGI. Briefly, the RNA-seq raw reads were mapped to the 
reference genome Synechocystis sp. PCC6803 chromosomal DNA (RefSeq 
NC_020286.1) to summarise the distribution of reads between samples. RNA 
reads from the bacteria E. coli CFT073 and Bacillus subtilis subsp natto 195 were 
identified in each sample during the mapping procedure and removed for 
downstream analysis.  Bioinformatic analysis involved pairwise comparisons 
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between control (wild type strain (WT)) and treatment (Δ strain) in both full light 
and light-dark cycling (for WT vs ΔvapBCslr1209/1210) and light-dark cycling (for 
WT vs ΔvapBCssl2138/sll1092). Differentially expressed genes were identified by 
determining the Log2 expression ratio (Δ strain/WT strain) where differential 
expression was termed significant if the expression ratio was >2.0 Fold with a P-
value <0.05. 
 
3.2.6.4 Reverse Transcription Quantitative Real-Time PCR (RT-qPCR)  
3.2.6.4.1 Genomic DNA Removal and cDNA Library Construction 
DNA removal from total RNA was achieved using DNase (Promega, 
Madison WI) treatment. 1 μg of total RNA was treated with 1 μl of RNase-free 
DNase and incubated at 37 °C for 3 hrs, shaking at 600 rpm. DNase was 
inactivated by the addition of 1 μl 25 mM EDTA (pH 8) and incubation at 65 °C 
for 10 min. The cDNA library was constructed from the DNase treated total RNA 
by reverse transcription using Bioline Tetro Reverse Transcriptase (RT) enzyme 
(Bioline, UK) with random hexamer primers. Total RNA was incubated with 100 
ng primers, 200 x U RT, 0.1 μM dNTPS and 1 X RT buffer. The following 
cycling conditions were used for cDNA amplification: 
  25 °C   10.00 (min:sec) 
  45 °C   30.00 
  85 °C   5.00 
   
 To confirm there was no contaminating genomic DNA, a negative control 
was set up for each sample as above, but with no reverse transcriptase. An end 
point PCR test on both samples was done to confirm no amplification from the 
negative control. cDNA was frozen at -20 °C until required.  
 
3.2.6.4.2 Primer Design 
Primers for each gene were designed using Primer 3 v.0.4.0 
(http://bioinfo.ut.ee/primer3-0.4.0/). Where possible, primers were designed to 
have similar properties so that PCR for different genes could be performed in the 
same run. All primers were supplied by IDT and resuspended in 1 x TE. A list of 
all primers is presented in Table A.2 in the Appendices.  
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3.2.6.4.3 Reaction Set Up 
All RT-qPCR reactions were carried out in triplicate 20 μl volumes using 
the 5 x HOT FIREPol® EvaGreen® qPCR Supermix (DNature, NZ). A master mix 
was prepared for each primer set consisting of 1 x Supermix buffer (containing 
Optimized buffer, GC-enhancer, 2.5 mM MgCl2, dNTP blend containing 
dUTP/dTTP, EvaGreen® dye, and HOT FIREPol® DNA Polymerase), 100 nM 
primers, 10 μl of diluted cDNA and DNase free water to bring the volume to 20 
μl. cDNA was diluted 1:50 to make a final concentration of 1:5 for qPCR 
analysis.  
 
3.2.6.4.4 qPCR Run 
RT PCR was performed on the Rotor-Gene 6000 (Corbett Research, 
Australia). The following cycling conditions were used for amplification: 
  95 °C   12.00  (min:sec) 
  95 °C   0.15 
  60 °C   0.30 
  72 °C   0.30 
  80 °C   0.10 
 
Data was acquired on the 80 °C step in the green channel for SYBR 
Green. Immediately following amplification, a melt curve was performed 
consisting of 90 sec at 55 °C, followed by 5 sec steps with 0.5 °C increase in 
temperature per step rising to 95 °C. The identity of the PCR product was verified 
by the melt curve profile. Each RT-qPCR run included a no template control 
(NTC) per amplicon. 
 
3.2.6.4.5 Analysis  
Firstly, the geometric mean of the two housekeeping genes (rrn 16s and 
rnpB) was calculated (Ct HKG = √(rrn 16s Ct x rnpB Ct))  for both the WT and 
the ΔvapBC sample qPCR using their average Ct values generated from the Rotor-
Gene 6000 software. The genes of interest (GOI) were then normalised against the 
housekeeping genes by calculating the ΔCt in both the WT sample (Ct GOIwt – Ct 
HKGwt) and the Δ sample (Ct GOIΔ – Ct HKGΔ). The ΔΔCt for each GOI was 
x 35 
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then calculated (ΔCtΔ – ΔCtwt) and the fold difference (2
(-ΔΔCt)
) where differential 
expression was termed significant if the expression ratio was >2.0 Fold.   
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3.3 Results 
3.3.1 M. aeruginosa NIES-843 vapBC Loci Identification 
M. aeruginosa NIES-843 (MIC_NIES_843) was the strain chosen for this 
investigation because it is the only fully assembled and annotated M. aeruginosa 
genome available. Further information regarding the choice of strains chosen for 
this research is in the Appendices. To identify all putative vapBC loci in M. 
aeruginosa NIES 843, the Toxin-Antitoxin Database (TADB) (Shao et al., 2011) 
was consulted. The TADB is a web-based tool to identify Type II TA loci in 
bacterial genomes based on sequence alignment and conserved domains. M. 
aeruginosa NIES-843 has one chromosome and no plasmids so all vapBC loci are 
chromosomal. 46 VapBC systems are predicted in the genome (Table 3.1).  
 
Alignments from NCBI nucleotide BLAST for all predicted 46 VapBC 
systems show that I) 27 have high conservation with VapBC systems in the 
closely related organism M. aeruginosa PCC 7806 (Table 3.1) (Frangeul et al., 
2008), II) 18 have very low or no conservation with VapBC systems in M. 
aeruginosa PCC 7806 and are homologous to other cyanobacteria, including 
Cyanothece and Calothrix sp., Nodularia spumigena, Anabaena cylindrica PCC 
7122, Nostoc sp. PCC 7524, Synechococcus sp. PCC 7502, Oscillatoria 
acuminate PCC 6304, Anthrospira platensis, Synechocystis PCC 6803 and 
Cyanobacterium aponinum PCC 10605, III) 1 VapBC system has highest 
conservation with a VapBC system in the proteobacteria Burkholderia 
rhizoxinica, and IV) none of the 46 are closely related to each other, ruling out 
gene duplication as a recent mechanism for their expansion in the genome. 
  
1
1
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Table 3.1. List of the 46 predicted VapBC pairs in M. aeruginosa (MIC_NIES_843) with NCBI nucleotide BLAST alignments. Highlighted 
pairs indicate VapBC systems chosen for in vitro characterization 
TA Pair (VapB-VapC) VapC/B (MAE) NCBI BLAST Alignment (Nucleotide) 
 
COG2442-PIN 
(16)a 
COG2442 proteins contain a DNA/RNA-binding 3-helical bundle and are among 
the most abundant PIN-associated predicted antitoxins. 
 
Present in variety of bacterial and few archaeal genomes (abundant in 
cyanobacteria/chloroflexi). 
05270/05280 78% conservation with  Nodularia spumigena (96% coverage) 
10430/10420 99% conservation with M. aeruginosa PCC 7806 (PCC 7806) (50% coverage) 
18190/18180 99% conservation to PCC 7806 (100% coverage) 
21350/21340 95% conservation to PCC 7806 (100% coverage) 
24740/24730 70% conservation with Anabaena cylindrica PCC 7122  (PCC7122) (43% coverage) 
30350/30360 79% conservation with Nostoc sp. PCC7524 (98% coverage) 
32540/32550 87% conservation with PCC 7806 (98% coverage ) 
32560/32550 87% conservation with PCC 7806 (49% coverage) 
34480/34490 84% conservation with PCC 7806 (96% coverage) 
34790/34800 99% conservation to PCC 7806 (100% coverage) 
34850/34840 99% conservation with PCC 7806 (100% coverage) 
35570/35580 68% conservation with  Synechococcus sp. PCC 7502 (88% coverage) 
42140/42130 98% conservation with PCC 7806 (100% coverage) 
45530/45540 84% conservation with Cyanothece sp. (98% coverage) 
47160/47150 99% conservation with PCC 7806 (100% coverage) 
49650/49640 99% conservation with PCC 7806 (100% coverage) 
 
COG2886-PIN 
(6a) 
COG2886 are an uncharacterised family of proteins associated with PIN genes 
which are abundant in Archaea and cyanobacteria.  
01050/01060 95% conservation with PCC 7806 (100% coverage) 
04250/04260 97% conservation with PCC 7806 (100% coverage) 
04270/04280 97% conservation with PCC7806 (60% coverage) 
04320/04330 97% conservation with PCC7806 (96% coverage) 
43220/43230 100% conservation with PCC 7806 (37% coverage) 
46970/46960 76% conservation with PCC 7113 (31% coverage) 
Xre-PIN 
(6a) 
Xre proteins have HTH DNA binding domains and have diverse regulatory roles 
not always related to TA systems. 
 
03580/03590 72% conservation with Oscillatoria acuminate PCC 6304 (94 % coverage) 
08700/08690 80% conservation with Anthrospira platensis (71% coverage) 
15740/15750 98% conservation with PCC 7806 (92% coverage) 
20360/20370 99 conservation with PCC 7806 (92% coverage) 
34530/34520 99% conservation with PCC 7806 (100% coverage) 
47340/47330 99% conservation with PCC 7806 PCC 7806 (100% coverage) 
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PHD-PIN 
(5a) 
PHD has a DNA binding domain and are associated with a range of Type II toxins 
06990/07000 75% conservation with Proteobacteria Burkholderia rhizoxinica (19% coverage) 
23820/23810 83% conservation with Cyanothece sp. ATCC 51142 (66% coverage) 
33180/33190 88% conservation with Cyanothece sp. PCC 7822 (99% coverage) 
56140/56150 97% conservation with PCC 7806 (67% coverage) 
58010/58020 81% conservation with Calothrix sp. PCC 7507 (53% coverage) 
RHH-PIN 
(4a) 
Antitoxin contains ribbon-helix- helix (RHH) DNA binding domain. 
07680/07670 93% conservation with PCC 7806 (33% coverage) 
13550/13540 76% conservation with PCC 6803 (92% coverage) 
17540/17530 75% conservation with Cyanobacterium aponinum PCC 10605 (79% coverage) 
37970/37980 
88% conservation with ATCC 51142 (76% coverage) 
75% conservation with Nostoc sp. PCC 7524 (78% coverage) 
AbrB-PIN 
(2a) 
AbrB proteins have a DNA binding domains and are common in thermophilic 
prokaryotes  
31220/31210 
100% conservation with PCC 7806 (39% coverage)  
89% conservation with Oscillatoria acuminata PCC 6304 (95% coverage) 
54730/54740 67% conservation with PCC 7524 (39% coverage) 
VapC* 
(2a) 
18130/18120 99% conservation with PCC 7806 (100% coverage) 
62610/62620 98% conservation with PCC 7806 (99% coverage) 
PIN*  
(5a) 
03490/03480 99% conservation with PCC 7806 (100% coverage) 
07520/07510 66% conservation with PCC 7502 (65% coverage) 
08780/08770 80% conservation with Calothrix sp. PCC 6303 (100% coverage) 
20360/20350 99% conservation with PCC 7806 (85% coverage) 
62210/62200 79% conservation with Cyanothece sp. PCC 7424 (91% coverage) 
a 
Number of loci in genome 
* TADB prediction of toxin only 
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3.3.2 Identification and Cloning of Representative M. aeruginosa VapBC 
Systems for Expression in E. coli 
Two of the 46 vapBC operons from M. aeruginosa NIES-843 were chosen 
as representative systems and codon optimised for E. coli expression. The two 
operons vapBCMAE49640/50 and vapBCMAE43230/20 (Table 3.2) were chosen based on a 
selection criteria that included I) VapC was >112 aa and included all conserved 
acidic residues for catalytic activity (Figure 3.1), II) there must be at least 1 bp 
overlap between vapB and vapC, and III) protein sequence comparisons shows 
either a) the protein shares high similarity to other bloom forming strains or is a 
ubiquitously conserved VapBC system, or b) The system appears unique to allow 
investigation of potentially novel VapBC functions in cyanobacteria. The operons 
were designed for insertion into the pET28b-pstI vector for E. coli expression 
with a C-terminal His tag. To increase the chances of expression, the overlapping 
region between vapB and vapC were reduced to 1-4 bp.  
 
Figure 3.1. A visual depiction of the hidden Markov model that defines the 
conserved amino acids of PIN-domain proteins. The height of each letter is 
proportional to the amount of ‘information’ it provides about the respective 
position in the PIN-domain family. The width of each column is also an indication 
of the importance of this position in defining the family. Sequence regions that 
contain insertions are shown as dark and light pink columns. Figure from Arcus et 
al. (2011). 
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Table 3.2. M. aeruginosa representative vapBC operons vapBCMAE43230/20 and 
vapBCMAE49640/50 for cloning, expression and purification in E. coli. 
VapBC Description: VapBCMAE43230/20 Reason for Selection 
Locus ID 4985 Novel VapB: COG2886 is an 
uncharacterised family of small proteins 
associated with PIN genes. Found 
mostly in archaea and cyanobacteria 
All COG2886-PIN TA pairs share ≥95% 
sequence similarity to PCC 7806 (with 
exception of TA ID 4992) (Makarova et 
al., 2009) 
There are only 6 copies of COG2886-
PIN TA pairs in the MIC NIES-843 
genome 
VapC has all conserved acidic residues. 
The last D residue is at 99 instead of 112 
High sequence conservation similarity 
with PCC 7806 
Size 730 bp with 8 bp overlap 
VapC 
 
VapCMAE43220: PIN domain with 
conserved residues D7, E39, D92 
and D99 
VapB VapBMAE43230: COG2886 domain 
contains a HTH DNA binding 
motif 
Nucleotide 
Sequence 
Analysis 
100% sequences conservation to 
PCC 7806 over conserved regions 
and poor conservation in non 
conserved regions 
VapBC Description: VapBCMAE49640/50 Reason for Selection 
Locus ID 4999 Ubiquitous VapB: COG2442 is a family 
among the most abundant new PIN-
associated predicted antitoxins. Present 
in a variety of bacterial and a few 
archaeal genomes but are most abundant 
in cyanobacteria and chloroflexi 
(Makarova et al. 2009). 
VapC has all conserved acidic residues. 
The last D residue is at 108 instead of 
112. 
The most abundant TA pair in the MIC 
NIES-843 genome is COG2442-PIN 
with 16 identified. 
High sequence conservation with PCC 
7806. 
Size 605 bp with 4 bp overlap 
VapC 
 
VapCMAE49650: PIN domain with 
conserved residues D9, E42, D94, 
D113 
VapB VapCMAE49640: COG2442 domain 
contains a DNA/RNA-binding 3-
helical bundle 
Nucleotide 
Sequence 
Analysis 
99% sequences similarity to PCC 
7806 with 100% coverage over 
entire operon. 
   
Attempts to clone each of the M. aeruginosa vapBC, vapB or vapC into 
the expression vectors pET28b-pstI, pETDUET, pPROEX or the pOPIN vector 
suite were conducted. Each vapBC operon or vapB and vapC gene that was 
successfully cloned into its respective vector for protein expression was confirmed 
by sequencing vector DNA from positive transformants with T7 or M13 forward 
and reverse primers that flanked the multiple cloning site (MCS). Successfully 
cloned operons and genes were tested for protein expression in E. coli with small 
scale expression trials.  
Chapter Three 
 120 
3.3.2.1 Small Scale Expression Trials 
Small scale expression trials of VapBC and VapC were carried out to 
evaluate protein expression and Ni
2+
 binding affinity. A summary of the 
expression trials (Table 3.3) show that most expression vectors were unsuccessful, 
with only one operon being successfully expressed (vapBCMAE43230/20) in 1 of the 5 
vectors tested (pOPINS). To determine if the overlap between vapB and vapC was 
a translational hindrance for E. coli and the reason for unsuccessful expression, 
the vapC genes from each operon were extracted from the GeneArt_vapBC 
plasmids and inserted into pET28b-pstI for expression. Expression trials show 
there was no soluble overexpression of either VapC (Figure 3.3). Attempts to 
improve expression by repeating at temperatures from 18-37 °C were not 
successful. 
Table 3.3. Summary of M. aeruginosa VapBC and VapC small scale 
expression trials and His tag binding. 
Vector His tag Gene Protein Expression? 
pET28b-pstI C vapBCMAE49640/50 VapBCMAE49640/50 N 
vapBCMAE43230/20 VapBCMAE43230/20 N 
vapCMAE49650 VapCMAE49650 N 
vapCMAE43220 VapCMAE43220 N 
pPROEX N vapBCMAE49640/50 VapBCMAE49640/50 N 
pOPINF N vapBCMAE43230/20 VapBCMAE43230/20 N 
pOPINM N vapBCMAE43230/20 VapBCMAE43230/20 N 
pOPINS N vapBCMAE43230/20 VapBCMAE43230/20 S 
Abbreviations: no protein expression (N), and soluble protein expression (S). 
 
To allow co-expression of VapB and VapC without the overlap, both 
genes were extracted from the GeneArt_vapBC plasmid and attempted to be 
inserted into two different cloning sites in the multiple cloning site (MCS) of the 
pETDUET vector. Transformation of the vapB into the vector for both operons 
proved unsuccessful and expression in this system could not be trialled. 
Alternatively, an attempt was made to clone the vapBC operons into the 
expression vector pPROEX, an alternative to pET28b-pstI, with an N-terminal His 
tag. VapBCMAE43230/20 cloning was unsuccessful but VapBCMAE49640/50 was 
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successful and expression was tested with the empty plasmid used as the negative 
control. No expression was observed (Figure A.3 in the Appendices).  
 
Because the standard expression systems mentioned above proved 
unsuccessful, a high throughput pOPIN vector suite cloning system ((Berrow et 
al., 2007) commonly used for problematic protein expression was adopted. The 
vapBC operons were extracted from the GeneArt plasmids and had homologous 
extensions incorporated to allow insertion into pOPIN plasmids with various 
fusion proteins and tags. Table A.3 in the Appendices lists all plasmids used for 
expression trials. Cloning of vapBCMAE49640/50 was unsuccessful, however cloning 
of vapBCMAE43230/20 was successful and expression trials were conducted.  
 
From the expression trials only the pOPINS vector showed promising 
VapBC expression (Figure 3.2). pOPINS contains an N-terminal His tag followed 
by a SUMO fusion protein. SUMO proteins are commonly used as fusion proteins 
that bind to and increase solubility and expression of otherwise toxic or insoluble 
proteins (Marblestone et al., 2006). The SUMO protein with an N-terminal His 
tag (His-SUMO) is 13.21 kDa, which can be seen in the SDS-PAGE gel of the 
empty vector expression trial (Figure 3.2). SUMO-His bound to VapB (His-
SUMO-VapB) is 22.17 kDa, which can be seen on the gel of the 
pOPINS_43230/20 expression trial. Both proteins appear larger on the gels, which 
is discussed later. VapC is 17.57 kDa, which is not obviously expressed in this 
screen. To confirm if both VapB and VapC were being expressed, this system was 
taken into the large scale expression and purification system.  
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Figure 3.2. pOPINS+vapBC43230/20 small scale expression trial. Schematic of 
the pOPINS system indicating the N-terminal His tag-SUMO-VapB fusion 
protein and VapC expression. SDS-PAGE analysis of small scale expression trial 
with white boxes indicating expected band size. Labels: whole cell fraction (WC), 
soluble fraction (S), insoluble fraction (I), flow through (FT), wash (W) and 
nickel beads with protein bound after wash steps (B).  
 
3.3.2.2 Large Scale Expression and Protein Purification of VapBCMAE43230/20 
Following evidence of soluble protein expression of VapBCMAE43230/20 in 
small scale screens (Figure 3.2), protein expression cultures were scaled up as in 
Section 3.2.2.3.1 and protein was purified by IMAC (Figure 3.3). Non-specific 
protein eluted early from the column at a low concentration of imidazole, whereas 
His tag associated protein eluted later in the gradient with a greater concentration 
of imidazole. His-SUMO protein elutes earlier in the gradient (~100-150 mM 
imidazole), His-SUMO-VapB protein elutes slightly later (~150 mM imidazole) 
and His-SUMO-VapBC protein elutes as the last peak (~ 200-325 mM imidazole) 
(Figure 3.3).  
Chapter Three 
 123 
A 
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Figure 3.3. IMAC purification and corresponding SDS-PAGE analysis of 
His-SUMO-VapBCMAE43230/20. The chromatograms depict the UV absorbance and 
elution profile of each purification. The corresponding SDS-PAGE gels depict the 
insoluble fraction (I), soluble fraction loaded onto the column (L) and the flow 
through (FT). Fractions and their elution position are shown by the coloured bars 
(A) IMAC purification of the empty pOPINS vector showing elution peak of His-
SUMO at ~100-150 mM imidazole concentration. (B) IMAC purification of 
pOPIN_43230/20 showing elution of His-SUMO as in (A), His-SUMO-
VapBMAE43230 at ~150 mM imidazole, and His-SUMO-VapBCMAE43230/20 later in 
the gradient as the largest peak at ~200-325 mM imidazole concentration. 
 
The protein was further purified by size exclusion chromatography (SEC) 
using a Superdex column (GE Healthcare) (Figure 3.4).  The majority of VapBC 
elutes in the first peak which corresponds to proteins ≥ 669 kDa or soluble 
aggregated protein. A small proportion of the complex elutes off the column in the 
second peak, which corresponds to approximately 440 kDa. This is much larger 
than the expected tetramer (159 kDa); however, the corresponding gel fraction 
shows no sign of aggregation, suggesting that the protein is stable in this fraction. 
The last peak in the trace contains the free VapB, shown by the gel fraction, 
which elutes off the column at approximately 67 kDa. This is also much larger 
than the expected dimer of VapB (44 kDa). The position of the peak suggests a 
tetrameric state of VapB (89 kDa). The unexpected increased size of the proteins 
observed in both small scale and large scale protein expression and purification 
could be explained by co-purification with genomic DNA. VapB binds DNA and 
the tetrameric state of VapB or VapBC is only possible in the presence of DNA, 
suggesting that VapBCMAE43230/20 is being co-purified with DNA. The 
chromatogram also shows significantly more His-SUMO-VapB expressed 
compared to His-SUMO-VapBC. VapBC protein co-expression is thought to 
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occur in a ratio of up to 10:1 VapB:VapC. This is a result of the overlap present 
within the operon. The translational machinery has to slip at the end of the VapB 
transcript and re-start translation at the overlapping start site of the VapC 
transcript. This slippage occurs at a lower rate than the standard initiation of 
transcription for VapB, resulting in more VapB being translated than VapC. This 
result indicates that the vapBCMAE43230/20 is being transcribed as a normal vapBC 
operon.  
 
 
Figure 3.4. SEC of VapBCMAE43230/20 and corresponding SDS-PAGE gel. The 
chromatogram depicts the UV absorbance profile of protein elution and the gel 
depicts the fractions and their elution position (and approximate size) is shown by 
the coloured bars. 
 
In summary, expression of VapBCMAE49640/50 was unsuccessful and 
expression of VapBCMAE43230/20 was successful only when expressed with a 
SUMO fusion protein attached to VapBMAE43230. VapBMAE43230 and VapCMAE43220 
are co-expressed with an excess of VapB being expressed relative to VapC. This 
expression ratio indicates that vapBCMAE43230/20 is expressed as a typical vapBC 
operon, where expression is characterised by a ratio of up to 10:1 VapB:VapC. 
VapBMAE43230 and VapCMAE43220 may form a tetrameric VapBCMAE43230/20 protein 
complex, which may be bound to DNA and unstable, with the majority of the 
complex forming a large species (possible soluble aggregate). VapBMAE43230 also 
appears to be purified bound to genomic DNA and forms a tetramer.  Further 
optimisation is required to reduce the aggregation of the complex and removal of 
co-purified DNA before in vitro characterisation can be conducted. 
 
3.3.2.3 Cloning of Synechocystis vapBC into pET28b-pstI 
Synechocystis VapBC systems where deletion strains had been made for 
characterisation by growth experiments (Section 3.2.1.6) were used for cloning 
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and expression trials. vapBC operons successfully cloned into pET28b-pstI with a 
C-terminal His tag for protein expression (Table 3.4) were confirmed by 
sequencing and tested for protein expression using small scale expression trials in 
E. coli. 
Table 3.4. Synechocystis vapBC operons successfully cloned into pET28b-pstI 
for protein expression with a C-terminal His tag and predicted protein 
molecular weight (MW). 
vapBC Operon Expected MW (kDa) 
VapB VapC VapBC 
vapBCslr1209/1210 12.37 16.46 28.83 
vapBCslr1327/ssr2201 8.40 17.98 26.38 
vapBCssl2138/sll1092 7.70 16.33 24.03 
vapBCssr2962/slr1767 8.23 13.98 22.21 
 
3.3.2.4 Small Scale Expression Trials 
Small scale expression trials were carried out to evaluate protein 
expression and His tag binding affinity (Table 3.5). Only one of the four VapBC 
systems (vapBCslr1209/1210) tested shows soluble expression of both VapB and 
VapC (Table 3.5).  
Table 3.5. Summary of Synechocystis VapBC small scale expression tests and 
His tag binding. 
Operon Protein Expression? 
VapB VapC 
vapBCslr1209/1210 VapBCslr1209/1210 S S 
vapBCslr1327/ssr2201 VapBCslr1327/ssr2201 N N 
vapBCssl2138/sll1092 VapBCssl2138/sll1092 N I 
vapBCssr2962/slr1767 VapBCssr2962/slr1767 S N 
Abbreviations: no protein expression (N), Insoluble protein expression (I) and Soluble protein 
expression (S). 
 
All VapBC systems expressed poorly in the pET28b-pstI expression 
system, with the exception of VapBCslr1209/1210 (Figure 3.5). VapBCslr1327/ssr2201 
shows no protein expression (Figure A.4, Appendices). VapBCssl2138/sll1092 
expressed only VapC, which was insoluble (Figure A.4, Appendices). 
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VapBCssr2962/slr1767 expressed only VapB, with the majority of the protein in the 
insoluble fraction (Figure A.4, Appendices). VapBCslr1209/1210 expressed very well 
and showed high affinity for the nickel beads (Figure 3.5), and was taken into the 
large scale expression and purification system.  
 
Figure 3.5. SDS-PAGE 
analysis of E. coli_pET28b-
pstI_VapBCslr1209/1210 small 
scale expression trial. White 
boxes indicate expected band 
sizes. Labels: soluble fraction 
(S), insoluble fraction (I), flow 
through (FT) and nickel beads 
with protein bound after wash 
steps (B).  
 
 
3.3.3 Large Scale Expression and Protein Purification of VapBCslr1209/1210 
Following evidence of soluble protein expression of VapBCslr1209/1210 in 
small scale screens, expression cultures were scaled up (Section 3.2.2.3.1); 
however, scaling the cultures up at 37 °C resulted in insolubility of 
VapBCslr1209/1210. The large scale protein expression cultures were subsequently 
incubated at 30 °C post induction, which increased the solubility of the VapBC 
complex. Protein was purified by IMAC and the chromatograms and 
corresponding SDS-PAGE gels (Figure 3.6) depict the column load, flow though 
and purification fractions. Non-specific bound protein eluted early off the column 
at a low concentration of imidazole (~90-120 mM), whereas His tag associated 
protein eluted later in the gradient with a greater concentration of imidazole 
(~130-220 mM).  
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Figure 3.6. IMAC purification and corresponding SDS-PAGE analysis of 
VapBCslr1209/1210. The chromatogram depicts the UV absorbance and elution 
profile. The corresponding SDS-PAGE gels depict the insoluble fraction (I), 
soluble fraction loaded onto the column (L) and the flow through (FT). Fractions 
and their elution position are shown by the red bar.  
 
The protein was further purified by SEC (Figure 3.7). The SEC 
chromatogram shows that VapBCslr1209/1210 is being purified as a complex. 
VapBCslr1209/1210 elutes as a single peak at approximately 67 kDa based on elution 
volume. The expected size of VapBCslr1209/1210 is either a dimer of 57.66 kDa, or 
tetramer of 115.32 kDa when bound to DNA. The elution profile suggests that the 
protein is not bound to DNA and is in a dimeric state. 
 
 
Figure 3.7. SEC of VapBCslr1209/1210 and corresponding SDS-PAGE gel. The 
chromatogram depicts the UV absorbance profile of protein elution and the gel 
depicts the fractions. Their elution positions are shown by the red bar.   
 
SEC purified protein was used for crystallisation trials and electrophoretic 
mobility DNA shift assays (EMSA), or further treated for disruption of the 
complex to analyse VapBslr1209 or VapCslr1210 individually.  
 
3.3.4 Preliminary VapBCslr1209/1210 DNA Electrophoretic Mobility Shift 
Assays (EMSA) 
EMSAs were conducted with purified VapBCslr1209/1210 to investigate if it 
is capable of autoregulation. As an initial attempt to identify the VapBCslr1209/1210 
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recognition sequence, a 150 bp DNA fragment (Pslr1209A) of the vapBslr1209 
promoter region was designed and tested by EMSA, and no shift was observed 
(Figure 3.8). The promoter region was subsequently investigated for palindromic 
sequences indicative of VapB recognition motifs and two overlapping 
palindromic sequences were identified (Figure 3.8). One palindromic sequence 
occurs between the bases 39 to 150 bp upstream of the start codon with each 
inverted repeat (IR) containing 10 bp and a 92 bp spacing region (Long IR1&2) 
(Figure 3.8). The other palindromic sequence occurs 147 to 168 upstream of the 
start codon, with each IR containing 4 bp and a 14 bp spacing region (Short 
IR1&2) (Figure 3.8). A new DNA fragment was designed to include these regions 
by extending Pslr1209A by 50 bp at the 5’ end (Pslr1209B) (Figure 3.8) and the EMSA 
was repeated (Figure 3.8). A shift in mobility was observed at 3.0-4.5 pM VapBC 
when incubated with Pslr1209B (DNA:protein molar ratio 1:1000-1500) (Figure 
3.8).  To determine the specificity of binding unlabelled specific DNA and non-
specific DNA, pET28bpstI_vapBCslr1209/1210 was added in 120 x excess, which did 
not affect the shift (Figure 3.8). These results suggest that VapBCslr1209/1210 does 
bind to the promoter region of its own operon, however the assay conditions need 
further optimisation to confirm specificity.  
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Figure 3.8. Preliminary VapBCslr1209/1210 autoregulation analysis by EMSA. 
Labels: Negative control with 3.0 fM DIG labelled DNA and no protein (0), 3.0 
fM DIG labelled DNA and 0.3 pM protein to give a 1:100 DNA:protein ratio 
(0.3pM), 3.0 fM DIG labelled DNA and 3.0 pM protein to give a 1:1000 
DNA:protein ratio (3.0pM), 3.0 fM DIG labelled DNA and 4.5 pM protein to give 
a 1:1500 DNA:protein ratio (4.5pM), 3.0 fM DIG labelled DNA and 4.5 pM 
protein to give a 1:1500 DNA:protein ratio (4.5pM) + 120 X unlabelled specific 
DNA (S), 3.0 fM DIG labelled DNA and 4.5 pM protein to give a 1:1500 
DNA:protein ratio (4.5pM) + 120 X unlabelled non-specific DNA (pET28b-
pstI_vapBCslr1209/1210) (N). (A) VapBCslr1209/1210 EMSA with Pslr1209A. (B) 
VapBCslr1209/1210 EMSA with Pslr1209B. (C) Schematic of Pslr1209 containing the 
potential palindromic binding recognition sequences at -39 to -150 bp (Long 
IR1&2) and -147 to -168 bp (Short IR1&2) upstream of the operon start codon.   
 
 In summary, these preliminary results indicate the VapBCslr1209/1210 does 
bind to the promoter region of its own operon, suggesting that it is autoregulatory. 
Binding is observed only when the full palindromic sequences are present from 
both putative recognition motifs. This suggests that these sequences are important 
for protein:DNA interaction, in particular the region containing the overlapping 
IR half sites at 141 to 150 upstream of the start site. Further investigation into 
these sequences is important to determine the recognition motif of 
VapBCslr1209/1210, however, given the spacing region between the two putative 
motifs, the short palindromic sequence is a likely candidate. It is important to note 
these results are preliminary and optimisation of the assay conditions as well as 
further investigation into alternative regulatory mechanisms are important to 
elucidate the mechanism of regulation in this system. 
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3.3.5 Preliminary VapCslr1210 Ribonuclease (RNase) Activity  
VapC proteins, in general, have been tested for nucleotidase activity on 
double stranded (ds) DNA (dsDNA), single stranded (ss) DNA (ssDNA), dsRNA 
and ssRNA, and show exclusive activity on ssRNA (Cook et al., 2013).To test 
VapCslr1210 RNase activity, the VapBCslr1209/1210 complex was disrupted by acid 
SEC (Section 3.2.2.4.1) to release VapCslr1210 (Figure 3.9). The SEC trace and 
SDS-PAGE analysis show that acidification (pH 3) of the purification buffer is 
successful in liberating VapCslr1210 from VapBslr1209. The fractions that were 
enriched in VapC were pooled and concentrated for screening of RNase activity 
using the pentaprobe system (Section 3.2.4.2). 
 
 
Figure 3.9. Acid SEC of VapBCslr1209/1210 and corresponding SDS-PAGE gel. 
The chromatogram depicts the UV absorbance profile of protein elution and the 
SDS-PAGE analysis shows the protein loaded onto the column and the 
subsequent purification fractions. Labels: VapBCslr1209/1210 in purification buffer at 
pH 3 (Load), blue line represented VapBCslr1209/1210 still in complex that elutes off 
the column as the first peak. The red line represents free VapCslr1210 protein 
elution. 
 
3.3.5.1 In vitro RNase Pentaprobe Assays 
To test purified VapCslr1210 for general ssRNA RNase activity, pentaprobe 
screens were conducted. Pentaprobe RNase activity screens, collectively, contain 
every possible combination of five bases, and have been previously described 
(Section 3.2.4.2) (McKenzie et al., 2012a). All six pentaprobe RNAs (from the 
forward direction) were tested as substrates for VapCslr1210 RNase activity (Figure 
3.10). Comparison of assays after one hour in the presence and absence of 
VapCslr1210 indicated that there was slight degradation of pentaprobe 927 
exclusively. To confirm RNase activity of VapCslr1210 on pentaprobe 927 the assay 
was repeated with the following controls: assay conducted with no VapC to check 
for any contaminating RNases in the assay buffers (RNA), VapBCslr1209/1210 was 
added instead of VapCslr1210 to see if the see if the presence of VapBslr1209 
inhibited VapCslr1210 activity (VapBC), and EDTA was added to the assay buffer 
Chapter Three 
 131 
to test for metal
 
dependant endonuclease activity and to check for any metal
 
independent RNase contamination (EDTA). All assays were incubated for 1 hr 
(Figure 3.10).   VapCslr1210 displayed metal dependant RNase activity against the 
927 pentaprobe RNA, which was abolished in the presence of EDTA. The 
banding pattern of the degraded 927 pentaprobe show two prominent bands 
between 50-80 bp, suggesting that VapCslr1210 selectively cleaves in the centre of 
the RNA molecule in an endonuclease mode, to produce two RNA fragments ~70 
bp and 80 bp (Figure 3.10). VapBCslr1209/1210 showed no RNase activity, indicating 
that VapBslr1209 inhibits VapCslr1210 activity.  No RNA degradation was observed 
in the RNA or EDTA controls indicating that there was no RNase contamination. 
Sequence specificity is shown by the different banding patterns produced by the 
cleaved fragments compared to general smearing that would be observed with 
non-specific RNase activity (Figure 3.10).  
A -VapC 60 min  
 
 
Figure 3.10. Preliminary time course 
assays showing ribonuclease activity of 
VapCslr1210 using the pentaprobe system. 
Each pentaprobe assay is labelled at the top 
of each lane. Numbers down the side of the 
urea-denaturing gels denote the low range 
ssRNA ladder base sizes. The multiple 
bands observed are due to the secondary 
structures in the RNA molecules. The red 
boxes indicate prominent degradation 
fragments (A) Each pentaprobe assay after 
1 hr incubation in the absence of VapC. (B) 
Each pentaprobe assay after 1 hr in the 
presence of VapC. (C) The 927 
pentaproble assay with appropriate 
controls. Labels: assay run in the absence 
of VapC (RNA), Assay run in the presence 
of VapC (VapC), assay run in the presence 
of VapBC (VapBC), assay run in the 
presence of VapC with EDTA added to 
assay buffer (EDTA).  
 
B +VapC 60 min 
 
 
C 927 Pentaprobe 
 
 
 
In previous studies using the pentaprobe system, binding of specifically 
degraded pentaprobes was observed by an EMSA-type shift, indicating a dual 
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recognition function of the VapC by binding and cleaving its RNA substrate. The 
binding was abolished in the presence of VapB or EDTA (McKenzie et al., 2012a; 
McKenzie et al., 2012b). VapCslr1210 does not appear to bind to the 927 
pentaprobe, suggesting it does not have the dual function.  
 
To determine sequence specificity of VapCslr1210 future work will include 
oligomers of the 927 pentaprobe around the putative central cut site, which then 
will be used as substrates for VapCslr1210.  Cleaved oligonucleotides will then be 
subjected to MALDI-TOF MS (McKenzie et al., 2012a) to identify the cleaved 
fragments and target recognition sites.  
 
3.3.6 Synechocystis ΔvapBC Deletion Strain Construction and 
Characterisation 
3.3.6.1 Synechocystis ΔvapBC Deletion Strain Generation 
In order to investigate the role of cyanobacterial VapBC systems, in vivo 
attempts were made to generate markerless ΔvapBC deletion strains of each of the 
12 chromosomal Synechocystis VapBC systems. Of the 12 VapBC systems 
present in Synechocystis, a total of five markerless Synechocystis ΔvapBC deletion 
strains were successfully constructed (Figure 3.11). Generation of other deletion 
strains were unsuccessful due to mutations arising in coding regions or incomplete 
segregation of all 12 chromosomes to ensure mutation is present in every 
chromosome.  
 
The generation of each markerless deletion strain required, firstly, the 
generation of a marked deletion strain, containing a cassette with selection 
markers (kanamycin resistance and sucrose sensitivity) to identify successful 
homologous recombination. Briefly, the marked deletion strain was generated by 
transforming the plasmid pUC19 + L&R + sacRB/Kan(R) construct  (Section 
3.2.1.5) into the wild type (WT). Kanamycin was introduced as the selection for 
homologous recombination and cells were passaged for 14 days. Successful 
deletions were confirmed by PCR diagnostics (Section 3.2.1.6.3) using the 
forward left fragment primer and the reverse right fragment primer for each 
operon. Transformants produced a band >5 kb containing the flanking regions (2-
2.5 kb) of the operon and the 3.7 kb cassette that replaced the operon, which is too 
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large to be visualised by gel electrophoresis. The absence of a band represented a 
successful marked deletion. The WT band was approximately 2.5 kb (operon + 
flanking regions). Successful deletion colonies were streaked onto new kanamycin 
agar plate to ensure all chromosomes had the deletion present. 
 
Colonies from the marked deletion strain agar plate were then transformed 
with plasmid pUC19 + L&R construct (Section 3.2.1.5) and incubated for 4 days. 
Post- transformation cells were plated on agar plates with 5% (w/v) sucrose and 
incubated for 7 days or until colonies appeared. Colonies were then patched onto 
both agar plates + kanamycin and agar plates + sucrose to detect unmarked 
deletion strains. Colonies that grew only on sucrose agar plates were streaked onto 
sucrose agar plates again to ensure all chromosomes had the unmarked deletion 
present.  Transformants were screened by colony PCR (Section 3.2.1.6.3) to 
confirm deletion and cassette removal using primers designed to amplify only the 
vapBC operon. Successful deletion strains showed a region of the operon 
removed, which was represented by a smaller band on the gel compared to the 
WT PCR product (Figure 3.11).  
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Figure 3.11. Schematic of Synechocystis markerless ΔvapBC deletion strains 
and PCR diagnostic gels confirming deletion. The top scale indicates the 
position of the operon on the chromosome. Each gene within the operon and 
adjacent to the operon are represented by arrowed boxes. The region of DNA 
within the operon that was removed, including regions of both vapB and vapC, are 
shown in black. The size of the deleted region is shown in the WT strain and the 
gel represents this by change in size of the operon PCR product band of WT vs Δ. 
 
3.3.6.2 Synechocystis ΔvapBC Deletion Strain Growth Experiments 
To investigate if deletion of the VapBC systems had an affect on growth, 
three deletion strains were grown alongside the WT in BG-11 media under both 
full light (40 μmol photons m-2 s-1) and 12 hr light-dark cycling conditions. 
Cultures were set up in triplicate and OD750 readings were taken every 12 hrs over 
a 9 day period (Figure 3.12). OD600 (contamination) and OD680 (chlorophyll) measurements 
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showed identical growth patterns to the OD750 cell density measurements (Figure 
3.12) indicating an absence of fast growing bacteria and no uncoupling of 
photosynthesis (as measured by chlorophyll) and cell growth. The Synechocystis 
ΔvapBCssr2201/slr1327 strain showed no difference in growth compared to the WT 
strain in both full light and light-dark cycling (Figure 3.12). The Synechocystis 
ΔvapBCslr1209/1210 strain showed no difference in growth compared to the WT in 
light-dark cycles but grew slower than the WT under full light, especially during 
mid-late exponential growth (Figure 3.12). The Synechocystis ΔvapBCssl2138/sll1092 
strain grew slower than the WT in both conditions. In full light the deletion strain 
grew slower only for the first 12 hrs and in light-dark cycling the deletion strain 
grew slower for the full 9 days until the last time point (216 hrs) (Figure 3.12).  
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Full Light Light-Dark Cycling 
  
  
  
Figure 3.12. Growth of Synechocystis WT vs ΔvapBC strains over a 9 day 
period in either full light or 12 hr light-dark cycling. The graph is 
representative of one independent experiment with three biological replicates 
taken at each time point. The error bars represent SEM. Red arrows indicate time 
point (84 hrs) where samples were harvested for RNA-seq and RT-qPCR 
analyses. 
 
No obvious changes in culture appearance or cell morphology were 
observed between strains during the duration of the growth experiments. For each 
strain where a difference in growth was observed compared to the WT the growth, 
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experiments were repeated and RNA was extracted at mid to late exponential 
growth (Figure 3.12) for subsequent RNAseq and RT-qPCR analysis.  
 
3.3.6.3 RNA-seq Analysis of Synechocystis WT vs ΔvapBC Strains  
The Synechocystis ΔvapBCslr1209/1210 and ΔvapBCssl2138/sll1092 strains both 
showed a reduced growth rate compared to the WT. RNA-seq was used to 
investigate the transcriptional profiles of each strain and how the deletion of the 
VapBC systems resulted in slower growth for each of these strains. Cells were 
harvested at mid to late exponential phase (84 hours) to obtain a high enough 
yield of RNA for subsequent processing and analysis. Purified RNA was sent to 
BGI genome sequencing facility in Hong Kong for quality assessment, sample 
processing, cDNA library generation and sequencing, and analysis. 
 
3.3.6.3.1 RNA-seq Analysis of Synechocystis WT vs ΔvapBCslr1209/1210 
To confirm deletion of the vapBCslr1209/1210 operon the expression profile of 
each gene was assessed in the WT and deletion strain dataset using fragments per 
kilobase of transcript per million mapped reads (FPKM). In full light the WT 
expression profile for vapBslr1209 is 70.03 and vapCslr1210 is 5.29 showing 
expression of both of genes is low. In full light the deletion strain showed no 
expression of vapBslr1209, however vapCslr1210 is indicated as present (2.89). The 
raw transcript reads show that there are only 3 raw reads for this gene, suggesting 
that this could be an artefact of the RNA-seq analysis, rather than true expression. 
In the light dark cycling conditions the WT expression profile for vapBslr1209 is 
42.98 and vapCslr1210 is 5.43, again showing expression is low. In the deletion 
strain there is no expression of either vapBslr1209 or vapCslr1210, confirming that this 
operon has been deleted from the genome.  
 
Comparison of the transcriptional response of the WT compared to 
ΔvapBCslr1209/1210 grown under full light showed 16 differentially expressed genes 
(DEG) (>2.0 x change, P<0.05), with 5 genes upregulated and 11 genes 
downregulated in the deletion strain (Table 3.6). The most upregulated gene in the 
deletion strain is a putative transposase (slr0352), which has a 7.62 Fold increase 
in expression. Other upregulated genes include those encoding two hypothetical 
proteins (ssr3402 and sll5075), the Photosystem II accessory pigment CpcG2 
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(cpcG2) and a putative oxidoreductase (slr2008). The range of upregulation for 
these genes was between 2.22 Fold to 2.71 Fold. The most downregulated gene in 
the deletion strain is a putative transposase (sll0650), which is downregulated 
11.03 Fold. Other downregulated genes include genes encoding another putative 
transposases (slr0800), five hypothetical proteins (ssr6032, slr6075, slr1056 and 
ssr1768), the glucose transport protein (GlcP, glcP), the sulphate transport system 
binding protein (SbpA, sbpA), an assembly protein for Photosystem II (slr0286), a 
putative cation transporter (sll0671) and a putative endonuclease (sll0709). The 
range of downregulation for these genes was between 2.09 Fold to 10.82 Fold 
(Table 3.6). Although each DEG is statistically supported, all but 3 show very low 
expression (FPKM <74) (Table 3.6). As a result, the observed differential 
expression is likely artificially inflated and an artefact of the RNA seq analysis of 
low copy number comparisons, rather than true differential expression. Therefore, 
the genes cpcG2 and glcP, where the difference in FPKM is significant 
(ΔFPKM>100), are considered the only significant DEG from this analysis (Table 
3.6).  
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Table 3.6. List of genes that are differentially expressed (>2.0 x change, 
P<0.05) in Synechocystis ΔvapBCslr1209/1210 compared to WT under full light. 
Rows coloured in orange indicate DEG present in both full light and light-dark 
cycling. Rows coloured green indicate DEG with significant differences in FPKM 
(ΔFPKM>100).  
Locus Expression 
ratio
a
 
P-value WT 
expression 
(FPKM) 
Δ 
expression 
(FPKM) 
Encoded protein 
slr0352 7.62 3.03E-06 0.09 17.66 Putative transposase 
ssr3402 2.71 4.96E-05 11.01 72.21 Hypothetical protein 
cpcG2 2.38 2.94E-33 45.87 239.25 
Phycocyanin linker protein 
(CpcG2) 
slr2008 2.31 2.50E-05 14.85 73.61 Putative oxidoreductase (MrpC) 
sll5075 2.22 6.63E-05 12.19 56.83 Hypothetical protein 
sll0650 -11.03 5.21E-09 41.87 0.02 Putative transposase 
ssr6032 -10.82 5.28E-05 36.23 0.02 Hypothetical protein 
glcP -3.00 6.60E-77 177.47 22.13 
Glucose transport protein 
(GlcP) 
      
sbpA -2.56 4.52E-05 13.72 2.33 
Sulphate transport system 
substrate binding protein 
(SbpA) 
slr0286 -2.37 5.38E-09 
25.56 4.93 Assembly protein for 
Photosystem II 
sll0671 -2.32 9.77E-06 16.91 3.39 Putative cation transporter 
sll0709 -2.16 1.36E-10 32.51 7.31 Putative endonuclease 
slr6075 -2.10 2.13E-10 19.17 4.47 Hypothetical protein 
slr1056 -2.09 1.57E-13 30.67 7.22 Hypothetical protein 
ssr1768 -2.08 1.41E-4 98.2 23.15 Hypothetical protein 
slr0800 -2.08 6.18E-11 122.52 28.9 Putative transposase 
a 
Log2 expression ratio (ΔvapBCslr1209/1210/WT). 
 
Comparison of the transcriptional response of the WT compared to 
ΔvapBCslr1209/1210 grown under light-dark cycling showed 7 DEG (>2.0 x change, 
P<0.05) with 3 genes upregulated and 4 genes downregulated in the deletion 
strain (Table 3.7). The most upregulated gene in the deletion strain is a putative 
transposase (sll1997), which is upregulated 10.92 Fold. The 2 other upregulated 
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genes also encode putative transposases (sll1255 and slr0350) (5.96 Fold and 
10.24 Fold upregulated, respectively). The most downregulated gene in the 
deletion strain is a putative transposase (sll0651), which is downregulated 8.47 
Fold. Other downregulated genes include genes that encode another putative 
transposase (sll0315), the glucose transport protein (GlcP, glcP), and a putative 
major outer membrane protein (MomP, sll0772/momP). These genes are 
downregulated from 2.74 Fold to 5.97 Fold (Table 3.7).  Although each DEG is 
statistically supported, all but 2 show very low expression (FPKM <70) (Table 
3.7), and, as mentioned earlier, the observed differential expression of these genes 
is likely an artefact of RNA seq analysis. As a result the genes glcP, and momP, 
where difference in FPKM is significant (ΔFPKM>100), are considered the only 
significant DEG from this analysis (Table 3.7).  
Table 3.7. List of genes that are differentially expressed in Synechocystis 
ΔvapBCslr1209/1210 compared to WT in light-dark cycling. Rows coloured in 
orange represent DEG present in both full light and light-dark cycling. Rows 
coloured green indicate DEG with significant differences in FPKM 
(ΔFPKM>100).  
Locus Expression 
ratio
a 
P-value WT 
expression 
(FPKM) 
Δ 
expression 
(FPKM) 
Encoded protein 
sll1997 10.92 1.66E-06 0.01 19.37 Putative transposase 
sll1255 10.24 1.52E-09 0.01 12.08 Putative transposase 
slr0350 5.96 1.64E-15 0.47 29.33 Putative transposase 
sll0651 -8.46 1.37E-05 24.57 0.07 Putative transposase 
sll0315 -5.97 1.81E-20 68.75 1.1 Putative transposase 
glcP -3.30 3.62E-135 337.03 34.26 
Glucose transport protein 
(GlcP) 
      
sll0772 
(momP) 
-2.74 4.75E-104 262.05 39.19 
Probable porin, major outer 
membrane protein (MomP) 
      
a 
Log2 expression ratio (ΔvapBCslr1209/1210/WT). 
 
In summary, the RNA-seq analysis identified two genes, cpcG2 and glcP, 
grown under full light and two genes, glcP and momP, grown under light-dark 
cycling that are differentially expressed in the ΔvapBCslr1209/1210 deletion strain. 
cpcG2 is the only upregulated gene in the deletion strain and is only upregulated 
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in full light conditions. CpcG2 is a structural protein that composes part of the 
light harvesting antennae (phycobilisome) in Photosystem II of the photosynthetic 
pathway. Based on the observed differential expression, under full light conditions 
it appears VapBCslr1209/1210 normally downregulates CpcG2 expression. The genes 
glcP and momP are downregulated in both conditions, where glcP is significantly 
downregulated in both conditions (>2.0 x change, P<0.05, ΔFPKM>100) and 
momP is significantly downregulated in light-dark and 1.66 Fold (P=1.33x10
-35
, 
ΔFPKM=103.59) in full light. GlcP belongs to the sugar transport protein family, 
and is responsible for glucose and fructose transportation during heterotrophic 
growth in Synechocystis. MomP is a hypothetical protein annotated as a putative 
outer membrane protein and is found 91 bp downstream of glcP. Because these 
genes are downregulated in the deletion strain, it appears that VapBCslr1209/1210, 
when present, may play a role in inducing the expression of these genes. 
Collectively, it appears that VapBCslr1209/1210 plays a role in repressing the 
expression of CpcG2, which is involved in photosynthesis, and inducing the 
expression of GlcP and MomP, which sit adjacent to each other in the genome, 
forming an operon responsible for glucose uptake. 
 
3.3.6.3.2 RNA-seq Analysis of Synechocystis WT vs ΔvapBCssl2138/sll1092 
To confirm deletion of the vapBCssl2138/sll1092 operon the expression profile 
of each gene in the operon was assessed in the WT and deletion strain using 
FPKM. The WT expression profile for vapBssl2138 is 3.21 and vapCsll1092 is 39.13 
showing expression for both genes is low. The deletion strain also showed 
expression of both vapBssl2138 (4.75) and vapCsll1092 (37). This result was 
unexpected, considering the previous confirmation of the deletion from the 
genome (Figure 3.11). To investigate this further, the raw transcript read numbers 
of each gene were compared between the WT and deletion strain datasets. The 
WT dataset has 2 transcript reads of vapBssl2138, where the deletion strain has 1, 
and 50 transcript reads for vapCsll1092 where the deletion strain has 16. There are 
two possible explanations for this. The first is that expression of both genes is so 
low that the transcript reads are unable to be quantified accurately. The second 
explanation is that the operon has not been successfully deleted from the genome 
and further segregation is required to ensure the deletion in all chromosomes; 
however, this should have been detected in the initial diagnostic. The 
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transcriptional response of the WT compared to ΔvapBCssl2138/sll1092 was 
subsequently analysed however, the results of this comparison are provided as a 
preliminary assessment only.  
 
Comparison of the transcriptional response of the WT compared to 
ΔvapBCssl2138/sll1092 grown under light-dark cycling showed 19 DEG (>2.0 x 
change, P<0.05), with 5 genes upregulated and 14 genes downregulated in the 
deletion strain (Table 3.8). The most upregulated gene in the deletion strain is a 
putative transposase (sll0650), which is upregulated 11.76 Fold. All other 
upregulated genes encode for manganese transport (mntA, mntB and mntC) and a 
putative cell invasion protein (sipA), with upregulation from 2.02 Fold to 2.88 
Fold. The most downregulated gene in the deletion strain is a hypothetical protein 
(ssr3517), which is downregulated 11.96 Fold. Other downregulated genes encode 
for 3 putative transposases (slr0462, sll0651 and sll1397), 5 hypothetical proteins 
(slr1851, ssr1251, slr1611, sll0253 and ssr6048), the Chlorophyll a ring 
formation protein (ChlAII, chlAII), the Phosphoenolpyruvate synthase (Pps, pps) 
and a putative glycosyltransferase (slr1065). The range of downregulation of 
these genes are from 2.02 Fold to 10.87 Fold (Table 3.8). Although each DEG is 
statistically supported, 12 show very low expression (FPKM <78) (Table 3.8) 
indicating that the differential expression observed may be an artefact of the RNA 
seq analysis, as mentioned earlier, rather than a true differential expression. 
However, the genes mntA, mntB and mntC encode proteins involved in manganese 
transport and appear to form an operon. Although these genes have poor 
expression (FPKM <75), each one is upregulated in the deletion strain, suggesting 
that this may be a true disregulation of an entire operon. As a result, this operon 
and the 7 downregulated genes slr1851, ssr1251, sll0253, ssr6048 and sll1863 
(hypothetical proteins), chlAII and pps are considered significant DEG from this 
analysis (Table 3.8).  
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Table 3.8. List of genes that are differentially expressed in Synechocystis 
ΔvapBCssl2138/sll1092 compared to WT in light-dark cycling. Rows coloured green 
indicate DEG with significant differences in FPKM (ΔFPKM>100). Rows 
coloured in blue indicate low expression DEG that form the manganese transport 
machinery operon and are all upregulated indicating true differential expression 
irrelevant of low FPKM. 
Locus Expression 
ratio
a
 
P-value WT 
expression 
(FPKM) 
Δ 
expression 
(FPKM) 
Encoded protein 
sll0650 11.76 8.37E-09 0.01 34.76 Putative transposase 
mntC 2.88 1.22E-26 10.05 73.78 Manganese Transporter (MntC) 
mntB 2.58 4.62E-22 12.42 74.28 
Manganese transport system 
membrane protein (MntB) 
sipA 2.46 1.50E-4 9.16 50.24 
Putative cell invasion protein 
(SipA) 
mntA 2.02 2.51E-10 12.87 52.15 
Manganese Transport ATP-
binding protein (MntA) 
ssr3571 -11.96 1.03E-4 39.76 0.01 Hypothetical protein 
slr0462 -10.87 1.03E-4 18.78 0.01 Putative transposase 
sll0651 -5.18 1.01E-05 24.57 0.68 Putative transposase 
slr1851 -4.71 3.84E-25 140.09 5.37 Hypothetical protein 
sll1397 -4.63 4.34E-13 37.71 1.52 Putative transposase 
ssr1251 -3.91 2.52E-09 166.33 11.04 Hypothetical protein 
slr1611 -3.29 3.41E-08 57.32 5.84 Hypothetical protein 
chlAII -3.15 3.84E-34 110.57 12.47 
Chlorophyll a ring formation 
protein (ChlAII) 
sll0665 -2.56 1.91E-05 55.64 9.41 Putative transposase 
sll0253 -2.17 8.77E-92 928.26 206.13 Hypothetical protein 
ssr6048 -2.12 3.11E-09 220.35 50.73 Hypothetical protein 
pps -2.05 1.50E-289 660.86 159.24 
Phosphoenolpyruvate synthase 
(Pps) 
sll1863 -2.03 1.04E-28 530.36 129.63 Hypothetical protein 
slr1065 -2.02 3.81E-14 77.69 19.2 Putative glycosyltransferase 
a 
Log2 expression ratio (ΔvapBCssl2138/sll1092/WT). 
 
Aside from the manganese transport operon, all significant DEG are 
downregulated in the deletion strain, with the majority encoding hypothetical 
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proteins (5/7). The two characterised genes are pps, which encodes Pps, a protein 
involved in pyruvate and acetyl-CoA metabolism, and chlAII, which encodes 
ChlAII, an assembly protein of Chlorophyll a. Both of these genes are 
downregulated in the deletion strain indicating that VapBCssl2138/sll1092 plays a role 
in inducing the expression of these genes. Although these results are preliminary, 
they do suggest that VapBCssl2138/sll1092 plays a role in repressing the expression of 
an entire operon responsible for manganese transport, and inducing the expression 
of a cohort of hypothetical proteins and genes involved in both photosynthesis and 
the glucose metabolism.  
 
3.3.6.4 RT-qPCR Analysis 
Because of the success in protein expression of VapBCslr1209/1210 and 
subsequent preliminary in vitro characterisation of this system, the DEG identified 
in the ΔvapBCslr1209/1210 RNA-seq analysis were chosen for further RT-qPCR 
analysis (Table 3.9). To test whether transposases had true differential expression, 
four were selected for RT-qPCR validation. Additionally, the genes glcP and 
momP were chosen for validation as they were consistently downregulated in the 
deletion strain for both conditions tested, making them the most promising 
candidate of VapBC characterisation. 
Table 3.9. List of RNA-seq determined DEG in Synechocystis 
ΔvapBCslr1209/1210 analysed by RT-qPCR. Rows in green indicate DEG that were 
successfully validated by RT-qPCR (>2.0 x change). 
Gene Protein RNA-seq 
expression 
ratio
a 
WT strain 
expression 
profile 
(FPKM) 
Δ strain 
expression 
profile 
(FPKM)
 
RT-qPCR relative 
expression in  
(KO vs WT)
b 
sll1997 Transposase 10.92 0.01 19.37 Not detected 
sll1255 Transposase 10.24 0.01 12.08 Not detected 
slr0350 Transposase 5.96 0.47 29.33 1.24 
sll0315 Transposase 5.97 68.75 1.1 Not detected 
glcP GlcP 3.30 337.03 34.26 83.33 
momP Momp 2.74 262.05 39.19 3.15 
a 
Log2 expression ratio (ΔvapBCssl2138/sll1092/WT). 
b 
2
(-ΔΔCt)
 for upregulated genes and its reciprocal (1/(2
(-ΔΔCt)
)) for downregulated genes to represent 
ratio relevant to WT.  
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RNA-seq determined differential expression of all transposases tested 
could not be validated by RT-qPCR given the required parameters of this test 
(>2.0 x change) (Table 3.9). This result supports the previous assumption that the 
enrichment of transposases, and other genes with low expression, in the total DEG 
of the RNA-seq analyses are likely an artefact of the analysis, rather than actual 
differential expression. Both glcP and momP show significant differential 
expression, with both genes being downregulated in the deletion strain, validating 
the RNA-seq results (Table 3.9) (Figure 3.13). 
 
Figure 3.13. RT-qPCR 2
-∆∆Ct
 fold change expression profiles of glcP, momP, 
and slr0350 in ΔvapBCslr1209/1210 vs WT. RT-qPCR analysis sets the WT gene 
mRNA expression to an arbitrary expression level of 1 for comparison to the 
ΔvapBCslr1209/1210 gene expression.   
 
 
In summary, these results provide an indication, in combination with the 
RNA-seq results, that the VapBCslr1209/1210 system affects the expression of these 
genes. However, these results are preliminary and require further optimisation, 
with increased sample numbers to allow for the appropriate statistics to be done. 
Further investigation of the relationship between VapBCslr1209/1210 and the genes 
glcP and momP, as putative cellular targets provide an exciting avenue to 
elucidate the role of this VapBC system in cyanobacteria. 
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3.4 Discussion 
VapBC systems are the largest family of the Type II TA systems and have 
become a point of interest because of their overrepresentation in the genomes of 
pathogenic and environmentally hazardous bacteria. Several VapBC systems from 
a range of bacteria have been implicated in persistence and stress response via 
inducing growth arrest by inhibiting translation; however, the cellular targets and 
specific biological roles of most of these systems are yet to be elucidated.  
 
 The sole VapBC1283/4 system in M. smegmatis, the non-pathogenic relative 
of M. tuberculosis, is one of the best characterised systems and has provided 
significant insight into the biological functioning of VapBC systems. VapBC1283/4 
targets and cleaves mRNA transcripts that encode the glycerol transport 
machinery. In the ΔvapBC1283/4 strain glycerol uptake was greater than that of the 
WT, however the increased rate of consumption was uncoupled to biomass 
generation. From this, a model was proposed that VapBC1283/4 regulates the rate of 
glycerol utilisation to match the anabolic demands of the cell, allowing for fine-
tuning of the catabolic rate at a posttranscriptional level.  
 
 M. tuberculosis has an expansion of VapBC systems (47) encoded in its 
genome. Although preliminary characterisations have been done for a number of 
these systems, the actual biological targets remain to be elucidated. However, 
studies have implicated these VapBC systems as an intricate stress response array, 
where specific cohorts of VapBC systems are activated in response to different 
environmental triggers to induce bacteriostasis via translation inhibition. The 
dormancy, or persistence of M. tuberculosis, which is a result of bacteriostasis, is 
one of the most challenging characteristics of this pathogen in terms of human 
infection and treatment, as current treatments are in the form of antibiotics that 
target active cells. As a result, VapBC systems are a valuable biological target for 
investigating the capacity to prevent persistence and increasing susceptibility to 
antibiotic treatment.   
 
 The environmentally hazardous toxic bloom forming M. aeruginosa shares 
physiological characteristics with M. tuberculosis, in particular, its ability to 
persist in a dormant state while nutrients are limiting. M. aeruginosa also has an 
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expansion of VapBC systems (46 predicted by TADB) encoded in its genome, 
however, none of these systems have been investigated. In fact, there is only one 
VapBC system in cyanobacteria that has been characterised: VapBC10 
(ssr2962/slr1767) from Synechocystis, the model organism of cyanobacteria. 
VapC10 was shown to induce the characteristic bacteriostatic phenotype of a 
VapC toxin, which is reversed upon the introduction of VapB. It is proposed that 
VapC10 exerts its growth arrest via translation inhibition, like many other 
characterised VapC toxins, however this has not been confirmed experimentally. 
Because this is the only VapBC system to be characterised in cyanobacteria and 
the functional mechanism is still unknown, it is difficult to make any 
generalisations about the biological role that these VapBC systems play. In this 
study, two M. aeruginosa VapBC systems and three Synechocystis VapBC 
systems have been investigated. 
 
3.4.1 In vitro Investigation of Cyanobacteria VapBC Systems in this Study 
To investigate the VapBC systems in M. aeruginosa, two representative 
VapBC systems were selected: VapBCMAE49640/50 and VapBCMAE43230/20. 
Expression in E. coli of VapBCMAE49640/50 was unsuccessful and expression of 
VapBCMAE43230/20 was successful only when expressed with a SUMO fusion 
protein attached to VapBMAE43230. VapBMAE43230 and VapCMAE43220 are co-
expressed with an excess of VapB being expressed relative to VapC. This 
expression ratio indicates that vapBCMAE43230/20 is expressed as a typical vapBC 
operon, where expression is characterised by a ratio of up to 10:1 VapB:VapC as 
a result of the overlap present within the operon. VapBMAE43230 and VapCMAE43220 
form a tetrameric VapBCMAE43230/20 protein complex bound to genomic DNA, 
which appears to be unstable, with the majority of the complex forming a soluble 
aggregate. VapB MAE43230 also appears to be purified bound to genomic DNA and 
forms a tetramer.  Further optimisation is required to reduce the aggregation of the 
complex and removal of co-purified DNA before in vitro characterisation can be 
conducted. 
 
Because of the difficulty faced with expression of the M. aeruginosa 
VapBC systems, Synechocystis VapBC systems were trialled for expression. All 
VapBC systems expressed poorly, with the exception of VapBCslr1209/1210. 
VapBslr1209 and VapCslr1210 are co-expressed and form a stable dimeric complex 
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that is not bound to DNA. The ratio of expression could not be determined for this 
systems as the His tag was bound to VapC, resulting in excess VapB being lost 
during the initial IMAC purification step. Disruption of the complex was achieved 
by subjecting the complex to acidic buffering conditions, which resulted in a 
change in net charge of each protein and subsequent disruption the ionic 
interactions that stabilize the complex. 
 
Preliminary EMSA assays indicate autoregulation by VapBCslr1209/10 by 
binding to the promoter region of the vapBCslr1209/1210 operon.  Analysis of the 
promoter region identified two overlapping palindromic sequences as putative 
VapBslr1209 recognition motifs, and EMSA assays show that the presence of these 
sites are necessary for binding to occur. To validate these results, additional 
mutation work is required to confirm the recognition sites, and assays should be 
optimised to confirm the specificity of binding.  
 
Using the RNA pentaprobe system VapCslr1210 was confirmed to have 
metal specific endoribonuclease activity. VapCslr1210 ribonuclease activity was 
observed only on pentaprobe 927, which was inhibited when EDTA or VapBslr1209 
was added to the assays. The degradation pattern shows two prominent bands 
between 50-80 bp, suggesting that VapCslr1210 selectively cleaves the RNA at the 
centre of the 150 bp molecule in an endonuclease mode to produce two RNA 
fragments ~70 bp and 80 bp. The site of cleavage is certainly not optimal due to 
the slow rate of cleavage. Binding of VapCslr1210 to the 927 pentaprobe was not 
observed, suggesting there is no dual recognition function by binding and cleaving 
its RNA substrate. This lack of dual function has also been observed, using the 
pentaprobe system, in characterised VapC proteins from M. tuberculosis and 
Pyrobaculum aerophilium. The only exception to this is the sole M. smegmatis 
VapC1284, where binding of the pentaprobe was observed. The binding was 
abolished in the presence of VapB or EDTA.  
 
3.4.2 In vivo Investigation of VapBC Systems 
Markerless deletion strains of five different Synechocystis vapBC operons 
were made, and growth experiments of three of the deletion strains were 
conducted to determine the affect of the deletion of these VapBC systems on 
fitness of the organism. Growth experiments of Synechocystis WT vs ΔvapBC 
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strains identified a reduced growth rate in two of the deletion strains: 
ΔvapBCslr1209/1210 and ΔvapBCssl2138/sll1092. Transcriptomic analyses of both 
deletions strains were subsequently carried out to investigate the cause of the 
observed phenotypes.  
 
RNA-seq analysis of the WT in both full light and light-dark cycling show 
that both VapBCslr1209/1210 VapBCssl2138/sll1092 systems are expressed in relatively 
low abundance.  RNA-seq analysis of the ΔvapBCssl2138/sll1092 transcriptome (light-
dark cycling) show transcripts present for both VapBssl2138 (1) and VapCsll1092 
(16), which are very low and, as a result, difficult to acknowledge as true 
indication of expression. RNA-seq analysis of the ΔvapBCslr1209/1210 transcriptome 
in light-dark cycling confirmed the deletion of the vapBCslr1209/1210 operon, 
however in the full light analysis there are 3 raw transcript reads for VapCslr1210, 
which is also so minimal that it is difficult to acknowledge as true expression. 
Given that deletions were confirmed prior to RNA-seq analysis, for the purposes 
of this study, it is assumed that all expression profile comparisons of poorly 
expressed genes cannot be accurately quantified and are unreliable. This was 
supported by RT-qPCR analysis, where a number of RNA-seq identified DEG 
that were poorly expressed could not be validated. As a result, a significant 
number of DEG identified by BGI analysis have been removed from this study, 
including all transposases.  
 
Comparison of the transcriptional response of the WT compared to 
ΔvapBCssl2138/sll1092 grown under light-dark cycling showed 10 DEG with 3 genes, 
mntA, mntB and mntC, upregulated and 7 genes, slr1851, ssr1251, sll0253, 
ssr6048, sll1863 (hypothetical proteins), chlAII and pps, downregulated in the 
deletion strain. All 3 upregulated genes form an operon that encodes manganese 
transport machinary (MntA, MntB and MntC). Accumulation of manganese is 
essential for the assembly of the Photosystem II manganese cluster in 
Synechocystis and subsequent oxygenic photosynthesis (Bartsevich & Pakrasi, 
1996). Because this manganese transport operon is upregulated in the deletion 
strain, it is possible that they are targets of VapBCssl2138/sll1092, which acts to inhibit 
their translation; however, further validation of these genes as targets is required. 
The two characterised downregulated genes encode Pps, a protein involved in 
pyruvate and acetyl-CoA metabolism and ChlAII, an assembly protein of 
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Chlorophyll a. As both of these genes are downregulated in the deletion strain, it 
is possible that VapBCssl2138/sll1092 plays a role in inducing the expression of these 
genes, however further validation is required.  
 
Comparison of the transcriptional response of the WT compared to 
ΔvapBCslr1209/1210 grown under both full light and light-dark cycling showed 
differential expression of genes exclusively involved in photosynthesis and 
glucose uptake. In full light, the two differentially expressed genes are cpcG2, 
which is upregulated, and glcP, which is downregulated. Under light-dark cycling 
glcP is also downregulated, as well as the gene momP, which is found 91 bp 
downstream of glcP. Both glcP and momP downregulation was validated by 
preliminary RT-qPCR analysis and cpcG2 was not tested.  
 
cpcG2 encodes CpcG2, a structural protein that composes part of the light 
harvesting antennae (phycobilisome) in Photosystem II of the photosynthetic 
pathway. Based on the observed differential expression, under full light 
conditions, it appears VapCslr1210 normally downregulates cpcG2 expression.  
Given that this protein is overexpressed in the deletion strain, which is likely due 
to increase light harvesting abililty and subsequent carbon fixation and glucose 
production, it is interesting that the effect is a reduced growth phenotype 
compared to the WT. As mentioned earlier, the only other well characterised 
biological targets of VapBC systems are that of M. smegmatis VapBC1283/4, which 
also include the cellular machinery responsible for carbon utilisation and 
metabolism. Deletion of VapBC1283/4 had an uncoupling affect of carbon uptake 
and biomass production, which identified the role of VapBC1283/4 in regulating the 
rate of glycerol utilisation to match the anabolic demands. It also appears that the 
deletion of VapBCslr1209/1210 in Synechocystis results in a similar disregulation 
between autotrophic processes of carbon fixation, via CpcG2, and biomass 
production, as shown by the reduced growth phenotype.  
 
glcP encodes GlcP, which is responsible for glucose transportation during 
heterotrophic growth in Synechocystis and sits upstream of momP. Previous 
studies have investigated both glcP and momP for their role in sugar transport in 
Synechocystis and if they function as a polycistronic operon (Schmetterer, 1990; 
Zhang, Durand, Jeanjean, & Joset, 1989; Zhang, Jeanjean, & Joset, 1998). All 
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studies identified GlcP as an essential glucose importer, however the function of 
MomP still remains unknown. Zhang et al. (1989) state that it is highly possible 
that both genes are co-transcribed as a single mRNA as the distance between the 
two genes is quite short. Pfam (Finn et al., 2014) analysis of the MomP protein 
sequence shows the closest alignment is to an OprB family member, a 
carbohydrate selective-porin protein from Pseudomonas aeruginosa, indicating a 
putative role in carbohydrate transport. Because these genes are downregulated in 
the deletion strain, it appears that VapBCslr1209/10 may play a role in inducing the 
expression of these genes.  
 
 With the exception of VapBCssl2138/sll1092 also affecting the expression of an 
operon encoding magnesium transport and a cohort of hypothetical proteins, the 
general observation is that both VapBC systems appear to target genes involved in 
carbon assimilation and metabolism via both photosynthetic and heterotrophic 
processes. Both VapBC systems appears to target genes involved in 
photosynthesis, in particular the light harvesting apparatuses, which are essential 
for phototrophic carbon fixation. In terms of heterotrophic growth, 
VapBCssl2138/sll1092 targets genes involved in the initial states of glycolysis, and 
VapBCslr1209/1210 targets an operon involved in glucose transport. Given the 
similarity in cellular targets between M. smegmatis VapBC1283/4 and both 
Synechocystis VapBC systems, in particular VapBCslr1209/1210, it is tempting to 
speculate that these protein systems share similar biological functions; that is, they 
fine-tune the regulation of carbon metabolism by controlling the rate of glucose 
utilisation (via both carbon fixation and glucose transport) to match the anabolic 
demands of the cell. 
 
Although these results are preliminary, they have provided insight to allow 
us to begin elucidating the cellular targets of these uncharacterised VapBC 
systems and their potential role in cyanobacteria. Future work to test the 
hypotheses developed from these preliminary findings is discussed in Chapter 4.
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4 Summary Chapter 
In this thesis I have focused on the mechanisms of transcription and post 
transcriptional regulation in the context of the environmental organisms M. 
smegmatis and cyanobacteria (M. aeruginosa and Synechocystis). These 
organisms are characterised as slow growing opportunists that are exposed to 
constantly fluctuating environments. The tight regulation of their cellular 
processes in response to their changing environments is crucial for their 
adaptation, making them suitable candidates for this research. The role of the 
poorly understood transcription factor AmtR in M. smegmatis was investigated 
and characterised for its role in adaptation to nitrogen limitation. The mRNA 
interferases, VapBC systems, were investigated and identified primarily as 
putative post-transcription regulators of carbon metabolism in M. aeruginosa and 
Synechocystis. 
 
4.1 Transcriptional Regulation by M. smegmatis AmtR 
There is an extraordinary diversity and abundance of transcription factors 
that span the prokaryotic kingdom, with over 30 different superfamilies. 
Transcription factors are responsible for regulation of the expression of genes 
involved in specific cellular processes in response to the environment. One of the 
most well understood transcription factors is the nitrogen regulatory system 
(NtrBC), present in most bacteria, which is responsible for response to nitrogen 
limitation. In bacteria that do not have an NtrBC system, including a number of 
actinobacteria, the global transcription factors GlnR and AmtR function as the 
major nitrogen-limiting response players. In the actinobacteria C. glutamicum, the 
response to nitrogen limitation is regulated via AmtR, which acts as a repressor of 
over 35 genes under nitrogen surplus. AmtR interacts with the PII protein GlnK, 
under nitrogen limitation, leading to the release of AmtR from its target DNA and 
subsequent upregulation of its regulon. The C. glutamicum AmtR regulon is 
composed of genes that encode proteins responsible for ammonia uptake and 
assimilation, and alternative nitrogen uptake and metabolism.  
 
The actinobacteria M. smegmatis also lacks a NtrBC system but encodes 
both GlnR and AmtR proteins. GlnR has been identified as an important nitrogen 
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regulator that controls the genes encoding ammonia uptake and assimilation, 
alternative nitrogen uptake and metabolism, and the signal transduction PII 
proteins. The preferred nitrogen source of M. smegmatis is ammonium but it is 
capable of scavenging different nitrogenous compounds under changing 
environmental conditions. The genome has a high prevalence of genes involved in 
urea transport and metabolism, suggesting that urea is an important alternative 
nitrogen source during nitrogen limitation. AmtR has been identified as a 
repressor of a number of genes involved in alternative urea metabolism and amino 
acid transport during non-nitrogen limiting conditions.  
 
The first AmtR structure to be solved (described here) reveals the 
regulatory domain that contains a deep binding pocket and the DNA binding 
domain is defined by a helix-turn-helix (HTH) motif. AmtR forms a homodimer 
with each monomer composed of 10 α-helices that constitute two domains. The 
DBD aligns with the QacR family of TetR transcription factors, which are unique 
in their DNA binding mechanisms as they bind DNA as pair of dimers where 
TetR DNA binding is generally by one dimer.  The similarities of AmtR and 
QacR suggest that AmtR binds DNA as a pair of dimers in the same mechanism 
as QacR. The large binding pocket in the centre of the LBD is accessed by a long 
entrance site and contains a residue Glu170 on helix α8 which forms a potential 
gate at the entrance site of the pocket that may influence the stability or efficiency 
of ligand binding.   
 
Our work validated previous work that identified the M. smegmatis AmtR 
regulon, and subsequently we determined the DNA recognition sequence. The 
AmtR regulon has previously been identified as a cohort of genes involved in 
alternative nitrogen uptake and urea metabolism (Jessberger et al., 2012). We 
confirmed this with microarray analysis of the M. smegmatis AmtR deletion 
strain, which showed deregulation of an operon that encodes proteins responsible 
for alternative nitrogen uptake and urea metabolism: an amino acid permease, two 
hypothetical proteins, a urea carboxylase (UC), and an allophanate hydrolase 
(AH) respectively. The UC and AH proteins are known to form an enzyme 
complex that converts urea to ammonium via an ATP-dependent process. 
Subsequently, the AmtR DNA recognition sequence in the promoter region of this 
operon was identified by EMSA mutation work. The recognition motif is the 16 
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bp semi-palindromic ATCTGTCATCTGACAG, which shares similarities to its 
close relative, the C. glutamicum AmtR recognition motif. Both the nucleotide 
specificity and the size of the spacing regions between the two half sites of the 
recognition sequence region are critical for binding. Using the M. smegmatis 
AmtR binding sequence, a new actinomycetes AmtR consensus sequence was 
generated: the semi-palindromic 16-18 bp sequence ATnTnTn6-8AnAG. 
 
Finally, we identified two potential signalling molecules specific to AmtR 
that appear to function via a co-repressor mechanism of regulation. Previously, no 
information was known regarding how the signal for nitrogen limitation was 
transferred to AmtR in M. smegmatis. AmtR, like all TetR transcription factors, 
acts as a repressor of gene expression when bound to DNA in the promoter region 
of the genes that it regulates. M smegmatis AmtR was tested for GlnK binding but 
no interaction was observed with either the native or adenylylated GlnK, 
suggesting that GlnK is not a signalling protein for AmtR. Screening of small 
molecules as potential ligands identified two molecules, xanthine and allantoin, as 
potential ligands for AmtR. Interestingly, the interaction was only observed when 
AmtR was bound to DNA, suggesting that the AmtR-DNA interaction is 
stabilised by the presence of these molecules. This is the first example where the 
repression of a TetR protein is potentially enhanced by the presence of a co-
repressor, and it is the absence of the co-repressor that releases AmtR from the 
DNA to lift repression. Xanthine and allantoin are both metabolites of nitrogen 
metabolism and decreases in their intracellular levels are valid signals for 
intracellular nitrogen limitation. This dissipation signal would directly result in 
AmtR repression being lifted, and subsequent induction of the proteins involved 
in alternative nitrogen uptake and urea metabolism would occur as a response to 
nitrogen limitation.  
 
4.2 Post-Transcriptional Regulation 
Post-transcriptional regulation occurs by a diverse range of mechanisms. 
This thesis has focused on one particular mechanism: the VapBC family of the 
Type II Toxin Antitoxin (TA) systems found in the cyanobacteria M. aeruginosa 
and Synechocystis. VapBC systems are a point of interest because of their 
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overrepresentation in the genomes of pathogenic and environmentally hazardous 
bacteria, including the toxic bloom formers M. aeruginosa.  
 
 Investigation of M. aeruginosa VapBC systems was limited by poor 
cloning and expression. However, one system, VapBCMAE43230/20, had increased 
expression after incorporating the SUMO fusion protein into the expression 
system. Preliminary in vitro investigation of this system showed that 
VapBMAE43230 and VapCMAE43220 are co-expressed and formed a tetrameric 
complex that appears to be bound to DNA. Significantly more VapB is expressed 
relative to VapC, suggesting that the vapBCMAE43230/20 operon is expressed as a 
typical vapBC operon. Future characterisation of this operon will provide great 
insight into the role of VapBC systems in M. aeruginosa. 
 
Due to the difficulties involved with M. aeruginosa VapBC investigations, 
the cyanobacteria model organism Synechocystis VapBC systems were 
subsequently investigated. Similar to the M. aeruginosa, all but one VapBC 
system proved too difficult to express and purify.  The sole soluble VapBC 
system, VapBCslr1209/1210, was investigated in vitro. VapBslr1209 and VapCslr1210 are 
co-expressed and form a dimeric complex that does not appear to be bound to 
DNA and could be disrupted by acid dissociation. Preliminary EMSA assays 
indicate VapBCslr1209/1210 is autoregulatory and binds to the promoter region of its 
own operon by recognising palindromic sequences upstream of the start codon. 
Using the RNA pentaprobe system, VapCslr1210 shows metal
 
specific 
endoribonuclease activity, which could be inhibited by VapBslr1209.  
 
Markerless deletion strains of five different Synechocystis vapBC operons 
were made, and growth experiments of three of the deletion strains were 
conducted to determine the effect of the deletion of these VapBC systems on 
fitness of the organism. Growth experiments identified a reduced growth rate in 
two of the deletion strains: ΔvapBCslr1209/1210 and ΔvapBCssl2138/sll1092. 
Transcriptomic analyses of both deletions strains were subsequently carried out to 
investigate the cause of the observed phenotypes.  
 
With the exception of VapBCssl2138/sll1092 also affecting the expression of a 
cohort of hypothetical proteins, the general observation is that both VapBC 
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systems appear to target genes involved in carbon assimilation and metabolism 
via both photosynthetic and heterotrophic processes. Interestingly, 
VapBCslr1209/1210 targets an operon involved in glucose transport, which is also the 
cellular process targeted by the only other well characterised VapBC system, M. 
smegmatis VapBC1283/4, which targets the cellular machinery responsible for 
carbon transport and metabolism and functions to regulate the rate of glycerol 
utilisation to match the anabolic demands. Given the similarity in cellular targets 
between M. smegmatis VapBC1283/4 and both Synechocystis VapBC systems, in 
particular VapBCslr1209/1210, it is tempting to speculate that these protein systems 
share similar biological functions. As a result of this and initial characterisation of 
VapBCslr1209/1210, it is proposed that VapBCslr1209/1210 may also fine-tune the 
regulation of carbon metabolism by controlling the rate of glucose utilisation (via 
both carbon fixation and glucose transport) to match the anabolic demands of the 
cell.  
 
4.3 Further work 
4.3.1 M. smegmatis AmtR Transcription Factor 
Further investigation of the identified co-repressor ligands xanthine and 
allantion should be carried out to determine their roles in the regulatory process. 
Co-crystallisation of AmtR and each of these ligands will provide significant 
information regarding ligand binding and AmtR:DNA interactions. Subsequently, 
the X-ray crystallographic structure of the AmtR:DNA complex (most with ligand 
bound) would be the most informative protein structure for this investigation. 
Binding affinities of AmtR to each ligand can be used determine the strength of 
signalling provided by each ligand and the relevant concentrations that resemble 
ligand depletion and subsequent AmtR repression to be lifted. Finally, 
characterisation of the urea metabolic pathway that AmtR regulates and its role in 
alternative nitrogen regulation should be investigated. 
 
4.3.2 Cyanobacteria VapBC systems 
Structural analysis of all possible VapBC structures should be completed 
to elucidate more information regarding both the VapBC complex properties and 
the individual protein structural and functional characteristics. Continued protein 
purification and functional characterisation of the VapBCMAE43230/20 system would 
also be valuable, and any functional characterisation of this system should be 
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compared to Synechocystis VapBC systems to determine conservation of 
functions between the organisms.  
 
To overcome current protein expression and solubility problems associated 
with expression of cyanobacteria derived proteins in the E. coli expression 
system, a Synechocystis expression system could be developed. The system could 
be designed similar to the method adopted to generate markerless knock out 
strains described in Chapter 3. Homologous recombination via pUC19 constructs 
could introduce a stronger promoter and a terminal 6 x histidine tag to the vapBC 
operons. The result would allow for in vivo over expression of the VapBC 
proteins that could subsequently be purified by IMAC with the terminal 6 x 
histidine tag.  
 
Further RT-qPCR should be completed in order to validate more DEG 
identified in RNA-seq work. Continued characterisation of the VapBCslr1209/1210 
system should be expanded to include investigations of substrate specificity by in 
vitro RNase activity assays in combination with MALDI_TOF MS of 
oligonucleotides from the 927 pentaprobe containing the putative central cut sites. 
Once cut sites have been determined, they can be searched for in the cellular 
targets identified in the transcriptomic analyses. EMSA should be additionally 
optimized to identify both the mode of autoregulation and the VapBslr1209 
recognition motif in the promoter region. Overexpression studies would be 
valuable to identify if VapCslr1210 can cause the characteristic bacteriostatic effect, 
which can be relieved by addition of VapBslr1209. Finally, characterisation of 
remaining Synechocystis vapBC deletion strains would provide a more 
comprehensive understanding of these systems in cyanobacteria.  
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Appendices 
Appendix A: Primers and DNA oligonucleotides 
Table A.1. Primers and DNA oligonucleotides used in this study 
Primer Sequence 
Chapter Two: 
Cloning primers 
glnK (msmeg_2426) Fwd GGAATTCCATATGATGAAGCTGATTA 
glnK (msmeg_2426) Rev CCCAAGCTTCTACAGGGCGTCG 
T7 Fwd TAATACGACTCACTATAGGG 
T7 Rev TAGTTATTGCTCAGCGGTGG 
EMSA Primers 
msmeg_1283/4 Fwd GAACAGGAGCGGATCGACTG 
msmeg_1283/4 Rev CATCAAACACCCGGAAGCCG 
msmeg_2184 Fwd GGGCATACCGGCGATTG 
msmeg_2184 Rev CGCTGCTGGTCATGGGT 
msmeg_2185 Fwd CTGAGCATCGCCGCCAC 
msmeg_2185 Rev CAGGTCAGATTCTCGGCG 
msmeg_phoH2 Fwd ATGGCTAGCGACCTGCTCTGCTGTC 
msmeg_phoH2 Rev TCAGTCACGTGGCGCTCCTAGGGGA 
EMSA DNA oligonucleotides sequences 
2184_40 Fwd GCGCCCATTGTTATCTGTCATCTGACAGGTAAGAGCTGGC 
2184_40 Rev GCCAGCTCTTACCTGTCAGATGACAGATAACAATGGGCGC 
2184 Fwd_mut GCGCCCATTGTTATAAGAAATCTAAAAGGTAAGAGCTGGC 
2184 Rev_mut GCCAGCTCTTACCTTTTAGATTTCTTATAACAATGGGCGC 
AmtR co-crystallisation DNA oligonucleotides sequences 
AmtR_bind Fwd TGTTATCTGTCATCTGACAGGTAA 
AmtR_bind Rev CATTACCTGTCAGATGACAGATAA 
Chapter Three: 
Cloning primers* 
MAE49650_pET28bpstI Fwd AACTGCAGATGAGCAGCCTGCGTCTGC 
MAE49650_pET28bpstI Rev GGGAAGCTTACGAATCGGCAGTTTACGA 
MAE43220_pET28bpstI Fwd AACTGCAGATGCCGAATGTTATTGCAG 
MAE43220_pET28bpstI Rev GGGAAGCTTACCTTCGCCTGCCAGTTTC 
MAE49640/50 pOPIN Fwd AAGTTCTGTTTCAGGGCCCGGTTATCAAAGAACT 
MAE49640/50 pOPIN Rev ATGGTCTAGAAAGCTTTAATTAACTGCCGATTCGT 
MAE43230/20 pOPIN Fwd AAGTTCTGTTTCAGGGCCCGATGTATCAGATTAC 
MAE43230/20 pOPIN Rev ATGGTCTAGAAAGCTTTAATTACCTTCGCCTGCCA 
slr1209/10 pET28bpstI Fwd AACTGCAGATGAATAGGAGACTGGTAGA 
slr1209/10 pET28bpstI Rev CCCAAGCTTACTAGGGTAATACTCTT 
ssr2201/slr1327 pET28bpstI Fwd AACTGCAGATGCACTCATTGTCATCACT 
ssr2201/slr1327 pET28bpstI Rev CCCAAGCTTCTGATTATCCATCATGG 
ssl2138/sll1092 pET28bpstI Fwd AACTGCAGATGACTACTGAAGCTGCCCT 
ssl2138/sll1092 pET28bpstI Rev CCCAAGCTTCAACCACAGGCGTTGAATCG 
ssl3615/sll1912 pET28bpstI Fwd AACTGCAGATGAGCACCATCGAGCAAGT 
ssl3615/sll1912 pET28bpstI Rev CCCAAGCTTATACGTTTCTAGGACGA 
ssr2962/slr1767 pET28bpstI Fwd AACTGCAGATGAATAGCTTACTGTCTCG 
ssr2962/slr1767 pET28bpstI Rev CCCAAGCTTGGAGTTGCTGATTTCTATGA 
EMSA Primers  
PPCC6803_slr1209 Fwd AGTGCTAGAAGCCAGGGCAAAACATTACGG 
PPCC6803_slr1209T Fwd AAGGTAATAATTTATTAAAAGTAGAGGTTA 
PPCC6803_slr1209 Rev ATAAAAATTCCTCCTAAATAACCCGATCAT 
pUC19 mutation construct primers* 
slr1209/10 left Fwd GATCGTCGACAGCACACCATGGCAATTAT 
Appendices 
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slr1209/10 left Rev GATCGGATCCACTGGCAATGCAATAAC 
slr1209/10 right Fwd GATCGAGCTCGATTGAAGCAACCGCAATTT 
slr1209/10 right Rev GATCGAATTCTAACTTGCCACCGCTCTGT 
ssr2201/slr1327 left Fwd GCATTCTAGATGCCATAGCGGTTGTCATAA 
ssr2201/slr1327 left Rev GATCGGATCCGCTCAGGAAATTCCAGTGATG 
ssr2201/slr1327 right Fwd GATCGAGCTCTCCTATCAACATTTTCAAGCTA 
ssr2201/slr1327 right Rev GATCGAATTCGTCCTCACCGTTTACGATT 
ssl2138/sll1092 left Fwd CGGAATTCCCGGCACCATGAAGGTGAACAA 
ssl2138/sll1092 left Rev CGAGCTCTACTCCTCAAATTCTTCTAAGGG 
ssl2138/sll1092 right Fwd CGGGATCCTTGAAGCTAGTTTTCAAAGAAC 
ssl2138/sll1092 right Rev GCTCTAGAATGGTTACCTTTTTACCTTTCC 
ssl3615/sll1912 left Fwd CGGAATTCGGGAGGAACAAGACACCATGGA 
ssl3615/sll1912 left Rev CGAGCTCAGTTCCTCACCATTACGCCGTAA 
ssl3615/sll1912 right Fwd CGGGATCCTACTGTCTTTAACGACAGAAGA 
ssl3615/sll1912 right Rev GCTCTAGATGCTCGCCGGGTAATTGGCCAT 
ssr2962/slr1767 left Fwd CGGAATTCTGCTACCTAAAATACCAATTAC 
ssr2962/slr1767 left Rev CGAGCTCGTCCGCCGTGCAGCAAACACTAG 
ssr2962/slr1767 right Fwd CGGGATCCTTGCCAACTCTGTAATCATGAC 
ssr2962/slr1767 right Rev GCTCTAGACTAATTAGCTTTGCCGAACTTT 
pUC19_M13 Fwd GTAAAACGACGGCCAGT 
pUC19_M13 Rev CAGGAAACAGCTATGAC 
* Sequences provided for primers only where successful cloning/expression was achieved 
 
 
Table A.2. List of primers used for RT-qPCR 
Gene Primer sequence Amplicon size 
Differentially expressed genes (DEG) 
sll1997_F CAGAGCCAGACAAGCATGAG 
211 
sll1997_R TGCTGACAATGGTTGAATCG 
sll1255_F TGCCAAAAATGAGAATGCAA 
178 
sll1255_F TGCTAACTCCCTTAGCCAGTG 
slr0350_F CCTAAATGGCGAACGGTCTA  
182 
slr0350_R TAGCCAGTTTCTTGGCCAGT 
slr1209_F TTATTGCATTGCCAGTGGAG  
125 
slr1209_R CCAGACTGCAATTCGGGTAT 
sll0315_F GAGACGCTAAACGCCACAGT 
100 
sll0315_R TGAGCATGACTTTAGTGCCTTG 
sll0771_F GCCATTGTTTCTGGCATTTT 
168 
sll0771_R GATCAGGAAAGCGCAAACTC 
sll0772_F AGTCTGTTGGCCATTCAACC 
107 
sll0772_R CAGCCATGGATTTGTACGTG 
House keeping genes (HKG) 
rrn 16s_F CACACTGGGACTGAGACAC 
190 
rrn 16s_R CTGCTGGCACGGAGTTAG 
rnpB_F CGTTAGGATAGTGCCACAG 
189 
rnpB_R CGCTCTTACCGCACCTTTG 
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Appendix B: Plasmids and Bacterial Strains 
Table A.3. Plasmids and bacterial strains used in this study 
Bacterial Strain Description 
Escherichia coli  
DH10B (TOP10) F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80 dlacZ ΔM15 ΔlacX74 deoR 
recA1 araD139 Δ(ara leu) 7697 galU galK rpsL endA1 nupG λ-  
DH5 fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-1 hsdR17 
BL21 (DE3) F-ompT hsdSB (rB-mB-) gal dcm (DE3) 
Mycobacterium smegmatis  
Mc
2
4517 M. smegmatis expression strain with T7 RNA polymerase; Km
r 
Cyanobacteria  
Synechocystis sp. Strain 
PCC6803 (PCC6803) 
Synechocystis sp. Strain PCC6803 wild type strain 
Plasmids*  
pYUB28b E. coli mycobacterium shuttle vector with T7 promoter, MCS 
pET28b, encoding both C-and N-terminal His tags; Hyg
r 
pET28b-PstI Modified pET28b where the NcoI site has been replaced with PstI 
site; C- or N-terminal His-tags; Km
r 
pUC19 E. coli cloning vector; Amp
r
 resistance 
pOPINS E. coli expression vector with In-Fusion enabled pTriEx2 backbone, 
lacZ insert and N-His-SUMO tag; Amp
r 
* Information provided for plasmids only where successful cloning/expression was achieved 
Hyg
r 
= hygromycin B resistance,  
Km
r
 = Kanamycin resistance 
Amp
r
 = Ampicillin resistance  
 
Determination of M. aeruginosa Strain for Experimental Analysis 
Minimal investigation has been done on cyanobacterial VapBC systems. 
In fact, no investigation has been done on the toxic-bloom forming members such 
as M. aeruginosa. Consequently, the first obstacle for this project was to 
determine the appropriate strain of M. aeruginosa to implement for experimental 
analysis. M. aeruginosa NIES-843 (MIC_NIES_843) was chosen because it is the 
only fully assembled and annotated M. aeruginosa genome available. The 
MIC_NIES_843 genome is highly plastid with 11.8 % composed of insertion 
sequences and miniature inverted-repeat transposable elements (Kaneko et al., 
2008). The plasticity of the genome is linked to the ability of M. aeruginosa to 
bloom in a wide range of ecosystems, as a result of integration and removal of 
genetic elements to provide an adaptive advantage (Humbert et al., 2013). 
Although MIC_NIES_843 is naturally transformable there has been minimal 
genetic manipulation and protein expression done in the scope of this organism. It 
is also incredibly slow growing, with a doubling time of 1.23 days under optimal 
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conditions (van der Westhuizen & Eloff, 1985) making it an inefficient laboratory 
organism. This strain is not available for experimental work in New Zealand and 
purchasing from overseas is costly and requires significant permit and ethical 
approval. Because of the obstacles associated with obtaining and experimenting 
with MIC_NIES_843, we decided to investigate their VapBC systems using E. 
coli as the host organism, a standard procedure adopted when working with 
difficult organisms (Bunker, McKenzie, Baker, & Arcus, 2008; Das et al., 2014; 
Mattison et al., 2006; Ning, Jiang, Liu, & Xu, 2013a; Sharp et al., 2012) 
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Appendix C: Buffers, Media and Solutions 
All concentrations in % are percentages in weight per volume (w/v) unless 
otherwise indicated.  
Table A.4. General buffers and solutions used in this study 
Reagent Description 
5 x DNA loading dye 0.05 % bromophenol blue, 0.25 % xylene cyanol, 30 % (v/v) 
glycerol 
Fairbanks Staining 
solution A 
0.05 % coomassie blue R-250, 25 % (v/v) isopropanol, 10 % (v/v) 
acetic acid 
Fairbanks Staining 
solution D 
10% (v/v) acetic acid 
GITC 295.4 g guanidine thiocynate, 2.5 g N-lauroyl sarcosine, 3.9 g tri-
sodium citrate, 3.6 ml 2/meracaptoethanol, 280 ml DEPC H2o 
Native Gel Loading buffer 0.3 M Tris-HCl, 1 % bromophenol blue, pH 6.8 
Resolving buffer 1.5 M Tris-HCl, pH 8.8 
4 x SDS loading buffer 200 mM Tris-HCl pH 6.8, 8 % SDS, 40 % (v/v) glycerol, 0.4 % 
bromophenol blue, 400 mM 2-meracaptoethanol 
SDS running buffer 25 mM Tris-HCl pH 6.8, 0.1 % SDS 190 mM glycine 
Stacking buffer 0.5 M Tris-HCl, pH 6.8 
10 x TAE 400 mM Tris-acetate, 20 mM EDTA 
1 x TAE 100 ml 10 x TAE + 900 ml H2O 
10 x TBE 0.89 M Tris-HCl, 0.89 boric acid, 20 mM EDTA 
1 x TBE 100 ml 10 x TBE + 900 ml H2O 
TE 10 mM Tris-HCl 
Tris-EDTA-SDS lysis 
solution 
0.1 M Tris, 0.05 M EDTA, 1 % SDS, 0.5 M NaCl 
Tris-Glycine Running 
buffer 
25 mM Tris-HCl, 250 mM glycine, pH 8.5 
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Table A.5. Media used in this study. 
Media Description 
BG-11 agar (1 L) 
15 g agar, 3.0 g sodium thiosulphate, 10 ml 100 x BG-11
 a
, 1 ml Trace 
elements
b
, 1 ml Iron stock
c, 
1 ml Phosphate stock
d
, 1 ml Na2CO3 stock
e, 
10 
ml TES buffer
f
, 10 ml 1M NaHCO3 
BG-11 agar + 
Sucrose (1 L) 
15 g agar, 3.0 g sodium thiosulphate, 10 ml 100 x BG-11
 a
, 1 ml Trace 
elements
b
, 1 ml Iron stock
c, 
1 ml Phosphate stock
d
, 1 ml Na2CO3 stock
e, 
10 
ml TES buffer
f
, 50 ml 50% sucrose 
BG-11 (1 L) 
10 ml 100 x BG-11
 a
, 1 ml Trace elements
b
, 1 ml Iron stock
c, 
1 ml Phosphate 
stock
d
, 10 ml 1M NaHCO3 
7H9 
0.47 g 7H9 powder, 0.2 % (v/v) glycerol in 90 ml H2O. autoclave then add 
10 ml ADC enrichment and 0.05 % (v/v) Tween 80 
7H10-agar 
1.9 g 7H10 powder, 0.5 % (v/v) glycerol in 90 ml H2O, autoclave then add 
10 ml ADC enrichment and 0.05 % (v/v) Tween 80 
LB-agar 1 % bactotryptone, 0.5 % yeast extract, 1 % NaCl, 15 g/L agar, pH 7.5 
LB 1 % bactotryptone, 0.5 % yeast extract, pH 8.0 
LBT-agar 
1 % bactotryptone, 0.5 % yeast extract, 1 % NaCl, 15 g/L agar, 0.05 % (v/v) 
Tween 80, pH 7.5 
LBT 
1 % bactotryptone, 0.5 % yeast extract, 1 % NaCl, 0.05 % (v/v) Tween 80, 
pH 7.5 
Low salt LB-agar 1 % bactotryptone, 0.5 % yeast extract, 0.5 % NaCl, 15 g/L agar, pH 7.5 
Modified Sauton’s 
0.5 g KH2PO4, 0.5 g MgSO4, 0.16 mM FeCl2, 0.48 g citric acid, 0-30 mM 
NH4Cl, 0.1 ml 1% ZnSO4, 60 ml glycerol per litre, 5 ml 10 % Tween 80, pH 
7.2 
PA-0.5G 
50 mM Na2HPO4, 50 mM KH2PO4, 25 mM (NH)4SO4, 1 mM MgSO4, 0.5 % 
glucose, 0.1 x metals mix*, 100 μg/ml each of 17 a.a (no Cys, Tyr or Met). 
Individual components autoclaved to sterilise 
SOC 
2 % bactotryptone or bactopeptone, 0.55 % yeast extract, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose 
ZYP-5052 
1 % bactotryptone, 0.5 % yeast extract, 50 mM Na2HPO4, 50 mM KH2PO4, 
25 mM (NH4)2SO4, 1 mM MgSO4, 0.5 % glycerol, 0.05 % glucose, 0.2 % α-
lactose, 1 x metals mix* 
a 
100 x BG-11 made by adding each of the following to 1 L of water: 149.6 g NaNO3, 7.49 g 
MgSO4.7H2O, 3.60 g CaCl2, 0.60 g citric acid, 1.12 ml of 0.25 M Na2EDTA pH8. 
 
b 
Trace elements made by adding each of the following to 100 ml of water and autoclaving: 286 
mg H3BO3, 181 mg MnCl2.4H2O, 22 mg ZnSO4.7H2O, 39 mg Na2MoO4.2H2O, 8 mg 
CuSO4.5H2O, 5 mg Co(NO3)2.6H2O. 
 
c 
Iron Stock made by adding 0.6 g ferric citrate to 100 ml of water and autoclaving. 
 
d 
Phosphate stock made by adding 3.05g K2HPO4 to 100 ml water and autoclaving. 
 
e 
Na2CO3 stock made by adding 2 g of Na2CO3 to 100 ml water and autoclaving. 
 
f 
TES buffer made by adding 22.9 g to 100 ml water, pH 8.2, filter sterilised. 
 
*1000 x metals mix made up from the sterile stock solutions of each component to give the 
following concentrations: 50 μM FeCl3 in 0.12 M HCl (filter sterile), 20 μM CaCl2, 10 μM MnCl2, 
10 μM ZnSO4, 2 μM CoCl2, 2 μM CuCl2, 2 μM NiCl2, 2 μM NaMoO4, 2 μM Na2SeO3, 2 μM 
H3BO3. 
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Appendix D: Gene and Protein Information 
M. smegmatis amtR and glnK Information 
M. smegmatis amtR (msmeg_4300)  
Modified to include NcoI restriction site at the N-terminus and the stop codon 
removed to allow for a C-terminal His tag.  
 717 bp 
ATGGCGACCACCTCCGGCCGTGGCCGCCCGCGGCTGGAGCAGCCGCGCAGGCCGGGG
CAGACCGCGCGCGAGGAGATCCTCGACGCGGCCGCCGAACTGTTCACCACCCACGGG
TACGGCAGCACCTCCACGCGCCGCATCGCCGACGAGGTGGGGGTGCGGCAGGCCTCG
CTGTATCACCACTTCGCCACCAAGGACGACATCCTCGACGCGCTGCTGGCGGGCACCG
TCGACGAGCCCCTTGAGCTCGCACACGGCCTGCTGGGGGAGTCGGGGCCTGCGGCAC
CGCGCCTGCATGCCCTGGTGATCTACGACGCCTCACAGCTGTGCGCGGGCCGCTGGAA
CCTGGGCGCGCTGTACCTGCTGCCCGAGTTGCGCACCGACCGGTTCGCGCCGTTCCGC
CGCCGCCGCGCCGAACTGCGCAGCGCATACCGCAGCCTGGCCGCTGCGGTCATCGCC
GAGTGCGGCGGACCGCCCGAGGCCGACGATCTGCCGTTCCGGCTCGTGGAGTCGGTG
ATCAACTCACGCTCCGACGACGCCGTCGTCCCTCCCGAACAACCCTGGGTGATCGGAG
AGGGTGCGCTGCGCGTGCTCGGCTTCGACGGGGACTTTGCCGAACTCGCCGCCGCAAC
CGCGTCACGGCTCGGTGTGCGACCGCCCGGGCGGGCCGCCCGCAAGCTTGCGGCCGC
ACTCGAGCACCACCACCACCACCACTGA 
 
M. smegmatis AmtR with C-terminal His tag 
238 a.a     25.82 kDa     pI 6.92 
MATTSGRGRPRLEQPRRPGQTAREEILDAAAELFTTHGYGSTSTRRIADEVGVRQASLYH
HFATKDDILDALLAGTVDEPLELAHGLLGESGPAAPRLHALVIYDASQLCAGRWNLGAL
YLLPELRTDRFAPFRRRRAELRSAYRSLAAAVIAECGGPPEADDLPFRLVESVINSRSDDA
VVPPEQPWVIGEGALRVLGFDGDFAELAAATASRLGVRPPGRAARKLAAALEHHHHHH 
 
M. smegmatis glnK (msmeg_2426) with N-terminal His tag 
402 bp 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGC
CATATGATGAAGCTGATTACTGCGATCGTCAAGCCGTTCACGCTGGAAGATGTCAAGA
CGGGCCTGGAGCAGACGGGCATCTTGGGCATGACCGTCAGCGAGGTTCAGGGCTACG
GGCGCCAGAAGGGCCATACTGAGGTGTACCGCGGTGCCGAGTACTCGGTGGACTTCG
TGCCCAAGGTCCGGGTGGAGGTCGTCGTCGACGACTCCGCCGTCGACAAGGTCGTCG
ACGTCATCGTCCAGGCTGCGCGCACCGGGAAGATCGGTGACGGCAAGGTGTGGGTGA
GCCCGGTGGAAACCGTGGTCCGTGTTCGCACCGGGGAGCGGGGAGCCGACGCCCTGT
AG 
 
M. smegmatis GlnK with N-terminal His tag 
133 a.a     14.41 kDa     pI 8.01 
 
MGSSHHHHHHSSGLVPRGSHMMKLITAIVKPFTLEDVKTGLEQTGILGMTVSEVQGYGR
QKGHTEVYRGAEYSVDFVPKVRVEVVVDDSAVDKVVDVIVQAARTGKIGDGKVWVSPV
ETVVRVRTGERGADAL 
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Cyanobacteria VapBC operon information 
M. aeruginosa VapBC systems 
 
MAE49640/50 with C-terminal His tag (644 bp) 
 
GTTATCAAAGAACTGGATCGTATTACCGTTAATCCGCAGATTTGTCTGGGTCAGCCGA
CCATTCGTGGTATGCGCATTACCGTTGTTTTTGTTCTGAAACTGCTGGCAAGCCAGCTG
AGCATTCAAGAAGTTCTGGAAGCATATCCGGAACTGGAAGAAGAAGATATTCGTCAG
GCACTGAATTATGCAGCATGGGCAGTTAGCGATTATATTGTTAGCTTTACCAGCGC*A
TGA*GCAGCCTGCGTCTGCGTGCAGATGTTCATATTAGTCCGCTGACCGTTGCCGCACT
GCGCCTGCAAGGTTATGATATTGTTCGTACCACCGATTTTCTGCCTGCAACCGCAGCA
GATGCAGAAATTCTGGAACTGGCACGTGTTGAAGGTCAGGTTATTCTGACCCAGGATC
TGGATTTTAGCCTGCTGGTTGCACTGAATAACTATGGTCTGCCGAGCCTGATTACCCT
GCGCCTGAGCAGCGCACGTCCGGATGTTGTTGCACAGCGTCTGCTGGATGTTCTGCTG
ACCGTGGAAACCGAACTGACCGAAGGTGCAGCAATTACCATTAGTGATGATAGCGTT
CGTGTTCGTAAACTGCCGATTCGTAAGCTTGCGGCCGCACTCGAGCACCACCACCACC
ACCACTGA 
 
*Underlined bases show overlapping region between MAE49640 stop codon and MAE49650 start 
codon. 
 
MAE49640 
 
77 a.a     8.68 kDa     4.25 kDa 
 
VIKELDRITVNPQICLGQPTIRGMRITVVFVLKLLASQLSIQEVLEAYPELEEEDIRQALNYA
AWAVSDYIVSFTSA 
 
MAE49650 with C-terminal His tag 
 
137 a.a     15.07 kDa     6.39 kDa 
 
MSSLRLRADVHISPLTVAALRLQGYDIVRTTDFLPATAADAEILELARVEGQVILTQDLDF
SLLVALNNYGLPSLITLRLSSARPDVVAQRLLDVLLTVETELTEGAAITISDDSVRVRKLPI
RKLAAALEHHHHHH 
 
 
MAE43230/20 with C-terminal His tag (776 bp) 
 
ATGTATCAGATTACCCTGAGCCTGCCGGATGAAACCGCACTGGCACTGCATCTGACAC
CGGAACAGCTGGCACAAGAAATTAGCCTGCTGGCAGCAATTAAACTGTATGAACTGG
GTAAACTGAGCAGCGGCACCGCAGCAAATCTGGCAGGTATTCCGCGTGTTGTTTTTCT
GAGCAAACTGGCCGATTATGGTGTTGATACCTTTCGTCTGAAAGAAGCCGAACTGATT
GAAGATCTGGCAAATGCA*TAATG*CCGAATGTTATTGCAGATACCAGCCCGATTCAG
TATCTGTATCAGACCAATCTGCTGGATCTGCTGCCGAACTTTTATGGTCAGATTATTAT
CCCGTTTAGCGTTGCACAAGAACTGGCAGTTGGTAAAGCAAGCGGTATTAGTCTGCCG
GATATTACCAGCCTGAGCTGGATTATCATTCAGCAGGCAAAAAGCGTGAGCCTGCTGC
CGCTGGTTACCGATCTGGGTAAAGGTGAAAAAGAAGTTCTGGCACTGGCAATTGAAA
TCACCGATTTTCTGGCCCTGCTGGATGATGGTCTGGCACGTCGTTATGCAAACCTGCT
GGGTATTAAACTGACCGGCACCATGGGTATTCTGCTGAAAGCAAAACAGAATGGTTA
TCTGCATCGTATTGAACCGATTCTGAATCAACTGGAACTGCTGAAATTTCGTCTGGAT
GCAACCACCCGTACCAGCGTTCTGAAACTGGCAGGCGAAGGTAAGCTTGCGGCCGCA
CTCGAGCACCACCACCACCACCACTGA 
 
*Underlined bases show overlapping region between MAE43230 stop codon and MAE43220 start 
codon. 
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MAE43230 
 
83 a.a     8.97 kDa     pI 4.30 
  
MYQITLSLPDETALALHLTPEQLAQEISLLAAIKLYELGKLSSGTAANLAGIPRVVFLSKLA
DYGVDTFRLKEAELIEDLANA 
 
MAE43220 with C-terminal His tag 
 
174 a.a     19.09 kDa     pI 7.26  
 
MPNVIADTSPIQYLYQTNLLDLLPNFYGQIIIPFSVAQELAVGKASGISLPDITSLSWIIIQQA
KSVSLLPLVTDLGKGEKEVLALAIEITDFLALLDDGLARRYANLLGIKLTGTMGILLKAKQ
NGYLHRIEPILNQLELLKFRLDATTRTSVLKLAGEGKLAAALEHHHHHH 
 
MAE43230/20 with N-terminal His tag and SUMO fusion protein (1088 bp) 
 
ATGGCACACCATCACCACCATCACGGGAGCGATAGCGAAGTGAACCAGGAAGCGAA
ACCGGAAGTTAAACCGGAAGTGAAACCGGAAACCCATATTAATCTGAAAGTTAGCGA
CGGCAGCAGCGAAATCTTTTTTAAAATTAAAAAAACCACCCCGCTGCGTCGCCTGATG
GAAGCCTTTGCGAAACGTCAGGGTAAAGAAATGGATAGCCTGCGCTTTCTGTATGAC
GGCATCCGTATTCAGGCCGATCAGACCCCGGAAGACCTGGATATGGAAGACAACGAT
ATTATTGAAGCGCATCGCGAACAGATCAGCAGCGGTCTGGAAGTTCTGTTTCAGGGCC
CGATGTATCAGATTACCCTGAGCCTGCCGGATGAAACCGCACTGGCACTGCATCTGAC
ACCGGAACAGCTGGCACAAGAAATTAGCCTGCTGGCAGCAATTAAACTGTATGAACT
GGGTAAACTGAGCAGCGGCACCGCAGCAAATCTGGCAGGTATTCCGCGTGTTGTTTTT
CTGAGCAAACTGGCCGATTATGGTGTTGATACCTTTCGTCTGAAAGAAGCCGAACTGA
TTGAAGATCTGGCAAATGCA*TAATG*CCGAATGTTATTGCAGATACCAGCCCGATTC
AGTATCTGTATCAGACCAATCTGCTGGATCTGCTGCCGAACTTTTATGGTCAGATTATT
ATCCCGTTTAGCGTTGCACAAGAACTGGCAGTTGGTAAAGCAAGCGGTATTAGTCTGC
CGGATATTACCAGCCTGAGCTGGATTATCATTCAGCAGGCAAAAAGCGTGAGCCTGCT
GCCGCTGGTTACCGATCTGGGTAAAGGTGAAAAAGAAGTTCTGGCACTGGCAATTGA
AATCACCGATTTTCTGGCCCTGCTGGATGATGGTCTGGCACGTCGTTATGCAAACCTG
CTGGGTATTAAACTGACCGGCACCATGGGTATTCTGCTGAAAGCAAAACAGAATGGT
TATCTGCATCGTATTGAACCGATTCTGAATCAACTGGAACTGCTGAAATTTCGTCTGG
ATGCAACCACCCGTACCAGCGTTCTGAAACTGGCAGGCGAAGGTTAAAATTAA 
 
*Underlined bases show overlapping region between MAE43230 stop codon and MAE43220 start 
codon. 
 
MAE43230 with N-terminal His tag and SUMO fusion protein 
 
198 a.a     22.17 kDa     pI 4.99 
 
MAHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLMEAFA
KRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQISSGLEVLFQGPMYQITLS
LPDETALALHLTPEQLAQEISLLAAIKLYELGKLSSGTAANLAGIPRVVFLSKLADYGVDT
FRLKEAELIEDLANA 
 
MAE43220 
 
162 a.a     17.69 kDa     pI 5.89  
 
MPNVIADTSPIQYLYQTNLLDLLPNFYGQIIIPFSVAQELAVGKASGISLPDITSLSWIIIQQA
KSVSLLPLVTDLGKGEKEVLALAIEITDFLALLDDGLARRYANLLGIKLTGTMGILLKAKQ
NGYLHRIEPILNQLELLKFRLDATTRTSVLKLAGEGN 
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PCC6803 VapBC systems 
slr1209/slr1210 with C-terminal His tag (751 bp) 
ATGAATAGGAGACTGGTAGAGTCTTTGGCAGAAGCAGTTATTGCATTGCCAGTGGAG
GATTATAGTTTATTTCAAAATACCCTCATGGCAAAGATGATCAAAAAAACACCAGGG
GTATGCGGTGGCCACGCTTGTATTCGGGATACCCGAATTGCAGTCTGGACAATTATTT
CTCTTATCAATCAAGGAGGTACGGATTTGGAGTTACTGGCCGATTTTCCTGGATTAAC
TGCCTTTGATTTGTTGACCATCAAAGAATATTACCAATCTCATCAGCAGGAAATTGAT
AATCTTATTGATTACCAAGATCAAGAAAATTATC*ATGATTAA*ATTCTATAGCAACG
AAAATTTATCCCTGGGCTTAGTTAATCAACTACGTCAATTAGGTTACAGTGTTTTGACT
TCCTATGATGCAGGGAGAGCCAACCAAAGAATTACTGATTTATCTGTTTTGAAAGATG
CAACAACTGATGGACGTTGTGTAATTACATTTAATCGAAATGATTTTATTGAATTACA
TTTGAATAGAATAAAACACAAAGGCATAATAATTTGTAAAGAAGATCGAGATCAGAT
TGGACAAGCATCAATAATTCATGATTTTTTAATTAATCAGAAAACTTTAGATAATCGT
TTAATCAGAATATTAAAACAAAATCAACCTGGATTGAAGCAACCGCAATTTACGATTA
AAGAGTATTACCCTAGTAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTG
A 
 
*Underlined bases show overlapping region between slr1209 stop codon and slr1210 start codon. 
 
slr1209 
109 a.a     12.37 kDa     pI 4.35 
MNRRLVESLAEAVIALPVEDYSLFQNTLMAKMIKKTPGVCGGHACIRDTRIAVWTIISLIN
QGGTDLELLADFPGLTAFDLLTIKEYYQSHQQEIDNLIDYQDQENYHD  
 
slr1210 with C-terminal His tag 
 
142 a.a     16.46 kDa     pI 9.71 
 
MIKFYSNENLSLGLVNQLRQLGYSVLTSYDAGRANQRITDLSVLKDATTDGRCVITFNRN
DFIELHLNRIKHKGIIICKEDRDQIGQASIIHDFLINQKTLDNRLIRILKQNQPGLKQPQFTIKE
YYPSKLAAALEHHHHHH 
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Pentaprobe Sequence + Flanking Vector Sequence 
Sequences represent the RNA sequence that is transcribed from the T7 promoter 
(excludes the T7 promoter). Yellow highlighting corresponds to the pentaprobe 
sequence.  
 
922 + Flanking sequences 
AGACCCAAGCTTGGTACCGGAATTCTACGAATTTTTCTTTTGTTTATTTCCTTTCGCTTT
GCTTCTCTTCCCTTCGGTTCTGTTCCGTTTTACCTTGTCTTGCCTTATCTTACTTTATCTA
GAGGGCCCTATTCTATAGTGTCACCTAAATGCTAGAGCTCGCT 
 
923 + Flanking sequences 
AGACCCAAGCTTGGTACTATCTTACTTTAGTTTCATTTAATTGTGTTGTACTCTCCTCT
GCGTTCACTTAGCTTAACTTGGTTTGGCTTGATTTGACTTCAGTTGCGCTCTATTCTAT
CTAGAGGGCCCTATTCTATAGTGTCACCTAAATGCTAGAGCTCGCT 
 
924 + Flanking sequences 
AGACCCAAGCTTGGTACCGCTCTATTCTACTGTCCTGTGCATTCAATCGTTGAGTTCGA
TCTAGTCTCGTCTAACCCTCCCCTGCTCCGCTGGTCTGGCCTCGCCTATCCTACCCATT
CTAGAGGGCCCTATTCTATAGTGTCACCTAAATGCTAGAGCTCGCT 
 
925 + Flanking sequences 
AGACCCAAGCTTGGTACTATCCTACCCATTGGGCTCATCTGATCCATCCGGTCCCGTC
CACTCGGCTATGTTATGCTGTATTGCAGTCGTGTCGCGTCGAGCTGCCCTAATCCCACC
TCTAGAGGGCCCTATTCTATAGTGTCACCTAAATGCTAGAGCTCGCT 
 
926 + Flanking sequences 
AGACCCAAGCTTGGTACCGAGCTCGGATCCACTAGTAACGGCCGCCAGTGTGCTGGA
ATTCTGCAGATCCTAATCCCACCTAGCGTATCGGGTCATGTAGTGCTACGTTACGGCC
CCCGCCCGGCATCATATTATATCACCCCAGTGTAATGTGGTGTGAGGTTGGAGCATCA
CACTGGCGGCCGCTCGAGCATGCATCTAGAGGGCCCTATTCTATAGTGTCACCTAAAT
GCTAGAGCTCGCT 
 
927 + Flanking sequences 
AGACCCAAGCTTGGTACGTGAGGTTGGAGTCCGACCTGGAATCTCAGCCTGACGTGCC
ATGCGGTGCGATGTCACGCCGCGCCACGGTATAGTATGGTACGGGATCCCGTCTAGA
GGGCCCTATTCTATAGTGTCACCTAAATGCTAGAGCTCGCT 
 
932 + Flanking sequences (932 = reverse complement to 926) 
AGACCCAAGCTTGGTACCGAGCTCGGATCCACTAGTAACGGCCGCCAGTGTGCTGGA
ATTCTGCAGATCTCCAACCTCACACCACATTACACTGGGGTGATATAATATGATGCCG
GGCGGGGGCCGTAACGTAGCACTACATGACCCGATACGCTAGGTGGGATTAGGCATC
ACACTGGCGGCCGCTCGAGCATGCATCTAGAGGGCCCTATTCTATAGTGTCACCTAAA
TGCTAGAGCTCGCT 
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Appendix E: Chapter 3 Additional Tables and Figures 
Table A.6. M. aeruginosa vapBC operons and genes successfully cloned for 
protein expression and predicted protein molecular weight (MW). 
Vector His tag position Operon/Gene Expected MW (kDa) 
VapB VapC VapBC 
pET28b-pstI C MAE_49640/50 8.68 15.07 23.75 
MAE_43230/20 8.97 19.09 28.06 
MAE_49650  15.07  
MAE_43220  19.09  
pPROEX N MAE_49640/50 12.21 13.55 25.76 
pOPINF N MAE_43230/20 11.11 17.57 28.68 
pOPINM N MAE_43230/20 51.67 13.55 65.22 
pOPINS N MAE_43230/20 22.17 13.55 35.72 
 
 
 
 
Figure A.1. SDS-PAGE analysis of E. coli_pET28b-pstI+MICvapBC small-
scale expression trials. White boxes indicate expected band size. Labels: whole 
cell fraction (WC), soluble fraction (S), insoluble fraction (I), flow through (FT), 
wash (W) and nickel beads with protein bound after wash steps (B). 
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Figure A.2. SDS-PAGE analysis of E. coli_pET28b-pstI+vapC small scale 
expression trials. White boxes indicate expected band size. Labels: whole cell 
fraction (WC), soluble fraction (S), insoluble fraction (I), flow through (FT), wash 
(W) and nickel beads with protein bound after wash steps (B). 
 
 
 
Figure A.3. SDS-PAGE analysis of E. coli_pPROEX+vapBC49640/50 small scale 
expression trial. White boxes indicate expected band size. Labels: whole cell 
fraction (WC), soluble fraction (S), insoluble fraction (I), flow through (FT), wash 
(W) and nickel beads with protein bound after wash steps (B). 
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Figure A.4. SDS-PAGE analysis of E. coli_pET28b-pstI+vapBC 
(Synechocystis) small scale expression trials. White boxes indicate expected 
band size. Labels: whole cell fraction (WC), soluble fraction (S), insoluble 
fraction (I), flow through (FT), wash (W) and nickel beads with protein bound 
after wash steps (B).  
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